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In the pulmonary circulation voltage-gated K
+ 
(KV) channels control resting 
membrane potential. Their direct contribution to the development of hypoxic 
pulmonary vasoconstriction (HPV), the unique response of the pulmonary artery 
(PA) to hypoxia, however remains controversial. KCNQ channels are thought to 
contribute to the control of PA excitability but their relative contribution 
compared to the KV channels and the role in HPV is unknown. Recent 
electrophysiological evidence suggests tight coupling between KV channels and 
mitochondria, a putative oxygen sensor in PA. No focussed studies to examine 
these questions in intact arteries were performed. Therefore, the main aims were 
to investigate: i) a relative role of KV and KCNQ channels in the regulation of PA 
excitability and contractility, ii) relative sensitivity of these channels to hypoxia, 
iii) a relationship between KV channels and mitochondria and cellular metabolism, 
in the intact PA. Rat mesenteric artery (MA) was used as a representative of 
systemic circulations. Small vessel myography, microelectrode technique, 
confocal imaging and western blot together with selective pharmacological agents 
were employed to address these questions. The main findings are: i) the presence 
of mutual physiological interaction between KV and KCNQ channels in the 
regulation of PA excitability, ii) KV, but not KCNQ, channels are inhibited by 
hypoxia in PA, iii) the existence of specific interactions between mitochondria 
and KV channels which are potentiated and altered in hypoxia in PA, not in MA, 
iv) these interactions may contribute to contractions caused by the KV inhibition 
2+ 2+ 
additionally to the voltage-dependent Ca entry and Rho-kinase dependent Ca
sensitisation, v) contractions are less metabolic dependent in PA than in MA, vi) 
the effects are not species dependent as some were observed in the mouse. These 
findings suggest the presence of specific mitochondrial-dependent mechanisms in 
PA which play role in physiological conditions and in HPV. 
iv
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1.1 Physiological role of pulmonary and systemic blood vessels 
The pulmonary circulation is distinguished from the systemic circulation by the 
fact that the pulmonary circulation handles the same cardiac output but in a very 
different way, enabling reoxygenation of blood at 20% of the vascular resistance 
seen in the systemic vasculature. This is achieved due to the unique characteristics 
of the pulmonary circulation, which is a low pressure and low resistance but high 
flow system. On the contrary, the systemic circulation delivers oxygenated blood 
to tissues at a high pressure and represents a high resistance system. The total 
resistance of the pulmonary circulation is less than one-tenth of that of the 
systemic circulation (Walter, 2003). The mean pressure in the pulmonary 
circulation is approximately 15 mmHg whereas in systemic arteries (e.g., aorta) it 
is approximately 95 mmHg. Similarly, pulse pressure is relatively lower in the 
pulmonary (~17 mmHg) than in the systemic circulation (~40 mmHg). Functional 
differences are supported by differences in vessel morphology. Pulmonary blood 
vessels are generally shorter and wider than their counterparts on the systemic 
side. Although the pulmonary arterioles (small resistance arteries) contain smooth 
muscles and can constrict, these vessels are far less muscular than their systemic 
counterparts, and their resting tone is low. Very small pulmonary arterioles 
(internal diameter <70 µm) do not have smooth muscle cell. The walls of the 
pulmonary vessels are as thin as the walls of veins elsewhere in the body. The 
thinness of vessel walls and paucity of smooth muscle make the pulmonary 
vessels highly compliant (Walter, 2003). The pulmonary vascular bed resembles 
that of the systemic circulation although the wall of larger pulmonary arteries are 
only 30% of the thickness of the aorta, and the small arteries have a smaller 
1

number of smooth muscle cells than their counterparts in the systemic vascular 
bed. These characteristics of the pulmonary circulation are essential for the 
maintenance of circulating O2 levels. When O2 levels are compromised (partial 
pressure of O2 (PO2) below 60 mmHg) in an area of the lungs pulmonary arteries 
respond uniquely by constricting and diverting blood flow to the areas of high 
oxygen availability (ventilation-perfusion matching), a phenomenon known as 
hypoxic pulmonary vasoconstriction (HPV), also historically known as the von 
Euler-Liljestrand mechanism (Dumas et al., 1999;Sommer et al., 2008). In 
addition, the high partial pressure of CO2 (PCO2) and/or low interstitial pH results 
in pulmonary vasoconstriction (Riley, 1951). This phenomenon thereby helps 
optimisation of gas exchange at the blood-air interface (Riley, 1951;Marshall et 
al., 1981;Orchard et al., 1983). Conversely, the systemic circulation responds to 
low PO2, high PCO2 and/or low pH by vasodilation to provide a better O2 supply to 
target organs (Wadsworth, 1994;Dumas et al., 1999). Features of the pulmonary 
vasculature in the rat and mouse are similar to that in humans, thus making these 
rodent species widely accepted models for study of mechanisms of HPV and 
pulmonary related diseases (Hislop & Reid, 1978). 
2

1.2 Morphology of blood vessel and vascular smooth muscle 
Depending on the vessel diameter and function, the pulmonary vasculature is 
composed of four distinct types of blood vessels: i) large extraparenchymal or 
conduit arteries, ii) small intrapulmonary arteries or resistance pulmonary arteries 
that control pulmonary vascular resistance, iii) capillaries and iv) pulmonary veins. 
The resistance pulmonary arteries bear special significance because they are the 
major site of HPV (Kato & Staub, 1966) and are also the focus for most of the 
pathophysiology of pulmonary arterial hypertension (Archer & Rich, 2000). For 
proper understanding of the pathophysiology of vascular diseases, extensive 
knowledge of the complex vessel structure and functional organisation in the 
cardiovascular system is essential (Pugsley & Tabrizchi, 2000). The morphology 
and functions of various vascular beds differ greatly from one to another. Despite 
the variation in different vascular beds, the basic structure of blood vessels is 
similar. 
The vascular wall is composed of three distinct regions or tunicas: tunica intima, 
tunica media and tunica adventitia. There are four building blocks that make up 
these tunicas: collagen fibres, elastic fibres, smooth muscle cells (SMCs) and 
endothelial cells (Fig. 1.1). The major vessels in mammals consist mainly of 
tunica media, primarily composed of SMCs and elastic fibres. There is variation 
in the number of SMC layers, the larger more muscular arteries, such as aorta, 
have many highly organised layers separated by an elastic lamella, whereas less 
muscular arteries have only one SMC layer (Tennant & McGeachie, 1990). 
Highly extensible elastic fibres account for most of the stretch of vessels at 
normal pressure elsewhere in the body, as well as bearing the stretch of 
pulmonary tissues in the pulmonary circulation (Emile, 2003). Vascular SMCs 
2+ 
exert tension mainly by means of active contraction that involves Ca -
calmodulin-dependent myosin light chain phosphorylation. However, relaxed 
vascular SMCs do not contribute to the elastic tension of the vascular wall, a 
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Figure 1.1 Structure of an artery. 
Cross section of the arterial wall shows three distinct layers or tunicas: the 
innermost layer or tunica intima, the muscular middle layer or tunica media 
and the outer collagen layer or tunica adventitia. 
Smaller arterioles (<70 µm diameter) and capillaries do not have a smooth muscle 
layer, rather only one intimal layer of endothelial cells resting on a basal lamina. 
Therefore, the control of blood flow by vasoconstriction and vasodilatation occurs 
in arteries of larger size (>70 µm diameter) (Christensen & Mulvany, 2001;Hester 
& Hammer, 2002). Vascular endothelial cells form a single, continuous layer that 
lines all vascular beds (Emile, 2003). Vascular endothelium acts not only as a 
passive barrier between plasma and extracellular fluid, but also as a source of 
potent mediators which actively control the contraction and relaxation of 
underlying smooth muscle cells (Aird, 2008). 
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1.3 Role of pulmonary artery with special implications to the 
phenomenon of HPV 
The pulmonary arteries carry de-oxygenated mixed venous blood to the lungs. 
After arising from the right ventricle, they bifurcate as they follow the bronchial 
tree, and their divisions ultimately form a richly anastomosing capillary bed that 
supply the alveoli, the site of gaseous exchange. The pulmonary capillaries have 
an average internal diameter of ~ 8 µm, and each segment of the capillary network 
is ~10 µm in length. After gas exchange in the alveoli, the blood is eventually 
collected in the pulmonary veins (Walter, 2003). The typical partial pressure of 
oxygen (Po2) in the alveolar air is 100 mmHg. Oxygen acts primarily on the 
pulmonary arterioles and a low Po2 causes HPV (German & Stanfield, 2005). In 
isolated, buffer-perfused lung, HPV starts within seconds after the onset of mild 
hypoxia (alveolar PO2 <100 mmHg) (Peake et al., 1981;Weissmann et al., 
1995;Weissmann et al., 2006b). Since HPV can also occur in isolated lungs and 
pulmonary arteries, it does not rely on either the nervous system or systemic 
hormones. It is generally believed that the low Po2 acts directly on the pulmonary 
vascular smooth muscle cells (Walter, 2003). Previous studies concluded that the 
smooth muscle layer of the precapillary resistance pulmonary arteries, located at 
the entrance of the acinus in close contact with alveoli, are both censor and 
effector cells of HPV (Kato & Staub, 1966;Staub, 1985;Hillier et al., 1997). Large 
PA, smaller, partially muscularised PA, or postcapillary vessels are significantly 
less responsive to hypoxia, when compared with resistance PA (Dawson et al., 
1978;Madden et al., 1985;Fike & Kaplowitz, 1994). Furthermore, isolated smooth 
muscle cells from resistance pulmonary artery contract in response to hypoxia at a 
PO2 of 25-50 mmHg, whereas smooth muscle cells from isolated cerebral arteries 
dilate, suggesting that SMCs could be the centre of oxygen sensing and therefore 
the main mediator of the HPV response (Murray et al., 1990;Madden et al., 1992). 
Although PA smooth muscle cells are considered as the primary locus of HPV, 
the endothelium plays important facilitatory role for sustained HPV (Ward & 
Aaronson, 1999;Liu et al., 2001b;Aaronson et al., 2002). The pulmonary artery 
endothelium synthesises and metabolises multiple vasoactive mediators that could 
2+
potentially interact with, or augment the intrinsic rise in [Ca ]i in order to 
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promote sustained HPV (Aaronson et al., 2002). Among the endothelium-derived 
vasoactive mediators nitric oxide (NO) and ET-1 are mostly considered to 
influence HPV. It has been suggested that hypoxic-inhibition of basal NO 
synthesis may uncover intrinsic vascular tone and so effectively cause HPV 
(Rodman et al., 1990;Ogawa et al., 1993;Terraz et al., 1999). On the other hand 
ET-1 has a non-specific potentiating effect of on HPV (Ward & Aaronson, 1999). 
How exactly PA constricts in response to hypoxia is mostly unknown. However, 
the hypothesised mechanisms including all those proposed for oxygen sensing in 
hypoxia by the peripheral chemoreceptor and mitochondria, will be further 
elaborated in section 2.7 of this chapter. 
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1.4 Physiology of vascular smooth muscle (VSM) contraction 
Smooth muscle cells (SMCs) are small spindle or fusiform in shape and contain a 
single central nucleus. The cells contain contractile actin (thin) and myosin (thick) 
filaments; however, they are not arranged in the regular, cross-striated patterns 
that are visible in both cardiac and skeletal muscle fibres. As a result, these 
muscle fibres appear smooth or non-striated and uniformly bright under light 
microscope. The myofilaments (actin and myosin) fill most of the cytoplasm. 
There is neither banding nor T tubules, however, SMCs do have a sarcoplasmic 
reticulum (SR) that can sequester and release calcium. Furthermore, myosin in 
SMCs is different from the myosin in striated muscle, and it forms a different type 
of thick filament that permits more overlap with actin and thus a greater degree of 
contraction. Although in SMC the thick and thin filaments are arranged in parallel 
with each other as in skeletal muscle, they tend to run obliquely in various 
directions, resulting in contraction along several axes (German & Stanfield, 2005). 
SMCs are found in internal organs, blood vessels, and other structures that are not 
under voluntary control. In blood vessels SMCs are arranged in a circular pattern 
(Fig. 1.1) and control blood pressure by altering luminal diameters. SMCs are 
involuntary muscles innervated and regulated by nerves from postganglionic 
neurons originating from the sympathetic and parasympathetic divisions of the 
autonomic nervous system. SMCs also make close contact with each other via 
specialised connections called gap junctions, which allow rapid ionic 
communications between muscle cells resulting in coordinated activity of smooth 
muscle sheets or layers (Eroschenko, 2005). 
Irrespective of muscle type (whether it is skeletal, cardiac or smooth), it is an 
2+
increase in the levels of intracellular free calcium concentrations ([Ca ]i) that 
2+
triggers muscle contraction. The time during which [Ca ]i remains elevated 
determines the duration of muscle contraction. The process by which ‘excitation’ 
2+
triggers the increase in [Ca ]i is called ‘excitation-contraction coupling’. In 
2+ 
SMCs, Ca can enter the cytoplasm from the extracellular space through voltage-
2+ 
gated or ligand-gated ion channels, or alternatively, Ca can be released from the 
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SR into the cytoplasm (Fig. 1.2). Thus both extracellular and intracellular sources 
2+
contribute to an increase in [Ca ]i (Mickelson & Louis, 1996). However, in SMCs, 
2+ 
L-type voltage-operated Ca channels (L-VOCCs) are one of the most important 
2+ 2+
routes for Ca entry (Rang H.P. et al., 2007). During excitation, [Ca ]i may rise 
from its resting level of less than 100 nM to a level greater than 10 µM , thus 
2+ 
resulting a huge gradient, which serves as a driving force for Ca influx 
(Himpens et al., 1992;Orallo, 1996). 
2+
In SMCs, an increased level of [Ca ]i activates the crossbridge cycle (i.e., binding 
of myosin with actin) and force generation by a cascade of intracellular signals. 
2+ 
Contractions in smooth muscle are triggered when Ca binds reversibly to 
calmodulin (CaM). This binding triggers a conformational change that enables the 
2+
Ca -CaM complex to bind to and activate an enzyme called myosin light chain 
kinase (MLCK). The activated MLKC then catalyzes the phosphorylation of 20 
kDa myosin light chain (MLC20) at ser19 (Kamm & Stull, 2001;Somlyo & 
P
Somlyo, 2003). The phosphorylated MLC20 ( MLC20) then activates and initiates 
crossbridge activity (Fig. 1.2). Crossbridge cycling then proceeds resulting in 
2+
smooth muscle contraction as long as the [Ca ]i level is enough to keep triggering 
the crossbridge cycling (German & Stanfield, 2005). The subsequent decrease in 
2+
[Ca ]i is the signal to cease crossbridge cycling (Mickelson & Louis, 1996). 
During the crossbridge cycle, contractile proteins convert the energy of ATP 
hydrolysis into mechanical energy. Because ATP stores are small, the cell must 
regenerate the ATP needed for muscle contraction (Mickelson & Louis, 1996). 
Termination of crossbridge cycling in smooth muscle requires more than just 
2+ 
removal of Ca from the cytosol, because the phosphate group attached to myosin 
is covalently bound and therefore does not dissociate easily. For this reason, 
termination of the crossbridge cycle in smooth muscle requires the action of 
myosin light chain phosphatase (MLCP), an enzyme which by removing the 
phosphate group inactivates myosin (Fig. 1.2). MLCP is constantly active and 
competes with MLCK by dephosphorylating 
p
MLC20, thus activation (and 
2+ 
phosphorylation) of MLC20 occurs only when enough Ca is present to activate 




The basic mechanism regulating VSM contractility is broadly determined by 
2+
factors which increase [Ca ]i causing VSM contraction, and by factors which 
2+
decrease [Ca ]i causing VSM relaxation. The mechanism responsible for 
2+
increasing and decreasing in [Ca ] in VSMCs will be discussed in the following 
section in more details. 
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1.5 General mechanisms regulating vascular smooth muscle (VSM) 
contractility 
Since the main function of arteries is to regulate blood flow by changing vessel 
diameter, the identification and understanding of mechanisms that regulate VSM 
contractility is important. The contractility of smooth muscle is primarily reliant 
2+ 2+
upon the levels of [Ca ]i. However, vascular tone depends not only on [Ca ]i but 
2+ 
also on Ca sensitisation of contractile apparatus (Somlyo & Somlyo, 1994). 
2+ 
Ca sensitisation is a phenomenon whereby a greater contraction is produced for 
2+
a given concentration of [Ca ]i with several receptor-mediated contractile 
2+ 
stimulations (Somlyo & Somlyo, 1994). It is thought that Ca sensitisation is an 
important regulator of pulmonary contractility and plays a key role in HPV 
(Robertson et al., 1995;Robertson et al., 2000a;Nagaoka et al., 2004;Aaronson et 
al., 2006;Oka et al., 2008;McNamara et al., 2008). 
2+
1.5.1 Mechanisms increasing [Ca ]i 
2+
Two main processes are responsible for elevation of [Ca ]i. The mechanism of 
2+ 
activation of Ca influx by changes in membrane potential is known as 
excitation-contraction coupling (E-C coupling) (Bauer & Sanders, 1985;Orallo, 
2+ 
1996). Ca can also be increased as a result of activation of receptors by 
neurotransmitters or hormones, which is known as pharmacomechanical coupling 
(Somlyo & Somlyo, 1968;Orallo, 1996). The main mechanisms contributing to 
the E-C coupling and pharmacomechanical coupling are schematically shown in 
Figure 1.2. These mechanisms can be broadly divided into two groups: a) 
2+ 
mechanisms that depend on extracellular Ca entry and b) mechanisms that 
2+ 
depend on the intracellular Ca release. The first group of mechanisms include: 
2+ 
1) voltage-dependent Ca entry via L-type voltage operated calcium channels (L-
2+ 
VOCCs); 2) voltage-independent Ca entry via ligand-gated (or receptor-
2+
operated) Ca -permeable channels (ROCCs); and 3) store-operated calcium 
channels (SOCCs) activated by depletion of the sarcoplasmic reticulum (SR). 
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Figure 1.2 Schematic diagram showing mechanisms controlling vascular 
smooth muscle contraction. 
SOCC- store operated calcium channel, A- agonist, G- G protein coupled 
receptor, ROCC- receptor operated calcium channel, K
+
- potassium channel, 
NSCC- non-selective cation channel, ClCa - calcium-activated chloride 
channel, VOCC- voltage operated calcium channel, PLC- phoshpholipase C, 
IP3- inositol triphosphate, IP3R- IP3 receptor, SR- sarcoplasmic reticulum, 
Mito- mitochondria, CaM- calmodulin, MLCK- myosin light chain kinase, 
MLC20 - 20 kDa regulatory myosin light chain, 
p
MLC20 - phosphorylated 20 
kDa regulatory myosin light chain, MYPT1- myosin phosphatase targeting 
subunit 1, 
p
MYPT1 - phosphorylated myosin phosphatase targeting subunit 1, 
CPI-17 – PKC-potentiated phosphatase inhibitor protein-17 kDa, 
p
CPI-17 – 




Two main intracellular Ca sources, which are known to contribute to elevation 
2+ 2+ 
of [Ca ]i, are: 1) Ca release from intracellular stores in response to excitatory 
agonists and corresponding activation of G-protein coupled receptors; 2) 
2+ 
mitochondrial Ca release. Recent evidence also suggests that other cellular 
2+ 
organelles such as lysosomes may also release Ca during hypoxia, thus 
contributing to the HPV responses (Kinnear et al., 2008;Calcraft et al., 2009). 
The above mentioned mechanisms are closely interdependent. Thus, voltage-
2+ 
dependent Ca entry will be determined by membrane depolarisation caused 
predominantly by inhibition of K
+ 
channels; however, activation of Cl 
¯ 
channels, 
and/or non-selective cation channels, including ROCCs and SOCCs, can also 
contribute to membrane depolarisation. 
In the vasculature, K
+ 
channels play a fundamental role in excitability by 
maintaining the membrane potential, a salient regulator of vascular tone (Archer 
& Michelakis, 2002). Ubiquitously expressed K
+ 
channels in VSMCs include: 
voltage-gated K
+ 







channels (KATP) and inward rectifier K
+ 
channels (Kir) 
(Moudgil et al., 2006;Ko et al., 2008). Recent evidence clearly demonstrates the 
presence of another group of voltage-dependent K
+ 
channels in VSMCs which 
belong to the KV7 subfamily encoded by KCNQ genes, and commonly known as 
KCNQ channels (Yeung & Greenwood, 2005;Joshi et al., 2006;Brueggemann et 
al., 2007;Yeung et al., 2008;Joshi et al., 2009). Furthermore, two-pore domain 
acid-sensitive K
+ 
channels such as TASK, were also found in VSMCs (Gurney et 
al., 2003;Gardener et al., 2004;Olschewski et al., 2006). KV, KCNQ and BKCa 
channels are activated by depolarisation of cell membrane. In addition, BKCa 
2+ 
channels are also activated by elevated intracellular free Ca , while KATP 
2+
channels are activated by Mg ADP and inhibited by a rise in intracellular ATP 
level. Membrane hyperpolarisation will deactivate or close-down voltage-gated 
K
+ 
channels such as KV, KCNQ and BKCa, but will activate Kir channels (Brayden, 
1996;Clapp & Tinker, 1998). Inhibition of any type of K
+ 
channel will result in 
2+ 
membrane depolarisation resulting in an increase in Ca influx through L-
VOCCs and leading to VSM contraction (Weir & Archer, 1995;Nelson & Quayle, 
1995;Takuwa, 1996;Sweeney & Yuan, 2000). 
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The resting membrane potential measured in intact blood vessels is typically 
between -60 and -50 mV (Berger et al., 1998). As the voltage-dependence of 
activation of L-VOCCs is very steep in this voltage range (Brayden & Nelson, 
1992), small decreases in the membrane potential could be sufficient to activate 
L-VOCCs, leading to VSM contraction. In different vascular beds this apparent 
threshold for the L-VOCC activation will be determined by the density of L-
VOCCs and the type and the density of K
+ 
channels expressed in SMCs. In 
pulmonary artery SMCs, for example, the current density of KV channels (defined 
as the peak current amplitude divided by the cell size determined in pF) is ~10-
fold higher than in mesenteric arterial SMCs (Firth et al., 2009a). 
Also, agonists causing VSMC contraction may directly activate non-selective 
cation channels (NSCCs), and thereby result in membrane depolarisation and an 
increase in [Ca
2+





channels by elevated [Ca ]i can also contribute to membrane depolarisation and 
thus to VSM contraction (Criddle et al., 1997;Saleh & Greenwood, 2005). 
TRP (Transient Receptor Potential) channels: 
It is generally accepted that TRP channels are responsible for the voltage-
2+
independent Ca -entry in VSMCs and represent molecular correlates for ROCCs 
and SOCCs. The TRP gene superfamily consists of 7 subfamilies with at least 28 
mammalian homologues. The TRP gene superfamily is known to encode a wide 
variety of cation channels with diverse biophysical properties, activation 
mechanisms and physiological functions (Yang et al., 2010b). Unlike voltage-
gated ion channels, TRP subunits do not possess a voltage-sensing moiety, 
making them voltage-independent (Owsianik et al., 2006). SOCCs in SMCs are 
2+ 
not highly selective for Ca and are considered to be non-selective cation 
channels. Single channel currents through SOCCs have been recorded in cells 
2+ 
isolated from rat and mouse aorta and showed little selectivity for Ca over 
monovalent cations such as Na
+ 
(Trepakova et al., 2000). TRP subunits are 
divided into several subfamilies according to their activation stimuli and the 
presence of regulatory domains on the cytosolic C-and N-termini. The subfamilies 
13

of TRP channels include canonical (TRPC), melastatin-related (TRPM), vaniloid 
receptor-related (TRPV), polycystins (TRPP), mucolipidins (TRPML), 
mechanoreceptor potential C (TRPN), and ankyrins (TRPA). TRPC is activated 
by G-protein coupled receptors, while a range of chemical and physical stimuli 
including capsaisin, lipids, acid, heat, shear stress and hypo-osmolarity can 
activate TRPV (Pedersen et al., 2005;Inoue et al., 2006). TRPM are activated in 
2+
response to increased [Ca ]i, oxidative stress, or exposure to cold (Pedersen et al., 
2005). Less distinctly related subfamilies such as TRPP, TRPML, TRPN and 
TRPA are associated with specific genetic disorder (Pedersen et al., 2005). 
Recent studies suggest that TRP channels (TRPC, TRPV and TRPM) play crucial 
roles in the regulation of vascular tone, hypoxic pulmonary vasoconstriction, 
smooth muscle cell proliferation, vascular remodelling, and pulmonary arterial 
hypertension (Firth et al., 2007;Yang et al., 2010b). Evidence accumulated over 
the past decade suggests that members of the canonical subgroup of TRP channels 
constitute tetramers of both ROCCs and SOCCs (Parekh & Putney, Jr., 
2005;Albert et al., 2007). Studies suggest that TRPC 1, 4 and 5 isoforms are 
sensitive to store depletion and could function as SOCCs, whereas TRPC 3, 6 and 
7 isoforms function as ROCCs (Pedersen et al., 2005). 
More than 10 TRP isoforms including TRPC, TRPV and TRPM have been 
detected in various vascular preparations [reviewed in (Firth et al., 2007)] 
including pulmonary and mesenteric artery smooth muscle cells (Walker et al., 
2001;Ng & Gurney, 2001;Wang et al., 2004;Lu et al., 2008;McElroy et al., 2008). 
ROCCs are probably NSCCs with some degree of selectivity for divalent cations 
2+ 
such as Ca (Orallo, 1996). ROCCs could be activated by agonists including ATP, 
norepinephrine, ET and serotonin (Orallo, 1996;Nilsson et al., 1998) and can also 
2+ 
cause membrane depolarisation leading to L-VOCCs activation and Ca influx. 
Several studies have presented evidence for TRPC1 being an essential component 
for SOCCs in VSMCs, including aorta (Xu & Beech, 2001;Brueggemann et al., 
2006), cerebral artery (Bergdahl et al., 2005), mesenteric artery (Saleh et al., 
2006), portal vein (Saleh et al., 2008), coronary artery (Takahashi et al., 
2007;Saleh et al., 2008), as well as PASMCs (Sweeney et al., 2002). TRPC 1 and 
6 isoforms have been found to be responsible for agonist- and acute hypoxia-
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induced vasoconstriction of pulmonary arteries (Lin et al., 2004;Weissmann et al., 
2006a) as well as mesenteric arteries (Saleh et al., 2006). On the other hand, 
expression of TRPC channels can also cause vasoconstriction via SOCC-mediated 
mechanisms in a wide range of vasculatures including pulmonary (McDaniel et al., 
2001;Ng & Gurney, 2001;Kunichika et al., 2004) as well as systemic arteries (Lee 
et al., 2002;Reading et al., 2005). As mediators of influx of positively charged 
cations, SOCCs may also contribute to cell depolarisation and activation of L-
2+ 
VOCCs. In comparison to ROCCs, SOCCs are highly selective for Ca over 
other cations (Hoth & Penner, 1992). 
G-protein coupled receptors and SR: 
2+ 
A special class of intracellular ligand-gated Ca channels (also called calcium-
2+ 
release channels, IP3 and ryanodine receptors) control the release of Ca from 
2+ 
intracellular Ca stores. IP3 receptors are present on the SR in VSMCs. The 
2+ 
predominant mechanism by which the SR can be stimulated to release Ca is by 
IP3 acting upon IP3 receptors. IP3 is increased after agonist receptor activation 
causing phospholipase C (PLC) induced hydrolysis of phosphotidylinositol 
bisphosphate (PIP2) to yield IP3 and DAG (Tasker et al., 1999). An increase in 
2+ 2+ 
[Ca ]i resulting from total agonist action or Ca entry via ROCCs and VOCCs 
2+ 2+ 
can induce further Ca release from the SR via interaction of Ca with ryanodine 
2+ 
receptors (RyRs), a phenomenon known as calcium induced Ca release (CICR) 
2+ 2+ 
(Lesh et al., 1998). Ca depletion of intracellular Ca stores triggers the SOCCs 
2+ 
in the plasma membrane to open and allow Ca entry. The exact mechanism by 
which SOCCs are activated is not completely understood (Barritt, 1999), however 
the role of Orai and STIM1 (stromal interaction molecule 1) proteins which can 
interact with certain types of TRPC have been implicated (Shuttleworth, 2009). 
2+
STIM1, a 90-kDa transmembrane Ca -binding protein, is constitutively resident 
in the sarco(endo)plasmic reticulum and plasma membrane, and the pore of these 
channels is comprised of both Orai1 and Orai3 subunits (Shuttleworth, 2009). 
STIM1 is thought to play a pivotal role in activation of SOCCs and store operated 
2+ 
Ca entry (SOCE) (Bakhramov et al., 1998;Minke, 2006;Lewis, 2007;Putney, Jr., 
2+
2007). It is well documented that [Ca ]i responses to hypoxia in distal PASMCs 




2005) require Ca -entry through SOCCs. A recent study confirms the importance 
of SOCE in HPV and also provides further evidence that HPV is greater in distal 
(resistance) than proximal (conduit) PA because greater number and activation of 
2+




) channels, abundantly distributed in the VSMCs, also play an 
important role in regulating VSM excitation and contraction (Kitamura & 
Yamazaki, 2001). Out of the five major categories of Cl 
-
channels only two types 
are associated with calcium signalling: (i) Cl 
-
channels that are activated by an 
increase in [Ca
2+




channels (ClCa) and (ii) 
Cl 
-
channels that are activated by change in cell volume, called swelling-activated 
or volume-sensitive Cl 
-
channels (ClV) (Frings et al., 2000;Hartzell et al., 
2005;Leblanc et al., 2005). The expression of ClCa have been found in both 
vascular and non-vascular smooth muscles, where they play an important role in 
the regulation of smooth muscle tone (Large & Wang, 1996;Leblanc et al., 2005). 
Their molecular identity has however been elusive (Nilius & Droogmans, 
2003;Hartzell et al., 2009). Several molecular candidates have been proposed for 
vascular ClCa channels including members of the CLCA and bestrophin gene 
families. CLCA1 was found to be expressed in mouse portal vein (Britton et al., 
2002) and CLCA4 in many VSMCs including aorta and coronary vessels (Elble et 
al., 2002). Most recently, Manoury et al. (2010) provided evidence that 
TMEM16A (or anoctamin 1), a member of the transmembrane 16 (TMEM16) 
protein family, forms ClCa channels in PASMCs (Manoury et al., 2010). ClCa 
channels play important roles in several cellular functions. They are of key 
2+
importance in VSMCs where they are activated by a rise in the level of [Ca ]i 
(e.g., in response to contractile agonist). Activation of ClCa channels leads to 
membrane depolarisation and thus contributes to contractile responses to 
constrictor hormones and neurotransmitters in vascular beds (Large & Wang, 
1996;Kitamura & Yamazaki, 2001;Leblanc et al., 2005). In smooth muscle cells, 
especially in vascular myocytes, the activation of ClCa is believed to be an 
excitatory depolarising mechanism which will lead to membrane depolarisation 





actively transported and actively accumulated within the cell by several classes of 
anion transporters (Chipperfield & Harper, 2000;Forrest et al., 2010), yielding a 




]i) levels ranging between 30 and 60 mM (Large 
& Wang, 1996;Chipperfield & Harper, 2000;Leblanc et al., 2005) resulting in a 
reversal potential for Cl 
-
between -20 and -30 mV in VSMCs. As this is more 
positive than the resting potential ( -60 to -50 mV) the net Cl 
-
efflux from the cell 
through ClCa will lead to membrane depolarisation, which (~ -20 mV) in turn 
2+ 
increases the open probability of L-VOCCs favouring Ca entry into the cell and 
2+ 
vasoconstriction (Large & Wang, 1996;Leblanc et al., 2005). Apart from Ca -
induced activation, reactive oxygen species (ROS) can also activate ClCa 
(Greenwood et al., 1997;Greenwood et al., 2002). In pulmonary arteries, the 
occurrence of this process could contribute to membrane depolarisation. 
The Turner and Kozlowski group in Oxford first reported the existence of ClCa in 
PASMCs (Salter et al., 1995). Studies using rat PASMCs suggest a relationship 
2+
between [Ca ]i and ClCa channels under hypoxic conditions. Hypoxia increases 
2+ 2+
[Ca ]i leading to opening of ClCa channels, and further increases in [Ca ]i. Under 
chronic hypoxic conditions, ClCa may play an important role in hypoxic 
pulmonary hypertension and may take part in the regulation of proliferation of 
PASMCs (Yang et al., 2006). The ClV channels, being activated by vascular 
distension caused, for example, by a rise in blood pressure in systemic arteries and 
veins could also lead to membrane depolarisation and subsequent opening of L-
VOCCs resulting in VSM contraction (Yamazaki et al., 1998;Kitamura & 
Yamazaki, 2001). A recent study also suggests that the inhibition of ClV may 




Accumulation of Ca by isolated mitochondria was first discovered in the 1950s 
2+ 
(Slater & Cleland , 1953) and in the early seventies it was elucidated that Ca
accumulation in the mitochondria occurs due to their highly negative (inside) 
membrane potential (∆ψm) (Scarpa & Azzone, 1970;Rottenberg & Scarpa, 1974). 




modulators of [Ca ]i, having a capacity to effectively uptake, store and buffer 
2+ 
sub-plasmalemmal Ca (Malli et al., 2003;Parekh, 2003;Szabadkai et al., 
2006;Szabadkai & Duchen, 2008). It is therefore suggested that mitochondria are 
2+ 2+ 
capable of regulating all components of Ca signalling machinery including Ca
2+ 2+ 2+ 
release via IP3 and RyR, Ca influx via SOCCs, Ca uptake and Ca extrusion 
2+ 2+ 
via the mitochondrial Na-Ca exchangers (NCX) to contribute to ER Ca
refilling (Malli et al., 2003;Szabadkai & Duchen, 2008;Walsh et al., 2009). 
2+ 
Experiments conducted in PASMCs have also shown that Ca release from SR, 
2+ 
via RyRs or IP3 mediated mechanisms, increases mitochondrial Ca levels 
(Drummond & Tuft, 1999). However, it is currently not fully understood to what 
2+ 
extent mitochondria are involved in ER filling and Ca homeostasis in the 
pulmonary and mesenteric circulation, although it is generally considered to be 
2+ 
important in the regulation of Ca homeostasis (Ward et al., 2004b). It is also 
2+ 
possible that mitochondrial regulation of Ca may have an important role in HPV 
2+ 
as hypoxia has indeed been shown to inhibit mitochondrial uptake of Ca (Kang 
et al., 2002) and to activate NADPH oxidase to increase intracellular reactive 
2+
oxygen species (ROS) and [Ca ]i through the mitochondrial ROS-PKCɛ 
signalling axis in PASMCs (Rathore et al., 2008). Mitochondria also contribute to 
KV channel mediated cellular excitability in PASMCs (Firth et al., 2009a). 
2+
1.5.2 Mechanisms decreasing [Ca ]i 
2+
Mechanisms which will directly or indirectly decrease [Ca ]i can be broadly 
subdivided into two groups: a) membrane-dependent mechanisms such as i) 
inhibition or closure of L-VOCCs via activation of K
+ 
channels, ii) activation of 
2+ 
exchangers, e.g., sodium-calcium exchanger (NCX), iii) activation of Ca -
2+ 
ATPase in the plasma membrane; and b) Ca sequestration mechanisms such as 
2+ 2+ 
i) Ca sequestration by sarco(endo)plasmic reticulum Ca ATPase (SERCA), ii) 
2+
increase in cAMP and cGMP, iii) cytosolic Ca -binding proteins (Juhaszova et 
al., 1996;Barritt, 1999). 
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The activation of K
+ 
channels either by voltage (KV, KCNQ, BKCa) or by an 
2+
increase in [Ca ]i (BKCa) will lead to membrane hyperpolarisation, and result in 
closure of L-VOCCs, leading to vasodilatation (Nelson & Quayle, 1995;Takuwa, 
1996). Thus the K
+ 
channels limit smooth muscle contraction. 




ATPase, also affects membrane potential depending on ion gradients. Activation 
of the NCX working in the reverse mode, i.e. extruding excess of Na
+ 
may 
hyperpolarise the cell membrane, although its physiological role in VSMCs has 
been questioned (Bolton, 1979;Juhaszova et al., 1996). However, inhibition of 
NCX during hypoxia in pulmonary arteries may contribute to the HPV response 
(Wang et al., 2000). 
The SR is the major store of intracellular calcium and its effective permeability is 
determined by the relative rate of influx and efflux mechanisms. The SERCA 
2+ 
serves to sequester Ca by removing it from the cytoplasm and refilling the 
2+ 2+
internal Ca stores (Orallo, 1996;Treiman et al., 1998). The levels of [Ca ]i at 
2+ 
each moment of time are reflective of the filling state of the internal Ca stores 
(Rueda et al., 2002). Thus SERCA is responsible for vasorelaxation. It has been 
2+ 
suggested that an active SERCA pump is essential to obtain optimal Ca release 
2+
in SMCs (Gomez-Viquez et al., 2003). Plasma membrane Ca -ATPase (PMCA) 
2+ 2+ 
pumps reduce [Ca ]i by Ca efflux utilising energy derived from ATP hydrolysis 
(Gonzalez et al., 1996). 
Cyclic nucleotides such as adenosine 3´,5´-monophosphate (cAMP) and cyclic 
guanosine 3´,5´-monophosphate (cGMP) also play significant roles in lowering 
2+
[Ca ]i in the VSMCs. When the inhibitory agonists (e.g., adenosine, β-agonists) 
bind to G-protein coupled receptors (GPCR), this leads to activation of K
+ 
2+ 
channels and inhibition of Ca channels and regulates the formation of cAMP 
and cGMP (Barritt, 1999). An increase in cytosolic levels of cAMP (by β-
adrenergic agonists, PGI2 or adenosine) or cGMP (by NO from endothelial cells) 
2+ 2+ 
mediates vasodilatation through reduction of both [Ca ]i and Ca sensitivity in 
VSMCs (Polson & Strada, 1996;Vaandrager & de Jonge, 1996). Increased levels 
2+




(PKA), including inhibition of PLC and Ca channels (Minami et al., 
2+ 
1993b;Takuwa, 1996). The increase in cAMP also reduces myofilament Ca
sensitivity, presumably by phosphorylation of MLCK and thereby decreasing its 
2+
affinity for Ca -calmodulin complex (Takuwa, 1996). Similarly, the increase in 
cGMP levels leads to the activation of protein kinase G (PKG), which in turn 
2+
reduces [Ca ]i through activation of SERCA, PMCA and NCX, inhibition of 
IP3R/IP3 synthesis, activation of K
+ 
channels and inhibition of L-VOCCs 
2+ 
(Vaandrager & de Jonge, 1996). PKG also reduces myofilament Ca sensitivity 
possibly by upregulating MLCP (Vaandrager & de Jonge, 1996;Somlyo & 
Somlyo, 2000). 
2+
Moreover, the myoplasma of the SMCs contains many Ca -binding proteins such 
as calmodulin, troponin C, saponin, calbindin, calretinin, parvalbumin and the 
2+ 
annexin family that may provide a mechanism for the rapid binding of Ca and 
2+
thereby reducing [Ca ]i (Heizmann, 1992;Horowitz et al., 1996;Niki et al., 1996). 
2+ 
Following entry into the SR, Ca binds to several hydrophilic proteins, such as 
2+ 
calreticulin or calsequestrin that are capable of binding large amounts of Ca
(Marin et al., 1999). 
2+ 
1.5.3 Mechanisms regulating Ca sensitisation 
2+ 
The ‘Ca sensitisation of the contractile apparatus’ can be modulated by either 
MLC20 phosphorylation-dependent or voltage-independent mechanisms. The 
MLC20 phosphorylation dependent mechanism involves two main kinases such as 
RhoA/Rho-kinase and PKC (Somlyo & Somlyo, 2000;Hirano, 2007). 
The catalytic enzyme MLCP consists of three subunits: a catalytic subunit 
(PP1Cδ; ~37 kDa), a large 110-130 kDa regulatory subunit termed myosin 
phosphatase target subunit (MYPT1) and a 20 kDa subunit of unknown function 
(Hartshorne, 1998;Ito et al., 2004). A small monomeric G-protein called RhoA 





MYPT1) inhibits MLCP’s catalytic activity, increasing MLC20 phosphorylation 
and thereby VSM contraction (Feng et al., 1999). Moreover, Rho-kinase as well 
as PKC may phosphorylate and activate CPI-17, a PKC-potentiated phosphatase 
inhibitor protein-17 kDa, leading to the inhibition of PP1Cδ, and thereby 
inhibiting MLCP (Li et al., 1998;Koyama et al., 2000). 
Additional mechanisms of increased contractility exist in VSMCs. The MLC20 
phosphorylation-independent mechanism depends on the regulation of cross-
bridges by thin filament associated proteins, such as caldesmon and calponin 
(Morgan & Gangopadhyay, 2001). Phosphorylation of caldesmon and calponin 
leads to enhanced cross-bridge cycling and thus to an enhanced contractile 
response without an increase in MLC20 phosphorylation (Winder et al., 1998). 
The importance of this mechanism in pulmonary function is yet not known. 
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1.6 Potassium channels in vascular smooth muscle cells 
K
+ 
channels are the key regulators of cellular excitability and contractility of 
VSMCs. As discussed above, activation of K
+ 
channels results in membrane 
hyperpolarisation and vasodilatation, whereas inhibition of K
+ 
channels will lead 
to membrane depolarisation and vasoconstriction (Yuan, 1995;Nelson & Quayle, 
1995;Ko et al., 2008). In the vasculature, including the pulmonary circulation, 
several functionally distinct types of K
+ 
channel have been identified. These 
include: KV, KCNQ, BKCa, KATP, Kir and K2P (Standen & Quayle, 1998;Moudgil 
et al., 2005;Ko et al., 2008). 
1.6.1 Structure and biophysical properties of potassium channels 
The majority of K
+ 
channels are composed of pore-forming primary α-subunits 
and regulatory β-subunits (Patel & Honoré, 2001). All KV channels are 
homotetramers (all four α-subunits are identical), but they may also form 
heterotetramers from two or more distinct types of α-subunits within the same 
family. Formation of heterotetramers is often responsible for altering the 
biophysical properties from those of any of the homotetramers (Russell et al., 
1994;Ottschytsch et al., 2002). The membrane topologies of the primary α-subunit 
of K
+ 
channels expressed in vascular smooth muscle cells are depicted in 
Figure1.3. 
Apart from the functional properties, based solely on the structural properties of 
α-subunits (e.g. transmembrane domain and pore formation), K
+ 
channels can be 
divided into three main families: 
6TM-1P family of K
+ 
channels: This family comprises the voltage-gated KV 
2+
subfamilies, the KCNQ subfamily, the EAG subfamily, the Ca -activated Slo 
2+
subfamily (e.g. BKCa) and the Ca -activated SK subfamily (SKCa). The pore-
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forming α-subunits form tetramers, and heteromeric channels may be formed 
within subfamilies (e.g. KV1.1 with KV1.2) (Wei et al., 2005). 
+
Figure 1.3 Putative topology of K channel α-subunits in vascular smooth 
muscle cells (a planar view). 
A and B, α-subunits of KV and BKCa channels, respectively; C, Kir subunit of 
KATP channels and D, K2P channels. The pore forming loops are defined as P-
Loops in A-C and P1 and P2 in D. The transmembrane (TM) domains are 
indicated in each subunit. TM, transmembrane; P, pore. 
4TM-2P family of K
+ 
channels: The primary pore-forming α-subunit contains 
two pore domains, hence termed two pore domain K
+ 
channel (K2P). They form 
functional dimers rather than the usual K
+ 
channel tetramers. These channels are 
open at all voltages and are thought to underlie many leak currents in native cells 
(Goldstein et al., 2005). 
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channels of this family (known as inward-
rectifier K
+ 





channels (Kir3.x) and the ATP-sensitive K
+ 
channels (Kir6.x) which combine with sulphonylurea receptors. The pore-forming 
α-subunits form tetramers and heteromeric channels may be formed within Kir 
subfamilies (e.g. Kir3.2 with Kir3.3) (Wei et al., 2005;Goldstein et al., 2005). 
Regulatory β-subunits: The regulatory β-subunits modulate the biosynthesis, 
expression and gating of α-subunits (Patel & Honoré, 2001). The β-subunits are 
important for association with KV types (KV1 and KV2) and BKCa channels. Three 
main regulatory KVβ-subunits (KVβ1- β3) have been identified (Pongs et al., 
1999). When associated with KV α-subunits, KVβ subunits interact with the amino 
terminus of α-subunits; and thus four β-subunits interact with four α-subunits to 
form a functional channel (Gulbis et al., 1999;Gulbis et al., 2000). 
Silent sub-units: There are other types of subunits called ‘silent’ or ‘modifier’ 
subunits for their inability to produce K
+ 
channel currents. Four KV families (KV5, 
KV6, KV8 and KV9) encode subunits that act as silent or modifier subunits (Salinas 
et al., 1997b). Kv9.3 belongs to this novel sub-family of electrically silent 
voltage-gated K
+ 
channels and is the first to be identified in vascular smooth 
muscle (Patel et al., 1997). Although the silent subunits do not express a K
+ 
channel current by themselves, but induce profound changes in the properties of 
the KV2 subfamilies by forming heterotetramers (Hugnot et al., 1996;Post et al., 




Structural features and gating of different K channels: 
KV channels: Among the functionally distinct five types of K
+ 
channels, KV 
channels are the predominant group of K
+ 
channels expressed in pulmonary 
vasculature (Yuan, 1995;Ko et al., 2008). KV channels comprise the largest family, 
subdivided into 12 subfamilies (Table 1.1) (Goldstein et al., 2005). Structurally, 
KV channels are homo or hetero tetramers composed of four pour forming α-
subunits, each comprising of six transmembrane spanning domains (TM1-TM6 or 
S1-S6) with a pore forming region called ‘P-Loop’ between the TM5 and TM6 
(Wray, 2009). Thus symmetrically arranged four α-subunits of K
+ 
channel form a 
central pore which is highly selective for the transportation of K
+ 
ions across the 
cell membrane (MacKinnon et al., 1990). The segment S4 or TM4 domain of the 
voltage-gated K
+ 
channels contains four positively charged arginine residues that 
are essential for depolarisation-dependent opening of the channel. The S4 segment 
is therefore called the voltage-sensing segment (Aggarwal & MacKinnon, 
1996;Jiang et al., 2003). 
Upon activation, the positively charged S4 segment moves outwards, leading to 
conformational changes in the α-subunits and opening of K
+ 
channels, and the 
negatively charged S2 and S3 segments are also involved in this process (Wray, 
2009). Membrane depolarisation may also lead to conformational changes of the 
cytoplasmic C- and N-domains of KV channels altering voltage-sensitivity of 
some KV channels (Kobrinsky et al., 2006). KVβ subunits interact with the amino 
terminus of the α-subunits to form a functional KV channel (Gulbis et al., 
1999;Gulbis et al., 2000). Thus heteromultimeric association of different β-











KV1.x KV1.1-KV1.8 KVβ1, KVβ2 TEA potent (KV1.1), 0.3 mM 
TEA potent (KV1.2), 560 nM 
TEA moderate (KV1.3, 1.6), 10 mM 
4-AP potent (KV1.5), 270 µM 
α-dendrotoxin (KV1.1, 1.2, 1.6), 20 nM 
Margatoxin (KV1.1, 1.2, 1.3), 2 nM 
Charybdotoxin (KV1.2), 14 nM 
Correolide (KV1.x), 90 nM 




TEA moderate, 2.6 mM 
4-AP poor (KV2.1), 18 mM 
4-AP moderate (KV2.2), 1.5 mM 
KV3.x KV3.1-KV3.4 MiRP2 
(KV3.4) 
TEA potent (KV3.1, 3.2), 100-200 µM 
4-AP potent (KV3.1, 3.2), 30-100 µM 
BDS-1 (KV3.4), 47 nM 








TEA (KV7.2), 0.16-0.50 mM 
TEA (KV7.4), 3 mM 
XE991 (KV7.1, 7.2), 0.7-0.8 µM 
XE991 (KV7.4), 5 µM 













E-4031 (KV11.1), 7.7 nM 
Astemizole (KV11.1), 1 nM 
Terfenadine (KV11.1), 56 nM 
1




Table 1.2 Subfamilies of KCa channels and their inhibitors




KCa1.1 (Slo, BK), 
KCa4.1-4.2 (Slack), 
KCa5.1 (Slick) 
TEA (200 nM) 
Charybdotoxin (<10 nM) 










Modified from Alexander et al., 2009 
BKCa channels: They also form tetramers consisting of 4 α and 4 β subunits. The 
α-subunit has extracellular N- and intracellular C-termini (Wallner et al., 1996). 
Due to an additional TM domain (TM0) the N-terminus of α-subunit of this 
channel lies extracellularly (Fig. 1.3 B). The α-subunit is the pore forming 
component of the channel and is composed of 11 hydrophobic domains, including 
7 membrane spanning (TM0-TM6) domains known as the ‘core’ region and 4 
cytosolic (S7-S10) domains known as the ‘tail’ region (Korovkina & England, 
2002a). This channel is regulated by the β-subunit which comprises of two 
membrane spanning domains separated by an extracellular loop. Similar to KV 
channels, in the α-subunit there is a pore forming region or P-Loop between TM5 
and TM6 and the TM4 contains positively charged amino acid residues that 
confers voltage sensitivity of the channel (Korovkina & England, 2002a). 
KATP channels: are octameric complexes of two different proteins of distinct 
function; four pore-forming Kir channel subunits (Kir 6.1 or 6.2) (Fig.1.3 C) 
surrounded by four sulphonyl urea receptors (SURs) (Aguilar-Bryan & Bryan, 
1999). SURs are ATP binding cassette proteins that bind to the pore-forming Kir 





whereas SUR subunits regulate channel activity depending on cellular ATP 
levels (Burke et al., 2008). Binding of ATP to Kir subunits results in 
conformational changes and thus channel closure (Tucker et al., 1997) whereas 
interaction of phospholipids with Kir activates KATP channels and thus relieves 
ATP inhibition (Shyng & Nichols, 1998). 
K2P channels: K2P or two pore domain K
+ 
channels have four TM segments 
(TM1-TM4) and two pore forming domains (P1 and P2). The α-subunit has a 
short cytoplasmic N-terminal and a long cytoplasmic C-terminal. In addition, an 
extracellular loop exists between the TM1 and P1 regions (Lesage & Lazdunski, 
2000) (Fig. 1.3 D). In structure, K2P channels differ from any other K
+ 
channels in 
that they have a single pore-forming motif within their α-subunit, whereas K2P 
channels have two. K2P channels are believed to assemble as a dimer of two α-
subunits to form functionally active channels (Nishida et al., 2007). The K2P 
channels expressed in VSMCs include TASK-1, TASK-2, TREK-2, THIK-1 and 




1.6.2 Role of potassium channels in regulation of excitability of 
pulmonary and systemic arteries 
Functional K
+ 
channels expressed in VSMCs are listed in Table1.3 and include: 
KV, KCNQ, BKCa, KATP, Kir, and K2P channels. In addition, ERG channels have 
also been identified in murine portal vein smooth muscle (Ohya et al., 
2002;Yeung & Greenwood, 2007). 
+
Table 1.3 Functional types of K channels expressed in VSMCs 
Potassium channels 
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1.6.2.1 KV Channels: 
The KV superfamily may be further subdivided into seven conserved gene families 
including voltage dependent KV channels (KV1.x-KV4.x), the KCNQ channels 
(KV7), the silent or modifier channels (KV5, KV6, KV8 and KV9 subunits), and the 
eag-like channels (KV10.x-KV12.x) (Gutman et al., 2005). KV channels are 
ubiquitously expressed in VSMCs including KV1.1-1.8, KV2.1-2.2, KV3.1-3.4, 
KV4.1-4.3, KV7.1, 7.4 & 7.5, KV9.1, KV11, KVβ1.1-1.3, KVβ2.1-2.2 (Cox & 
Petrou, 1999;Davies & Kozlowski, 2001;Ohya et al., 2003;Wang et al., 
2005b;Brueggemann et al., 2007;Yeung et al., 2007;Joshi et al., 2009;Zhong et al., 
2010b). In pulmonary arteries KV1.1, 1.2, 1.5, 2.1, 3.1, 9.3 and KVβ1-2; and in the 
mesenteric arteries KV1.1, 1.2, 1.3, 1.5, 2.1, 3.4, 4.2, 4.3, 9.3, and KVβ1-2 appear 
to dominate [reviewed in (Cox, 2005)]. As voltage-gated KV channels are 
activated by membrane depolarisation (which could result for example from 
activation of ClCa, ROCCs or VOCCs) and will induce membrane 
hyperpolarisation and vasorelaxation, they act as negative feedback regulators. 
Thus, the main function of KV channels is to dampen cell excitation, limit 
membrane depolarisation and maintain resting vascular tone (Nelson & Quayle, 
1995;Jackson, 2000b;Sobey, 2001;Korovkina & England, 2002a). Inhibition of 
KV channel activity resulting from sustained depolarisation could be associated 
with a range of pathophysiological conditions. For example, in diabetic patients, 
high circulating glucose levels have been associated with an increase in ROS by 
-
inducing superoxide (O2 ) production which impaired KV channel activity (Liu et 
al., 2001a;Liu & Gutterman, 2002). Notably, it was found that KV currents in mice 
PASMCs are more sensitive to TEA and less sensitive to 4-AP (Ko et al., 2007), 
unlike in the rat (Smirnov et al., 2002) suggesting that in different species, 
different KV channel types could contribute to the regulation of cell excitability. 
In general, the role of K
+ 
channels is crucial for maintenance of low resistance in 
the pulmonary circulation. It is well established that in PASMCs, KV channels 
play the central role in regulation of membrane potential and are thus postulated 
to be a major determinant of vascular tone (Yuan, 1995;Moudgil et al., 2006;Ko 
et al., 2008). They also contribute to hypoxic pulmonary vasoconstriction (Archer 











circulation contributes to pathogenesis of pulmonary artery hypertension (Yuan et 
al., 1998a;Yuan et al., 1998b;Bonnet et al., 2006) by enhancing cell proliferation 
and inhibiting apoptosis (Michelakis et al., 2002b;Remillard & Yuan, 2004). It 
has also been demonstrated that decreased KV channel activity and a subsequent 
2+
rise in [Ca ]i in PASMCs leads to medial hypertrophy by stimulation of PASMC 
proliferation in patients with pulmonary hypertension (Platoshyn et al., 2000). 
* 
Table 1.4 KV channel subfamilies with encoding genes and tissue distribution 
KV channels Gene name Channel distribution 
KV1. KCNA Pulmonary artery
1,2
, brain, heart, retina 
KV1. KCNA Pulmonary artery
2
, brain, atrium, ventricle, retina 
KV1. KCNA Brain, lung, islets, spleen, thymus, lymph node, testis 
KV1. KCNA Pulmonary artery
2
, brain, skeletal muscle, heart 
KV1. KCNA Pulmonary artery
2 
, aorta, smooth muscle, kidney 
KV1. KCNA Pulmonary artery
2
, brain, heart, lung, ovary, testis 
KV1. KCNA Pulmonary artery
3
, heart, placenta, skeletal muscle 
KV1. KCNA10 Brain, heart, kidney, adrenal gland, skeletal muscle 
KV2.1 KCNB1 Pulmonary artery
2
, brain, heart, lung, retina, eye 
KV2.2 KCNB2 Mesenteric artery
4
, brain, tongue, gut muscle 
KV3.1 KCNC1 Pulmonary artery
2
, brain, lung, skeletal muscle 
KV3.2 KCNC2 Mesenteric artery
4
, brain, islets, Schwann cells 
KV3.3 KCNC3 Mesenteric artery
4
, brain, central auditory nuclei 
KV3.4 KCNC4 Parathyroid, prostate, brain, skeletal muscle 
KV4.1 KCND1 Pulmonary artery
3
, brain, lung, stomach, liver 
KV4.2 KCND2 Brain, atrium ventricle, cochlear nucleus 
KV4.3 KCND3 Pulmonary artery
2
, heart, brain, smooth muscle 
KV5.1 KCNF1 Brain, heart, liver, kidney, skeletal muscle 
KV6.1 KCNG1 Cardiac myocytes, brain, uterus, ovary, bone, skin 
KV6.2 KCNG2 Myocardium, fetal brain, germinal centre B cells 
KV6.3 KCNG3 Brain, spinal cord, pituitary, testis, thymus 























KV7.2 KCNQ2/KQT2 Brain, lung, heart, eye, small intestine, placenta 




























, brain, sympathetic 
ganglia, skeletal muscle 
KV8.1 KCNV1 Brain, kidney 
KV8.2 KCNV2 Lung, liver, kidney, pancreas, spleen, thymus, testis 
KV9.1 KCNS1 Pulmonary artery
3
, brain, lens epithelium 
KV9.2 KCNS2 Pulmonary artery
3
, brain, retina, spinal cord 
KV9.3 KCNS3 Pulmonary artery
2,5
, brain, heart, kidney 
KV10.1 KCNH1 Brain, melanoma cells 
KV10.2 KCNH5 Brain 
KV11.1 KCNH2 Brain, heart, kidney, liver, lung, ovary, blood cells 
KV11.2 KCNH6 Brain, uterus, rat pituitary 
KV11.3 KCNH7 Brain, sympathetic ganglia, rat pituitary 
KV12.1 KCNH8 Brain, lung, uterus, testis, sympathetic ganglia 
KV12.2 KCNH3 Brain, lung 
KV12.3 KCNH4 Brain, lung, pituitary gland 
* 
Modified from Alexander et al., 2009 and Gutman et al., 2005 
1 2 3 4
Young et al., 2006; Wang et al., 2005b; Davies & Kozlowski, 2001; Xu et al., 
5 6 7 8
1999; Hulme et al., 1999; Joshi et al., 2009; Yeung et al., 2007; Ohya et al., 
9 10
2003; Brueggemann et al., 2007; Zhong et al., 2010b 
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KV channel currents are inhibited by hypoxia in PASMCs (Post et al., 
1992;Sweeney & Yuan, 2000;Coppock et al., 2001;Mandegar & Yuan, 
2002;Platoshyn et al., 2007). Hypoxia results in inhibition of gene expression of 
KV channel α-subunits in PASMCs (Wang et al., 1997;Wang et al., 2005b). 
Chronic hypoxia selectively downregulates KV channel expression, reduces KV 
current (IKV), and induces depolarisation in PASMCs (Smirnov et al., 
1994;Platoshyn et al., 2001). A 4-AP-sensitive KV channel was found to be 
involved in vasoconstriction under hypoxic conditions in rat isolated main 
pulmonary artery (Bardou et al., 2001) and isolated rabbit lungs (Liu et al., 
2001c). Among the twelve subfamilies of KV channels, KV1.5 and KV2.1 are 
thought to be the main contributors to the initiation of HPV in rat pulmonary 
artery myocytes (Archer et al., 1998). A most recent study provides compelling 
evidence that KV1.5 is an important hypoxia-sensitive KV channel in PASMCs 
(Firth et al., 2009b). KV1.2, KV1.4 and KV1.5 are the most important α-subunits 
in human PASMCs because these are the KV channel α-subunits that participate 
in forming functional channels in human PASMCs (Archer et al., 1998;Coppock 
et al., 2001;Archer et al., 2001;Platoshyn et al., 2004). Although KV3 and KV4 
subunits have also been reported to be hypoxia sensitive, only KV3.1b was found 
to be present in PA. Hypoxia inhibits KV3.1b channels expressed in L929 cells, 
and the expression of these channels was demonstrated in PASMCs suggesting 
their potential role in O2 sensing in PA (Osipenko et al., 2000). Chronic hypoxia 
decreases expression of KV1.1, KV1.5, KV1.6, KV2.1, KV4.3, and KV9.3 α-subunits 
(Osipenko et al., 2000;Platoshyn et al., 2001). The functional characteristics and 
physiological role of KV channels in relation to HPV will be further elaborated in 
the HPV section of this chapter. 
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Table 1.5 Potency of KV channel inhibitors 4-AP and TEA in pulmonary and 
systemic VSMCs 




0.30 (Okabe et al., 1987) 
>10 (Ko et al., 2007) 
0.35 (Smirnov et al., 2002) 
>100 (Okabe et al., 1987) 
1-5 (Ko et al., 2007) 




~1 (Smirnov & Aaronson, 
1992) 
5.1 (Xu et al., 1999;Lu et al., 
2001) 
9.9 (Xu et al., 1999;Lu et al., 
2001) 
For pharmacological characterisation of the KV1 subfamily, a wide range of 
specific toxins are available for individual subtypes but not for KV1.5 (Table 1.1). 
Only 4-AP and correolide (which blocks all KV1.x) are the tools available for 
pharmacological characterisation of KV1.5, the main contributor in HPV. 
However, an inhibitor such as TEA is another alternative pharmacological tool to 
investigate the properties of KV channels as the members of both the KV2 and KV3 
subfamilies are sensitive to TEA. Thus, the lack of a specific inhibitor of KV1.5 
channels has made the investigation of these types of channels difficult in intact 
preparations. It is widely accepted that 4-AP is the most frequently used and most 
selective known inhibitor of KV channels in vascular smooth muscle cells (Okabe 
et al., 1987;Beech & Bolton, 1989;Volk et al., 1991;Gelband & Hume, 
1992;Smirnov & Aaronson, 1992;Ishikawa et al., 1993;Robertson & Nelson, 
1994). Therefore, 4-AP has been used to distinguish KV currents from BKCa 
currents: both of which are activated by membrane depolarisation (Okabe et al., 
1987;Beech & Bolton, 1989;Smirnov & Aaronson, 1992). Although the IC50 of 4-
AP in isolated PASMC is <1 mM (Okabe et al., 1987;Smirnov & Aaronson, 
1994;Smirnov et al., 2002), much higher concentrations are necessary to cause 
contraction in intact pulmonary artery. For this reason, many studies using intact 
tissue and focussing on KV channel responsiveness have used higher 
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concentrations of 4-AP. For example, 2-16 mM in rat pulmonary artery (Han et al., 
2007), 10 mM in mouse pulmonary artery (Xu et al., 2008) and 10 mM in chicken 
ductus arteriosus (Greyner & Dzialowski, 2008;Cogolludo et al., 2009) were used 
(Table 1.6). Thus, there is always a marked difference in the concentration of 4-
AP used for inhibiting KV channels in single isolated cells versus intact tissue 
preparations. The concentration of 4-AP is usually chosen by the experimenter 
depending upon the purpose and nature of the experiment. 
Table 1.6 A comparison of the concentrations of 4-AP used in intact arteries 
in contraction studies 
Tissue Species 4-AP (mM) References 
Pulmonary artery Rat 10 Karamsetty et al., 1998 
Pulmonary artery Rat 2 to16 Han et al., 2007 
Pulmonary artery Mouse 10 Xu et al., 2008 
Pulmonary artery Lamb 10 Konduri et al., 2009 
Detrusor muscle Rat 10 Ning & Liang, 2009 
Diaphragm muscle Guineapig > 10 Ishida & Honda, 1993 
Ductus arteriosus Chicken 10 Cogolludo et al., 2009 
Ductus arteriosus Chicken 10 Greyner & Dzialowski, 2008 
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1.6.2.2 KV7 (KCQ) channels: 
1.6.2.2.1 KCQ genes and the role of their expression products: a brief 
history: 
KCNQ genes encode members of the KV7 family of K
+ 
channel subunits that now 
includes five members: KV7.1- KV7.5 or KCNQ1-KCNQ5. KV7 or KCNQ 
channels were first discovered in neurons and cardiac cells where they are thought 
to play an important role in regulation of membrane potential (Robbins, 
2001;Delmas & Brown, 2005). This is a relatively recently discovered group of 
the KV channel subfamily. The first publications came in 1996 (Wang et al., 1996) 
and first non-provisional gene patent filed in 1998 (Biervert et al., 1998;Charlier 
et al., 1998;Singh et al., 1998). Long before the discovery of these KCNQ 
channels, Brown and Adams identified a voltage-gated K
+ 
current that could 
account for a decrease of potassium conductance in frog sympathetic neurones 
and named ‘M-current’ due to its suppression by stimulation of muscarinic 
acetylcholine receptors (Brown & Adams, 1980). Identification of a gene product 
that could account for the long-established ‘M-current’ came in 1996 when Mark 
Keating and colleagues discovered KVLQT1 (now called KCNQ1) as one of the 
ion channels underlying the long-QT syndrome (a potentially fatal inherited 
cardiac arrhythmia) (Wang et al., 1996). Following the discovery of KVLQT1, in 
1998, neuronal KCNQ channels, specifically KCNQ2, 3 and 5, were cloned using 
the sequence homology with the important cardiac KVLQT1 channel (Yang et al., 
1998). Subsequent genetic analyses revealed numerous mutations in KCNQ2 and 
3 channels capable of producing a range of biophysical alterations or loss of 
function (Biervert & Steinlein, 1999). In 1999, mutations in another member of 
the family, KCNQ4, were found to be responsible for a form of autosomal 
dominant deafness, and this subunit (KCNQ4) was shown to play an important 
role in hair cell regulation in the cochlea (Kubisch et al., 1999;Kharkovets et al., 
2000). The fifth family member, KCNQ5, was first publicly disclosed in 2000 
(Lerche et al., 2000;Schroeder et al., 2000;Maljevic et al., 2010). 
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Out of the five members, KCNQ1 is predominantly expressed in the cardiac 
muscle and in epithelial cells and is believed to be generally absent from neuronal 
tissue (Robbins, 2001). In cardiac tissue KCNQ1 is involved in repolarisation 
following an action potential. In cardiac myocytes KCNQ1 subunits assemble 
with the accessory β-subunit (KCNE1) and form a channel complex constituting 
the delayed rectifier current (IKs), which is partly responsible for terminating the 
cardiac action potential (Barhanin et al., 1996;Sanguinetti et al., 1996). Mutations 
in KCNQ1 may lead to dysfunction of the channel and cause the cardiac long-QT 
syndrome. In epithelial tissue KCNQ1 is important in regulation of water and salt 
transport. A lack of functional KCNQ1 channel expression has been found to have 
severe implications in the epithelial tissues of organs such as lung, stomach, 
cochlea, intestine, and kidney, where salt and water transport is crucial for proper 
function. Thus humans with mutations in KCNQ1 may suffer from deafness 
(Jervell & Lange-Nielsen, 1957;Neyroud et al., 1997). Similarly, KCNQ1 knock 
out mice showed deafness, balance problems and morphological abnormalities in 
the inner ear and gastrointestinal tract (Lee et al., 2000;Casimiro et al., 2001). 
The other four members (KCNQ2-KCNQ5) are mainly expressed in the nervous 
system hence they are called neuronal KCNQ channels (Jentsch, 2000;Robbins, 
2001;Cooper & Jan, 2003). KCNQ2-KCNQ5 channels have been proposed to 
constitute the ‘M-current’, which is central in the control of neuronal action 
potential firing due to its modulation by neurotransmitters and voltage-sensitivity 
(Mackie & Byron, 2008). KCNQ2, KCNQ3 and KCNQ5 determine sub threshold 
excitability of neurons whilst KCNQ2 and KCNQ3 coassemble to form the ‘M-
current’ in the brain (Wang et al., 1998). KCNQ4 plays a physiological role in 
hearing by mediating potassium efflux from outer hair cells (Kubisch et al., 
1999;Kharkovets et al., 2000). Mutations in KCNQ2 and KCNQ3 cause benign 
familial neonatal seizures (Biervert et al., 1998;Charlier et al., 1998;Singh et al., 
1998), whilst mutations in KCNQ4 underlie congenital deafness (Kubisch et al., 
1999). However, no disease has yet been found to be related to KCNQ5 (Lerche et 
al., 2000;Schroeder et al., 2000;Maljevic et al., 2010). 
Intriguingly, expression of ‘neuronal’ KCNQ4 and KCNQ5 transcripts and 
protein has recently been found also in vascular smooth muscle cells (Yeung et al., 
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2007;Joshi et al., 2009;Zhong et al., 2010b), indicating their potential importance 
in the regulation of vascular excitability and contractility. This will be further 
elaborated below. 
1.6.2.2.2 KCQ expression and function in vascular smooth muscle: 
Recent studies provide consistent evidence that KCNQ1, 4 and 5 transcripts are 
expressed in vascular smooth muscle cells including pulmonary, mesenteric and 
other systemic blood vessels (Ohya et al., 2003;Yeung et al., 2007;Joshi et al., 
2009;Zhong et al., 2010b). KCNQ channels are voltage-gated channels, but their 
threshold for activation is substantially more negative (between -80 and -60 mV) 
than that for other voltage-gated K
+ 
channels (-30 and -40 mV) (Wang et al., 
1998;Gurney et al., 2010). KCNQ channels are characterised by some unique 
features such as (i) slow activation and deactivation, and (ii) their inability to 
inactivate during sustained depolarisation (Brown & Adams, 1980;Gurney et al., 
2010). These are the main reasons why they were suggested as the background K
+ 
currents found in PASMCs (Evans et al., 1996). The biophysical properties of 
KCNQ channels could be altered by a number of factors including PIP2 hydrolysis 
and heterotetramer formation. Furthermore, associated subunits of KCNQ 
channels (e.g., KCNE1-5) may also play significant modulatory role on channel 
expression, biophysical and pharmacological properties of these channels 
especially KCNQ1 [recently reviewed in (Greenwood & Ohya, 2009)]. 
KCNQ channels, expressed in a variety of VSMCs, play an important role in 
maintaining the resting membrane potential and vascular reactivity (Yeung & 
Greenwood, 2005;Joshi et al., 2006;Brueggemann et al., 2007;Yeung et al., 
2007;Yeung et al., 2008;Mackie et al., 2008;Mackie & Byron, 2008;Joshi et al., 
2009;Gurney et al., 2010). The expression of different subunits of the KCNQ 
channel subfamily in VSMCs is summarised in the Tables 1.4 and 1.7. 
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Table 1.7 Expression of KCQ channel subunits in VSMCs

KCQ subunit Species and tissue involved References 
KCQ1 Mouse portal vein Ohya et al., 2003 
KCQ 1, 4 and 5 Mouse aorta, carotid, femoral 
and mesenteric arteries 
Yeung et al., 2007 
KCQ5 Cultured rat aorta Brueggemann et al., 2007 
KCQ1 and 5 Rat aorta Brueggemann et al., 2007 
KCQ1, 4 and 5 Rat mesenteric artery Mackie et al., 2008 
KCQ1, 4 and 5 Rat pulmonary artery Joshi et al., 2009 
KCQ1, 4 and 5 Rat cerebral artery Zhong et al., 2010b 
Role of KCQ channels in pulmonary and mesenteric arteries: 
Recent evidence suggests that in addition to their role in neurons, KCNQ channels 
also play an important role in maintaining resting membrane potential and cellular 
excitability in arteries and are expressed in both pulmonary and systemic 
circulations. Out of the five KCNQ genes, three subunits (KCNQ1, 4 and 5) were 
found to be expressed in PASMCs, with KCNQ4 being expressed in a greater 
degree (Joshi et al., 2009). In contrast to KV channels, specific inhibitors of 
KCNQ channels are available making investigation of these channels easier. Two 
KCNQ blockers, linopirdine and XE991, have been developed and are widely 
used in study of the role of KCNQ channels. Both linopirdine and XE991 were 
demonstrated to be potent constrictors of pulmonary artery (Joshi et al., 2006) and 
linopirdine has been demonstrated to be a potent constrictor of mesenteric artery 
(Mackie et al., 2008). Among the activators of KCNQ channels, flupirtine and 
retigabine are widely used to activate all of the subtypes of KCNQ channels 
except KCNQ1, that lack a transmembrane tryptophan residue which is believed 
to be responsible for the action of these drugs (Schenzer et al., 2005;Wuttke et al., 
2005;Bentzen et al., 2006). These recent findings suggest that KCNQ channels 
could contribute to the regulation of resting membrane potential in pulmonary 
(Joshi et al., 2006) as well as mesenteric arteries (Mackie et al., 2008). However, 
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a very recent study suggests that among the KCNQ subtypes most probably 
KCNQ4 makes an important contribution to the regulation of pulmonary vascular 
tone, with a greater contribution in pulmonary than in systemic vessels (Joshi et 
al., 2009). It is noteworthy, however, that the whole cell KCNQ current density 
measured with the voltage-clamp technique is very small (≤ 1pA/pF at 0 mV) 
(Mackie et al., 2008;Joshi et al., 2009), which complicates its investigation at the 
single cell level. Therefore, most of the conclusions about their functional role 
were derived from the effects of KCNQ inhibitors and activators on intact arteries. 
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Table 1.8 Biophysical properties of potassium channels in VSMCs

KV KCQ 
Subtypes KV 1.1-1.7 and 1.10; KV 2.1; 
KV 3.1b, 3.3 and 3.4; KV 4.1, 
4.2 and 4.3; KV 5.1; KV 6.1-
6.3; KV 9.1 and 9.3; KV 10.1; 
and KV 11.1 
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1 * 2 * 3 * 4
Archer et al., 1998 ; Coppock & Tamkun, 2001 ; Platoshyn et al., 2004 ; 
* 5 * 6 7
Smirnov & Aaronson, 1994 ; Smirnov et al., 2002 ; Accili et al., 1997; 
* 8 9 10 
Nelson & Quayle, 1995 ; Aiello et al., 1996; Son et al., 2006; Berger et al., 
11 12 13 
1998; Cox & Petrou, 1999; Cachero et al., 1998; Osipenko et al., 1997; 
14 15 16 * 17
Yuan et al., 1995b; Cheong et al., 2001; Joshi et al., 2009 ; Mackie et al., 
18 19 20 21
2008; Ohya et al., 2003; Li et al., 2006; Yeung et al., 2007; Roura-Ferrer et 
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24 25 26 27
Orio et al., 2002; Brenner et al., 2000; Cox & Aldrich, 2000; Barman et al., 
* 28 29 30 31
2003 ; Bolotina et al., 1994; Brakemeier et al., 2003; Carl et al., 1991; Archer et al., 
32 33 34 35
2003; Zhang et al., 2001; Wang et al., 1997; Lu et al., 2005; Jackson, 2000b; 
36 * 37 38 39
Barman et al., 2004 ; Minami et al., 1993a; Tang et al., 2004; Schubert et al., 
40 41 42 43
2001; Alioua et al., 2002; Gao & Garcia, 2003; Giangiacomo et al., 1992; DeFarias 
44 45 46 * 47
et al., 1996; Tammaro et al., 2004; Li & Aldrich, 2004; Cui et al., 2002 ; Teramoto, 
48 49 50 51
2006; Isomoto et al., 1996; Sun et al., 2006; Wellman et al., 1998; Clapp & Gurney, 
52 53 54
1992; Quayle et al., 1995; Glavind-Kristensen et al., 2004; Wilson et al., 2000; 
55 56 57 * 58
Chrissobolis & Sobey, 2002; Jackson, 1993; Gardener et al., 2004 ; Gurney et al., 
* 59





1.6.2.3 BKCa channels: 
BKCa channels, abundantly expressed in VSMC, are activated by changes in the 
2+
[Ca ]i and membrane depolarisation thus contributing to the regulation of 
membrane potential and vascular tone especially in small myogenic vessels 
(Nelson & Quayle, 1995;Waldron & Cole, 1999;Korovkina & England, 
2+
2002a;Korovkina & England, 2002b). At physiological concentrations of [Ca ]i 
(≤100 nM), BKCa channels are generally shut, in the physiological range of 
2+
membrane potentials, however when [Ca ]i is increased (e.g. to micromolar 
level) these channels can be activated even at hyperpolarised potentials. Thus, 
2+
increased [Ca ]i enhances the voltage-dependence of BKCa channel activation by 
shifting it leftward to more hyperpolarised membrane potential (Stehno-Bittel & 
2+ 
Sturek, 1992). The resultant hyperpolarisation acts to limit excessive Ca influx 
by decreasing the opening of L-VOCCs. This feature makes BKCa channels an 
2+
ideal candidate for feedback inhibition when levels of [Ca ]i are significantly 
increased (Brayden & Nelson, 1992;Nelson et al., 1995;Knot et al., 1998;Burg et 
al., 2006;Yang et al., 2009). Pressure- or neurotransmitter-induced depolarisation 
in the VSMCs can be counteracted by the efflux of K
+ 
that results in the activation 
of BKCa channels (Brayden & Nelson, 1992). BKCa channel currents are sensitive 
to inhibition by external toxins including iberiotoxin, charybdotoxin and TEA at 
IC50 values of ~10, <10 and 200 nM, respectively (Miller et al., 1985;Langton et 
al., 1991;Giangiacomo et al., 1992;Nelson & Quayle, 1995). Amongst these, 
iberiotoxin is the most selective and potent blocker of BKCa channels (Wallner et 
al., 1995). Charybdotoxin has also been widely used as another BKCa channel 
blocker; however, it can also affect some KV channel subtypes (Table 1.1) as well 
as intermediate conductance KCa (IKCa) channels (Carl et al., 1991;Gebremedhin 
et al., 1996;Waldron & Cole, 1999). 
BKCa channel properties and expression can be altered in many 
pathophysiological conditions including hypertension, hypoxia and diabetes 
(England et al., 1993;Peng et al., 1999;Sobey, 2001). Changes in BKCa channel 
properties have also been reported to be associated with coronary atherosclerosis 
(Bolotina et al., 1991). Vascular remodelling is associated with both promotion of 
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VSMC proliferation and attenuation of programmed cell death or apoptosis. 
Activation of BKCa channels have also been shown to induce early apoptotic cell 
shrinkage, as well as downstream cytoplasmic casepase activation and DNA 
fragmentation which are essential for apoptotic cell death (Remillard & Yuan, 
2004;Burg et al., 2006). 
Role of BKCa channels in pulmonary and mesenteric arteries: 
In PASMCs, BKCa channel activity has been demonstrated to be attenuated by 
acute hypoxia (Post et al., 1995). In PASMCs, it has been shown that chronic 
hypoxia decreased levels of mRNA and protein of the BKCa α-subunit, suggesting 
a down-regulation of BKCa activity (Bonnet et al., 2003). Inhibition of BKCa 
channels completely restored blunted HPV in rats with experimental liver 
cirrhosis (Carter et al., 2000). It has been reported that oxygen caused fetal 
pulmonary vasodilation via BKCa channel activation, which led to membrane 
hyperpolarisation (Cornfield et al., 1996). The modulators of BKCa channels in 
2+
PASMCs include: cytosolic Ca , membrane potential, membrane stretch, fatty 
acids, NADH and NAD (Kirber et al., 1992;Lee et al., 1994). Although a BKCa 
channel inhibitor itself does not produce contraction, blocking of these channels 
significantly increased the contraction to PGF2α in rat mesenteric arteries 
(Abdullah & Docherty, 1999) and also further potentiated ryanodine-induced 
contraction in the rat cremester arteriole (Yang et al., 2009). These findings 
suggest an indirect influence posed by BKCa channels in the regulation of arterial 
tone. However, in rat intra PASMCs there is very little evidence for its 
contribution to the regulation of cell resting potential (Smirnov et al., 
1994;Smirnov & Aaronson, 1994). 
1.6.2.4 KATP channels: 
KATP channels represent another class of K
+ 
channels ubiquitously expressed in 
VSMCs (Noma, 1983;Nelson & Quayle, 1995), where they contribute to the 
maintenance of resting membrane potential and regional blood flow (Quayle et al., 
1997;Rodrigo & Standen, 2005). KATP channels show little or no voltage 
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dependency. Both in vivo and in vitro studies have shown that inhibition of KATP 
channels leads to vasoconstriction and membrane depolarisation in various types 
of VSMCs (Noma, 1983;Nelson et al., 1990;Nakashima & Vanhoutte, 
1995;Quayle et al., 1997;Teramoto, 2006). KATP channels are inhibited by 
intracellular ATP and activated by nucleotide diphosphates (Beech et al., 
1993;Clapp, 1995). The most frequently used pharmacological inhibitor of KATP 
channels is glibenclamide which has an IC50 value between 20 and 200 nM (Beech 
et al., 1993;Xu & Lee, 1994;Nelson & Quayle, 1995;Clapp, 1995). The inhibition 
of KATP channels is associated with impaired coronary and cerebral autoregulation 
(Narishige et al., 1993;Hong et al., 1994;Nelson & Quayle, 1995). On the other 
hand, activation of KATP channels is closely associated with several 
pathophysiological conditions, including systemic arterial dilation during hypoxia 
(Daut et al., 1990;Brayden, 2002), reactive hyperemia in coronary and cerebral 
circulation (Kanatsuka et al., 1992;Bari et al., 1998;Brayden, 2002), and 
endotoxemic shock-induced vasodilation (Landry & Oliver, 1992;Ishizaka & Kuo, 
1996;Kinoshita & Katusic, 1997). However, under basal conditions, it has been 
reported that the open probability of KATP channels is low (Jackson, 2000a). 
Role of KATP channels in pulmonary and mesenteric arteries: 
Robertson et al. (1992) suggested that KATP channels are normally closed in the 
pulmonary arteries and are not activated by the levels of hypoxia that cause a 
constriction (Robertson et al., 1992). Several studies suggested that KATP channels 
may contribute to the regulation of basal blood flow in the mesenteric vascular 
bed (Nelson et al., 1990;Moreau et al., 1994;Murphy & Brayden, 1995;Gardiner 
et al., 1996;Quayle et al., 1997). 
+
1.6.2.5 Two Pore Domain K (K2P) channels: 
K2P channels (also called KCNK or background or leak K
+
-selective channels) are 
accredited for regulating resting membrane potential and cell excitability. These 
channels have been identified in a range of vascular tissues including pulmonary 
as well as mesenteric artery SMCs (Evans et al., 1996;Gurney et al., 
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2003;Gardener et al., 2004;Olschewski et al., 2006;Gonczi et al., 2006). The 
activity of K2P channels is strongly regulated by physical factors. For example, 
TASK-1 is highly sensitive to extracellular pH (Duprat et al., 1997), volatile 
anaesthetics such as halothane (Gurney et al., 2003) and hypoxia (Olschewski et 
al., 2006). TREK-1, on the other hand, is temperature-sensitive (Maingret et al., 
2000), whilst TRAAK is stretch sensitive channel (Maingret et al., 1999). 
Functionally expressed K2P channels give rise to K
+
-selective currents that are 
activated at all voltages, unlike KV, KCa, or KATP channels whose activity is 
2+ 
controlled by voltage and Ca or metabolic regulation (Olschewski et al., 2006). 
In other words, K2P channels express a non-inactivating current, denoted IKN, 
which is characterised by having no time or voltage dependency (Evans et al., 
1996). The decrease in leak K
+ 
conductance leads to membrane depolarisation that 
enhances the open probability of L-VOCCs in SMCs, resulting in Ca
+ 
entry and 
vasoconstriction (Olschewski et al., 2006). It is notable that the lack of specific 
inhibitors of K2P channels complicates studies of their roles in intact multicellular 
preparations (Brenner & O'Shaughnessy, 2008). 
Role of K2P in pulmonary and mesenteric artery: 
Members of K2P channels expressed in pulmonary artery are TASK-1 TASK-2, 
THIK-1, TREK-2, and TWIK-2 and in mesenteric artery are TASK-1 TASK-2, 
THIK-1, TRAAK, TREK-1, TWIK-1 and TWIK-2; (Gardener et al., 2004). It is 
suggested that TASK-1 channels in pulmonary artery may play an important role 
in regulating resting membrane potential and eliciting vasoconstriction in 
response to hypoxia (Gurney et al., 2003). TASK-2 channels also have been 
suggested to have a functional role in setting the membrane potential in 
pulmonary artery myocytes (Gonczi et al., 2006). Blockade of K2P channels by 
anandamide or bupivacaine generated a small increase in pulmonary artery tone 
unlike mesenteric artery (Gardener et al., 2004). It is also important to note that 
TASK-1 channels in rat (Gurney et al., 2003) and in human (Olschewski et al., 
2006) pulmonary artery SMCs exhibit sensitivity to hypoxia and, as such, these 
channels may be functionally important in mechanisms underlying HPV. 
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1.7 Hypoxic pulmonary vasoconstriction 
Precapillary or resistance pulmonary arteries constrict during alveolar hypoxia 
resulting in the HPV response. HPV is a cardinal feature of the pulmonary 
circulation, with multiple mechanisms, one of which involves K
+ 
channel 
inhibition. HPV is an adaptive physiological mechanism of the lung that directs 
blood perfusion from poorly ventilated to well-ventilated lung areas to optimise 
gas exchange. Impairment of the HPV response under conditions of marked 
regional alveolar hypoxia (e.g., acute respiratory distress syndrome, or during 
anaesthesia) may result in poor arterial oxygenation that may lead to life-
threatening hypoxemia (Marshall, 1990;Naeije & Brimioulle, 2001). Alternatively, 
when hypoxia is rather global (e.g., at high altitudes), generalised vasoconstriction 
leads to acute pulmonary hypertension (PH). If PH is chronic (e.g., chronic 
obstructive pulmonary disease), in addition to vasoconstriction, a process of 
vascular remodelling occurs leading to right-heart failure (Raj & Shimoda, 
2002;Moudgil et al., 2005;Stenmark & McMurtry, 2005;Weissmann et al., 2006b). 
Historically, indication of HPV was revealed as early as 1894 when Bradford and 
Dean (1894) first recognised an increase in pulmonary arterial pressure in 
response to alveolar hypoxia (Bradford & Dean, 1894). The physiological role of 
this increase in pulmonary artery pressure in response to alveolar hypoxia was not 
clear until 1946, when von Euler and Liljestrand (Von Euler & Liljestrand, 1946), 
for the first time, found that PA pressure increased in feline lungs ventilated with 
low O2 mixtures, and decreased when ventilated with pure O2. From this 
observation they speculated that pulmonary vasoconstriction to hypoxia could 
help to improve gas exchange efficiency by diverting blood flow away form 
poorly ventilated lung regions and towards areas with better oxygenation. 
Recognising this fact, they suggested that ventilation-perfusion matching was the 
purpose of this response. Thus, the principle of HPV is also known as von Euler-
Liljestrand mechanism (Sommer et al., 2008). Since then, factors modulating 
HPV have been identified by dissecting the mechanism of HPV using a variety of 
approaches including isolated organs, tissues and single cells from a range of 
animals including humans. 
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In spite of extensive research the mechanisms of HPV are still incompletely 
resolved. Issues addressing the questions of how O2 levels are detected in 
PASMCs, what interim signalling is involved and which components act as 
effectors still remain controversial (Sato et al., 2000;Gurney, 2002;Moudgil et al., 
2005;Gurney & Joshi, 2006). At present, research on HPV is driven by several 
hypotheses and their associated mechanisms which are briefly highlighted below. 
1.7.1 Multiple mechanisms of HPV 
There are several mechanisms proposed to be involved in HPV. However, 
currently there is no single unified hypothesis that can entirely explain this 
phenomenon (Aaronson et al., 2006;Weissmann et al., 2006b), leading to 
common consensus that HPV is a complex multi factorial phenomenon with more 
than one underlying mechanism (Ward & Aaronson, 1999;Gurney, 2002). It is 
2+
currently well accepted that elevated [Ca ]i is crucial to the development of HPV. 
2+ 
One of the proposed mechanisms involves Ca entry via L-VOCCs (McMurtry et 
al., 1976), which is subsequent to hypoxia-induced inhibition of KV channels and 
membrane depolarisation (Archer & Michelakis, 2002;Moudgil et al., 
2005;Mauban et al., 2005). Although the mechanism of KV channel inhibition by 
hypoxia is not well understood, it may involve ROS produced by the 
mitochondrial electron transport chain (mETC) (Weir & Archer, 1995;Archer & 
Michelakis, 2002), or may engage a different mediator of mitochondrial origin, 
2+ 
e.g. Mg ions (Firth et al., 2008;Firth et al., 2009a). ROS hypothesis proposed by 
the Archer group relys on reduced ROS production by the mETC (Archer et al., 
1993;Archer & Michelakis, 2002;Michelakis et al., 2002a). However, others 
demonstrate an increase in ROS (Waypa & Schumacker, 2006). This would rather 
enhance and not inhibit KV channels (Reeve et al., 1995). An increase in ROS 
2+
leads to an increase in [Ca ]i and may not involve L-VOCCs (Robertson et al., 
2+ 
2000b). Ca release from intracellular stores triggering SOCC, the opening of 
2+
Ca -permeable cation channels, and sensitisation of the contractile apparatus to 
2+ 
Ca involving ROK are now increasingly postulated to be involved in the HPV 
response (Robertson et al., 2000a;Robertson et al., 2000b). Among the several 
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HPV hypotheses, a recent proposal suggests a role for adenosine monophosphate 
2+ 
(AMP)-activated protein kinase (AMPK) dependent, cADP ribose activated, Ca
release from the SR via RyR (Evans et al., 2005;Evans, 2006a;Evans, 2006b). 
However, the latest work by Gupte and colleagues proposed that glucose-6-
phosphate dehydrogenase (Glc-6-PD) and NADPH redox are crucially involved in 
the development of HPV (Gupte et al., 2010). 
1.7.2 Effector components of HPV 
Several effector components of HPV have been proposed. KV channel is one of 
2+ 
the most accepted effectors linked to Ca entry mediated via L-VOCCs as a result 
of hypoxia-induced inhibition of KV channels and consequent depolarisation 
(Weir & Archer, 1995;Olschewski et al., 2002;Archer & Michelakis, 2002). ROS 
and/or changes in the cellular redox state represent another effector in HPV, but 
controversy exists regarding which system and what redox changes mediate the 
HPV response. Recently, it has been proposed that activation of Glc-6-PD is a 
link between hypoxia-induced inhibition of glycolysis and mitochondrial ETC and 
the development of HPV (Gupte et al., 2010). Additionally, AMPK and 
RhoA/ROK have been shown to be involved in HPV mechanism. 
1.7.2.1 AMP-activated protein kinase (AMPK) 
Evans and his colleagues (Evans et al., 2005;Evans et al., 2006;Evans, 
2006a;Evans, 2006b) have proposed a novel effector mechanism in PASMCs 
which may be particularly sensitive to the metabolic stresses induced by hypoxia. 
This group reported that hypoxia induced an increase in the AMP/ATP ratio with 
2+ 
an ensuing AMPK dependent cDNA-ribose activated Ca release from the SR via 
RyRs. It has also been reported that AMPK activation is necessary for the effect 
of hypoxia in carotid body of neonatal rat (Wyatt & Evans, 2007;Wyatt et al., 
2007). Evidence suggests that activation of AMPK is a key event in the initiation 
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of the contractile response of intra pulmonary arteries (IPAs) to acute hypoxia. 
Preincubation of IPAs with the AMPK inhibitor compound C (40 µM) inhibited 
phase II, but not phase I of hypoxia (Robertson et al., 2008). Also it has been 
shown that hypoxia could activate AMPK via an increased mitochondrial ROS 
production by a mechanism independent of nucleotide concentration (Quintero et 
al., 2006) thus providing a potential link between different effectors in the HPV 
response. 
2+ 
1.7.2.2 Rho-Kinase and Ca sensitisation 
Calcium sensitisation and desensitisation are major mechanisms regulating 
2+ 
smooth muscle contraction (Somlyo & Somlyo, 2003). Hypoxia-induced Ca
sensitisation in VSMCs has helped, at least in part, to understand the mechanism 
underlying HPV. Hypoxia has been reported to increase ROK activity in 
PASMCs, and this increase was blocked by antagonists of Rho such as toxin B 
and exoenzyme C3 (Wang et al., 2001). Hypoxia increased MLC phosphorylation 
and decreased MP activity in PASMCs (Wang et al., 2003b). Specific antagonists 
of ROK, Y-27632 and HA-1077, have recently been used to study the 
involvement of RhoA and its downstream effector ROK in the signalling 
pathways activated by hypoxia. Y-27632 and HA-1077 block hypoxia-induced 
MLC phosphorylation and MP inactivation in PASMCs, phase II contraction of 
HVP in distal PAs, and HPV in isolated lungs and intact animals (Robertson et al., 
2000a;Wang et al., 2001;Wang et al., 2003b;Nagaoka et al., 2004;Fagan et al., 
2+ 
2004). The role of Ca sensitisation in both acute and chronic hypoxia has been 
proven since the discovery of this phenomenon (McMurtry et al., 2003). These 
2+
findings collectively suggest that HPV requires an increase in [Ca ]i, associated 
2+ 
with increase in Ca sensitivity which is mediated by RhoA/ROK. 
However, the mechanism of hypoxia-induced activation of RhoA/ROK is 
currently unclear. It is speculated that either hypoxia driven increases in ROS 
2+ 
(Waypa et al., 2001) or hypoxia induced elevation of Ca itself (Sakurada et al., 
2+ 
2003) activates the RhoA dependent Ca sensitisation. Further experimental 
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evidence advanced this hypothesis to the conclusion that PKC and ET-1 
2+ 
independent Ca sensitisation is responsible for the sustained response in acute 
hypoxia and that it is intrinsically reliant upon an intact endothelium (Aaronson et 
al., 2002;Robertson et al., 2003). These results further suggest that an 
endothelium derived putative constrictor factor, which could be released in HPV, 
2+ 
is involved in the RhoA/ROK mediated Ca sensitisation in HPV. Since 
RhoA/ROK plays the a central role in HPV (Ward et al., 2004a), inhaled Rho-
kinase inhibitors (e.g. Y-27632) may be very promising therapeutic candidates as 
vasodilators in patients with pulmonary hypertension (Nagaoka et al., 2005). 
1.7.2.3 Mitochondrial ROS and HPV 
Physiologically ROS could be formed by several different mechanisms. However, 
mitochondria represent an important source of ROS, an unavoidable by-product of 
cellular respiration. During this process, some electrons, which are passing down 
the mitochondrial electron transport chain (mETC), could leak away and can 
-
directly reduce oxygen molecules (O2) to superoxide anion (O2 ). This leak in the 
electron transport can occur at complexes I and III of the mETC (Turrens, 1997), 
although there is an agreement that the major source of ROS is complex III (Chen 
et al., 2003), where it has been extensively explored (Turrens et al., 1985). In the 
pulmonary circulation, it is now widely accepted that the O2 sensor during HPV 
resides in the mitochondria (Ward, 2008), which are also a putative source of 
ROS generation. Changes in ROS in response to hypoxia are well established and 
there is currently support for the involvement of the mETC in oxygen sensing in 
PASMCs (Moudgil et al., 2005;Waypa & Schumacker, 2005). However, there are 
two opposing hypotheses regarding ROS generation during HPV. The ‘redox 
hypothesis’ which states a reduction of ROS in HPV (Weir & Archer, 1995;Weir 
et al., 2002;Archer & Michelakis, 2002), whilst the ‘mitochondrial ROS 
hypothesis’ provides evidence for an increase of ROS during hypoxia (Waypa et 
al., 2001;Leach et al., 2001). 
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The ‘redox hypothesis’ proposed originally by Weir and Archer (Weir & Archer, 
1995;Weir et al., 2002;Archer & Michelakis, 2002) is based on the concept that 
under normoxic conditions, constitutive generation of ROS by mitochondria 
maintains K
+ 
channels in an oxidised and thus active open state. This hypothesis 
proposes that hypoxia suppresses the transfer of electron through the mETC 
causing a fall in ROS generation, thereby making the cytosol in PASMCs more 




with consequent depolarisation and Ca entry via L-VOCCs (Weir & Archer, 
1995;Michelakis et al., 2002a;Moudgil et al., 2005). This hypothesis predicts that 
inhibitors of the proximal mETC (rotenone acting on Complex-I and myxothiazol 
acting proximal to the active site of antimycin) should mimic hypoxia, thus 
preventing any further response to a subsequent hypoxic challenge. In support of 
this prediction, some reports have shown that at least some of these agents do 
cause vasoconstriction, at least transiently (Rounds & McMurtry, 1981;Archer et 
al., 1993;Archer et al., 1999), while some other reports have shown no 
vasoconstrictor activity at all (Zhao et al., 1996;Waypa et al., 2001;Leach et al., 
2001). However, both rotenone and hypoxia have been shown to increase 
NADH/NAD ratio, in favour of the ‘more reduced state’ of the cytosol as 
predicted by this hypothesis (Archer et al., 1993;Waypa et al., 2001). 
Conversely, the ‘mitochondrial ROS hypothesis’ suggests that hypoxia causes a 
paradoxical increase in mitochondrial ROS generation from the ubisemiquinone 
region of complex III, and, subsequently, this increase in ROS initiates the rise in 
2+
[Ca ]i (Chandel & Schumacker, 2000;Waypa et al., 2001;Leach et al., 
2001;Waypa et al., 2002). This hypothesis is arguably stronger as hypoxia has 
been shown to increase ROS in PASMCs; both ROS and HPV have been blocked 
by rotenone, myxothiazol and antioxidants; moreover oxygen sensing does not 
occur in mutant PA myocytes that lack functioning mETC (Waypa et al., 2001). 
Most recently, Waypa and colleagues measured redox status in the mitochondrial 
matrix, the intermembrane space, and the cytosol of PASMCs during hypoxia, 
using targeted expression of a thiol redox sensitive ratiometric fluorescent protein 
sensor, RoGFP. With the help of this novel approach they detected increased 
ROS signalling in the intermembrane space and the cytosol during hypoxia, and 
concluded that hypoxia activates subcellularly compartmentalised redox 
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signalling, which is associated with increase in cytosolic ROS, thus leading to the 
development of the HPV response (Waypa et al., 2010). 
These two opposing hypotheses raise the obvious question as to whether ROS 
actually increases or decreases during hypoxia. The proponents of both 
hypotheses mentioned the methods used for measuring ROS as a key problem. 
Further work is necessary to resolve this point-counter point argument. 
+
1.7.2.4 K channels 
In PASMCs, K
+ 
channels play a crucial role in the maintenance of negative 
resting membrane potential (-60 to -50 mV). As described in the earlier sections, 
functional K
+ 
channels expressed in PASMCs include KV, KCNQ (KV7), BKCa, 
KATP, and K2P. The involvement and role of these channels in the mechanisms 
underlying HPV will be discussed in this section. 
K2P channels have been recently identified in PASMCs as a non-inactivating 
current, denoted IKN, which is characterised by little time or voltage dependency 
(Evans et al., 1996). It has been reported that K2P subtype TASK-1 exhibits 
sensitivity to hypoxia (Olschewski et al., 2006), and, therefore, these channels 
may be functionally important in mechanisms underlying HPV. 
Another class, BKCa channels are expressed in PASMCs, though the relative 
contribution to the whole cell current varies between different species and in 
different regions of the pulmonary arterial tree (Mandegar et al., 2002). Recent 
report suggests that during hypoxia an attenuation of BKCa currents occurs via an 
inhibition of cAMP/PKA dependent pathway in rat PASMCs (Barman et al., 
2005). In the pulmonary arteries, currently, BKCa channels are not considered to 
be important in HPV. However, recent study suggests that BKCa channels in 
PASMCs might play an indirect role in HPV. Since BKCa channels contribute to a 
diminished vascular tone, their increased expression in remodelled PA (e.g., in 
COPD) might play a role in attenuating HPV (Peinado et al., 2008). 
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KATP is another ubiquitous class of K
+ 
channels, which show little or no voltage-
dependence. It is believed that under basal conditions the open probability of KATP 
channels is low (Jackson, 2000a). Some evidences suggest that KATP may 
contribute to resting membrane potential in PASMCs, although the regulatory 
mechanisms are still to be elucidated (Cui et al., 2002). There is no proposed role 
for KATP channels in HPV, as it has been suggested that KATP channels are 
normally closed in the pulmonary arteries and are not activated by the levels of 
hypoxia that cause a constriction (Robertson et al., 1992). 
KCNQ (KV7) channels are also expressed in PASMCs, where they play an 
important role in contractility (Joshi et al., 2006) but a role in HPV is currently 
not established. However, in PASMCs, KCNQ (Joshi et al., 2006) and TASK-1 
(Gurney & Manoury, 2009) channels are known to be open at the physiologic 
range of resting membrane potentials. Therefore, it is possible that if they are 
inhibited by hypoxia, it may contribute to membrane depolarisation in PASMCs, 
which will also promote activation of KV channels and lead to HPV (Olschewski 
et al., 2006;Gurney & Manoury, 2009). 
The role of KV channels in HPV was not established until 1992, when Post et al. 
described for the first time that hypoxia could inhibit KV channels in pulmonary, 
but not systemic, SMCs, and thus cause depolarisation (Post et al., 1992). This 
ground breaking discovery led to the K
+ 
channel hypothesis of HPV (Weir & 
Archer, 1995). Currently we have ample evidence to claim that a range of K
+ 
channel types may be inhibited to a greater or lesser extent by hypoxia (Lopez-
Barneo et al., 2001). It is well documented that the K
+ 
current suppressed by 
hypoxia in PASMCs is voltage-gated and sensitive to 4-AP, and therefore most 
probably are KV channels (Post et al., 1995;Osipenko et al., 1997;Turner & 
Kozlowski, 1997;Archer et al., 1998). Though the role of KV channels in HPV is 
generally established (Reeve et al., 2001), there is a controversy about which 
subtype of KV channels or which other types of K
+ 
channels might contribute to 
HPV (Gurney et al., 2002). 
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1.7.2.5 KV channels 
Hypoxia causes inhibition of KV channels in pulmonary arterial SMCs but does 
not inhibit K
+ 
current in systemic arterial SMCs, such as renal or mesenteric 
arteries (Post et al., 1992;Yuan et al., 1993). In PASMCs, the degree of K
+ 
current 
inhibition and membrane depolarisation is proportional to the severity of hypoxia 
(Olschewski et al., 2002). This study also suggests that hypoxia acts primarily on 
the KV current in rat PASMCs, as after inhibition of KV current with 4-AP (5 mM), 
hypoxia does not reduce the current further. Moreover, in resistance PA, 
pretreatment with 4-AP (10 mM) eliminates subsequent HPV, but not 
phenylephrine constriction (Archer et al., 2004). Collectively, these observations 
support the hypothesis that KV channels could play a central role in the 
mechanism underlying HPV. The importance of KV channels in the regulation of 
HPV has further been supported by Smirnov et al. (1994) who showed that 
chronic hypoxia (pO2 30-35 mmHg) was associated with a marked (40-50%) 
reduction in KV current (IKv) amplitude. Similar to acute hypoxic episodes, 
chronically hypoxic animals had a resting membrane potential that was 
significantly more positive (-43.5±2 mV) than that observed in normoxic animals 
(-54.3±2 mV) (Smirnov et al., 1994). Application of 1 mM 4-AP mimicked this 
depolarisation. 
Several attempts have been made to identify the molecular properties of native 
PASMC O2-sensitive KV channel subunits (Archer et al., 1996;Patel et al., 1997). 
These studies report that in the presence of the KV1.x channel inhibitor correolide, 
hypoxia exhibited reduced ability to depolarise resistance PASMCs, indicating a 
central role for the KV1.x family channels in hypoxic depolarisation (Archer et al., 
2004). Decreased mRNA expression and attenuated protein expression of the KV 
channel α-subunits (KV1.1, KV1.5, KV2.1, KV4.3 and KV9.3) have been reported in 
primary cultured PASMCs but not in MASMCs (Platoshyn et al., 2001). Multiple 
KV channel homotetrameric subunits (KV1.2, KV1.3, KV2.1 and KV3.1) and 
heterotetrameric subunits (KV1.2/ KV1.5, KV1.5/ KVβ1.1 and KV3.1/ KV9.3) have 
demonstrated sensitivity to acute hypoxia (Coppock & Tamkun, 2001). All the 
studies verify a potential role for the KV α-subunits KV1.2, KV1.5, KV3.1b and 
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KV2.1/KV9.3 which display similar hypoxic inhibition and are all slowly 
inactivating voltage-gated channels sensitive to 4-AP but not to ChTX. Several β-
subunits are expressed in PASMCs and may interact with the KV1.x family as 
oxidoreductase enzymes and can function as redox sensors (MacKinnon, 
1991;Yuan, 2001). β-subunits may have a significant role in O2 response as it has 
been demonstrated for the KV1.2β subunit co-expressed with the KV4.2α subunit 
(Archer et al., 1999). 
Among the KV subunits discussed above, KV1.5 alone or in association with 
KV1.2 seem to play central role in HPV. This is supported by various studies. 
Thus, hypoxia inhibits KV1.5 cloned from human PAs (Archer et al., 2004) and 
HPV is diminished in KV1.5 knock out mice (Archer et al., 2001). Interestingly, 
the effects of hypoxia, apparently are not directly on the channel protein, rather it 
appears to be tissue specific, because, when the human KV1.5 is overexpressed in 
MASMCs, hypoxia does not reduce IK. However, when it is overexpressed in 
PASMCs, hypoxia reduces IK by 40% (Platoshyn et al., 2006). A recent study 
using single-cell reverse transcription-PCR, has shown that in PASMCs the level 
of expression of KV1.5 correlates with the sensitivity of the IK in the individual 
PASMC to hypoxia (Platoshyn et al., 2007). This study therefore suggests that the 
response to hypoxia may vary between different PASMCs depending on the 
expression level of KV1.5. This observation gave rise to the concept of 
‘pacemaker’ PASMCs, which, in response to hypoxia, may initiate contraction 
and pass the signal to other PASMCs through gap junctions. The central role for 
KV1.5 α-subunits in HPV is also supported by the effect of chronic hypoxia on 
expression of mRNA and protein for KV channels, which is decreased relatively 
quickly in PASMCs (Smirnov et al., 1994;Osipenko et al., 1998;Reeve et al., 
2001). In the case of KV1.2, KV1.5 and KV2.1, the decrease in mRNA occurs 
within 6 hrs of the onset of hypoxia (Hong et al., 2004). In line with the decrease 
in KV channel expression, acute HPV is diminished in rats that have been exposed 
to chronic hypoxia (McMurtry et al., 1978), and can be restored by the 
transfection of human KV1.5 using an aerosol (Pozeg et al., 2003), again 
supporting the importance of KV1.5 in the mechanism of HPV. This notion is 
further supported by the findings that KV1.5 protein is most abundant in the SMCs 
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of resistance PAs, even though mRNA for many other KV channel is also present 
(Archer et al., 2004). 
Although it is widely accepted that hypoxic inhibition of KV channels forms the 
core of the K
+ 
channel hypothesis of HPV, it’s still unclear how acute hypoxia 
inhibits KV channel function and how chronic hypoxia downregulates KV channel 
gene expression. Potential intermediates or factors which may be involved in 
hypoxia-induced inhibition of KV channel function and expression, include 
oxygen radicals, mETC, NADPH oxidase, redox status, metabolic inhibition, 
cytochrome P-450 oxidoreductase, cytochrome c, cellular redox status changes, 
endothelin-1 production, and conformational changes of α- and β-subunits (e.g., 
due to cysteine reduction of the channel protein), and phosphorylation of α- and β-
subunits (Patel et al., 2004). 
According to the redox hypothesis cellular redox status, mitochondria, O2 sensing 
and KV channels are all linked together ultimately resulting in HPV. Archer and 
colleagues (1993) were the first group to propose a redox based O2 sensor as a 
regulatory point in the response of pulmonary vasculature to hypoxia. They 
suggest that a more reduced cytosolic state due to decrease in ROS is responsible 
for vasoconstriction via inhibition of K
+ 
channels, which were demonstrated to be 
responsive to changes in cell redox state (Weir & Archer, 1995). Since this initial 
observation this group has continued extensive research in support of this 
hypothesis. Later they were able to demonstrate opposing effects of oxidants 
(which increase cellular redox state) and antioxidants (which decrease cellular 
redox state) on whole cell K
+ 
channel currents (Reeve et al., 1995). Recent study 
also indirectly support the redox hypothesis by showing that the thiol oxidant 
diamide causes PA vasodilation via activation of K
+ 
channels and inhibition of 
SOCCs (Schach et al., 2007). Proponents of the redox hypothesis postulate that 
the high basal levels of H2O2 in PA may actually activate K
+ 
channels and, 
therefore, in hypoxia a decrease in mitochondrial H2O2 production would block 
them (Michelakis et al., 2004). This concept is supported by the finding that IKv is 
inhibited by mETC inhibitors, in particular those acting on complex I and III (the 
major sites of ROS generation) (Archer et al., 1993). On the contrary, 
mitochondrial uncouplers, which decrease mitochondrial membrane potential 
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(∆Ψm) (Yuan et al., 1996), and metabolic inhibitors (e.g. 2-deoxyglucose) (Yuan 
et al., 1994) also inhibit IKv in PASMCs, suggesting the presence of multiple, 
presently undetermined, mitochondria-dependent mechanisms which affect IKv in 
PASMCs. Importantly, these studies were only focussed on the inhibition of IKv 
amplitude, which does not allow for discrimination between mitochondria-
specific and non-specific actions of inhibitors (Searle et al., 2002). 
Interestingly, hypoxia also causes an enhancement of IKv at negative voltages in 
addition to its inhibition at positive voltages, an observation which is not 
discussed in studies demonstrating this phenomenon in both canine (Post et al., 
1992) and rat (Archer et al., 1993;Turner & Kozlowski, 1997) PASMCs. This 
phenomenon could however be explained by recent findings where the interaction 
between mitochondria and KV channels in PASMCs was studied in details. Thus, 
2+ 
Firth et al. (2008) described a novel Mg - and ATP-mediated mechanism by 
which mitochondria may directly regulate KV channel activity, in such a way that 
inhibition of mETC enhances IKv at negative potentials but decreases current 
amplitude at positive potentials, in addition to any effects of intracellular ROS or 
redox state. This study predicts that inhibition of IKv by hypoxia may only occur 
following partial depolarisation. Notably, in the following study Firth et al. (2009) 
show that this mechanism is facilitated by a very close approximation of 
mitochondria with the PASMC membrane, whilst in systemic artery SMCs this 
close approximation is absent. This discovery of a difference in the spatial 
distribution of mitochondria specifically in PASMCs has potentially opened a new 
avenue for further role of KV channels in the development of the HPV response. 
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1.8 Metabolic Regulation of Vascular Tone: mitochondrial oxidative 
phosphorylation and glycolysis 
1.8.1 Role of mitochondria in metabolic regulation of vascular tone 
The role of mitochondria as cellular energy provider is well established but its 
importance in the regulation of vascular contractility and HPV is poorly 
understood. Cellular energy is derived from metabolic fuels like glucose, fatty 
acids and amino acids. Initially these molecules are processed by anaerobic 
glycolysis in the cytosol and β-oxidation (fatty acid metabolism) in mitochondria. 
Figure 1.4 illustrates the main pathways for metabolism of glucose by glycolysis 
and oxidative phosphorylation. ATP, the end product of glycolysis and oxidative 
phosphorylation, is thus utilised to maintain cellular function as well as for the 
generation and maintenance of vascular tone. 
1.8.2 Mitochondrial oxidative phosphorylation 
The mitochondria occupy a considerable proportion of the cells cytoplasm and are 
crucial to cellular energy production enabling it to produce upto 38 ATP by 
mitochondrial oxidative phosphorylation whereas in glycolysis only 2 ATP is 
produced from each molecule of glucose (Leach et al., 2002) (Fig. 1.4). By a 
chemiosmotic process, large amounts of energy are harnessed in the inner 
mitochondrial membrane, which is used to drive the production of ATP. This 
chemiosmotic process was first proposed by Mitchell in 1961 (Mitchell, 1961) 
who further proposed that uncouplers of oxidative phosphorylation acted as 















































Figure 1.4 Simplified diagrams of smooth muscle metabolic pathways and 
cellular respiration. 
Glucose undergoes glycolysis to produce pyruvate and a net 2 ATP molecules. 
Pyruvate is transported by a pyruvate carrier into the mitochondrion where it is 
converted to acetyl CoA. Acetyl CoA is also derived from fatty acids (β-
oxidation) and amino acids (de-amination). Acetyl CoA then enters the Krebs 
cycle where the acetyl group is further oxidised to generate NADH and ubiquinon 
(enzyme Q). NADH acts as the reducing equivalent driving the mETC and 
enzyme Q additionally gains two H
+ 
that are also transferred to complex III, and is 
reduced to ubiquinol. Electrons are transported from complex I and II to III via 
coenzyme Q (Qe 
-
) and from complex III to IV via cytochrome c (cytc e 
-
). The 
electrochemical gradient (∆p) created by movement of protons into the inner 
mitochondrial space drives H
+ 
back across the membrane via the F0/F1 ATP 
synthetase, producing ATP which itself is transported out of the mitochondrion by 




1.8.3 Mitochondrial electron transport chain (mETC) 
The mitochondrial electron transport chain or respiratory chain (complexes I-V) is 
the major site responsible for ATP production by oxidative phosphorylation. 
Mitochondrial oxidative phosphorylation is the process by which a series of multi-
subunit of enzyme complexes interact in passing electrons down a series of redox 
reactions and simultaneously storing energy as an electrochemical proton gradient, 
which will ultimately drive the generation of mitochondrial ATP. During 
metabolism, substrate molecules are progressively dehydrogenated producing 
hydrogen ions. The hydrogen ions are transferred to nicotinamide adenine 
dinucleotide (NAD
+
) and flavin adenine dinucleotide (FAD) to form the reduced 
form of the co-enzymes NADH and FADH2. Reoxidation of these co-enzymes 
releases electrons (e 
-
) and protons which then enter the mETC. 
Complex I (ADH dehydrogenase) 
The reduced co-enzymes NADH and FADH2 are high energy electron carriers 
generated by the Krebs cycle and transferred to the inner mitochondrial membrane 
where NADH acts as a reducing equivalent feeding complex I. Complex I is 
reduced by accepting e 
-





are passed via flavin to ubiquinone (enzyme Q) which transports the electron to 
complex III. In this process ubiquinone is reduced to ubiquinol. 
Complex II (cytochrome b-c complex or Co-enzyme Q reductase) 
-
In addition to passing e to complex III, complex II also functions to add 
additional e to the quinone pool by removing e from succinate. Complex II 
bypasses complex I by transferring the electrons from succinate to co-enzyme Q. 
Complex III 
In complex III a phenomenon known as the Q cycle occurs. Ubiquinone is 
regenerated in complex III via ubisemiquinone, the putative site for ROS 
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generation, and cycles back to complex I and II within the inner mitochondrial 
membrane (Fig. 1.5). During the Q cycle four protons move across the 
mitochondrial inner membrane, adding to the proton gradient initiated in complex 
I (Yu et al., 1998a;Hunte et al., 2003). If the ∆Ψm is altered by metabolic 
inhibition or by drugs (e.g., antimycin A), the electron transport is disrupted. This 
might cause an increase in ROS production at this complex (Fig. 1.5). 
Complex IV (cytochrome oxidase) 
In the complex IV, the final acceptor of electron is the molecular O2 which 
accepts four electrons and subsequently is reduced to form a water molecule (Fig. 
1.5). 
Complex V (F0/F1 ATP synthetase) 
F0/F1 ATP synthetase is present in the mitochondrial inner membrane where the 
F0 part resides in the membrane whilst the F1 part protrudes above the membrane 
into the matrix. The F0/F1 ATP synthetase is driven by the proton gradient (∆p) 
that is created by complexes I, III and IV of the mETC across the mitochondrial 
inner membrane. Generated ∆p drives the formation of ATP from ADP and 
inorganic phosphate (Pi) (Stock et al., 2000). It can be summarised as: 
NADH + H
+ 
+ 3ADP + 3Pi + 
1
/2O2 � NAD + 3ATP + H2O. 
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Figure 1.5 Simplified diagram of the mETC and its complexes, showing point 
of action of key inhibitors. 
Oxidation of NADH at complex I and FADH2 at complex II results in transfer of 
electrons by ubiquinone (enzyme Q) to complex III and then to complex IV by 
cytochrome c. The final electron acceptor in complex IV is molecular O2 
-
generating water. Superoxide radicals (O2 ) are produced at both complexes I and 
III by a single electron transfer to molecular O2. The correct functioning of the 
mETC complexes maintains mitochondrial membrane potential (∆Ψm). mETC 
inhibitors and their site of action are rotenone (inhibiting complex I), myxothiazol 
(inhibiting complexes I and proximally in III), antimycin (inhibiting distally 
complex III) and cyanide (inhibiting complex IV). Inhibition at any point in the 
-
chain will cause proximal reduction and distal oxidation. Q, ubiquinone; e , 
electron; uQ, ubisemiquinone; Cyt c, Cytochrome c. 
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1.8.4 Anaerobic respiration 
Adenosine triphosphate (ATP) is a molecule capable of storing and transferring 
large amount of energy. Energy derived from the hydrolysis of ATP is essential 
for muscle contraction, protein synthesis and ion transport across cell membrane. 
In addition to mETC, ATP is also produced from anaerobic sources by glycolysis 
and creatine kinase. ATP and ADP are relatively large, immobile molecules reside 
within the mitochondria, or close to the site of energy utilisation. On the other 
hand phosphocreatine (PCr) is a small, freely diffusible molecule which can carry 
high energy bond from the mitochondria to the sites of utilisation. In the 
mitochondrial outer membrane ATP phosphorylates creatine (Cr) to form 
phosphocreatine; the process is catalysed by creatine kinase (Clark, 1994). The 
PCr carries high energy bond to the sites of utilisation where the creatine kinase 
reaction is reversed resulting in transport of phosphate from PCr to ADP, thus 
forming ATP: 
[ATP] + [Cr] ↔ [PCr] + [ADP] + [H
+
]. 
Another anaerobic mechanism which maximises energy production by generating 
ATP from ADP by transforming a high energy phosphate: 
[ADP] + [ADP] � [ATP] + [AMP]. 
Generally mitochondria provide the majority of ATP for cell function, however, 
vascular smooth muscles are unusual in that they exhibit high levels of glycolysis 
enabling them to generate ~30% of total ATP production even during normoxia, 
and accounts for ~90% of the glucose utilised by the cell (Paul, 1989). 
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1.8.5 Pharmacological tools to intervene mitochondrial oxidative 
phosphorylation and glycolysis 
Pharmacological tools utilised to intervene with oxidative phosphorylation, 
mainly target complexes I, III and IV of the mETC. The commonly used 
inhibitors of these complexes are shown in Fig. 1.5. 
An inhibitor of complex I, rotenone, blocks electron transfer in close proximity to 
the ubiquinone binding site (Andreyev et al., 2005). Inhibition of complex I by 
rotenone has already become a well established experimental model enabling 
mitochondria to become a pharmacological target (Szewczyk & Wojtczak, 2002). 
Antimycin A prevents transfer of electron by inhibiting the Q cycle distal to 
ubisemiquinone in (Fig. 1.5) causing accumulation of unstable semiquinone, thus 
stimulating superoxide production (Turrens, 2003). Myxothiazol, on the other 
hand, by inhibiting proximal to ubisemiquinone in the Q cycle (Fig. 1.5), prevents 
and/or inhibits the effect of antimycin A, leading to inhibition of superoxide 
production in mammalian mitochondria (Zoccarato et al., 1988;Korshunov et al., 
1997). Mitochondrial inhibitors rotenone and myxothiazol dose-dependently 
inhibit HPV without mimicking the effect of HPV in normoxic conditions 
(Weissmann et al., 2003). However, another report suggests that rotenone, 
cyanide, myxothiazol and oligomycin mimic the effects of hypoxia via inhibition 
of a background K
+ 
current leading to membrane depolarisation and voltage-gated 
2+ 
Ca entry (Wyatt & Buckler, 2004). Cyanide inhibits cytochrome c at complex 
IV, thus causing disruption of the mETC at the final step. Thus cyanide could be a 
helpful pharmacological tool to investigate the dependence of contraction on the 
oxidative metabolism mediated by mitochondria in intact arteries (Otter & Austin, 
2000;Leach et al., 2001;Swärd et al., 2002). Two commonly used inhibitors of the 
ATP synthetase are oligomycin, which binds between the F0 and F1 subunits, and 
dicyclohexylcarbodiimide (DCCD) which binds in the F0 subunit of the F0/F1 
ATP synthetase. These inhibitors selectively inhibit mitochondrial oxidative 




When the mETC is impaired, e.g. in the presence of inhibitors or uncouplers, the 
proton gradient will be reduced, but respiration will proceed. However, the ATP 
synthesis will be activated in the reverse mode resulting in ATP hydrolysis instead 
of synthesis, in order to maintain mitochondrial membrane potential. 
Both iodoacetate and 2-deoxyglucose (2-DOG) inhibit anaerobic production of 
ATP by blocking glycolysis (Stanbrook & McMurtry, 1983), and therefore were 
used to assess the role of glycolysis in intact preparations (Gasser et al., 
1993;Conway et al., 1994;Leach et al., 2001;Fukumoto et al., 2005). The 
combination of cyanide with 2-DOG is also useful to obtain a complete inhibition 
of both glycolysis and oxidative phosphorylation, thus preventing the majority of 
ATP production (Lancaster & Harrison, 1998). 
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1.9 Aims and objectives of the thesis 
Studies carried out in isolated cells undoubtedly support the proposal for the 
leading role of KV channels in the regulation of resting membrane potential in the 
pulmonary circulation. The close link between the KV channels and mitochondria, 
specifically in the pulmonary artery, has also been proposed. This hypothesis is 
based on electrophysiological studies performed in single myocytes, but whether 
such a relationship exists in intact arteries is not known. The KCNQ channels 
have also recently been considered as the regulator of the pulmonary vascular tone. 
However, the relative contribution of KV and KCNQ channels to the regulation of 
the cell membrane potential in intact pulmonary artery has not been addressed. 
The main aims of this thesis therefore were: to investigate the relative contribution 
of the KV and KCNQ channels in the regulation of pulmonary artery excitability 
and contractility under normal and hypoxic conditions and to establish a potential 
interaction between the KV channels and mitochondria in intact pulmonary 
arteries. To determine the specificity of the observed effects to the pulmonary 
circulation, the rat mesenteric artery was used as a representative of the systemic 
circulation. 
Thus, the initial objectives of this thesis were: 
1.	 To identify the relative role of KV and KCNQ channels in vascular 
contractility using selective pharmacological inhibitors, small vessel 
myography, microelectrode technique and confocal imaging. 
2.	 To investigate the involvement of KV and KCNQ channels in acute 
hypoxia-induced pulmonary vasoconstriction. 
3.	 To assess the relative contribution of the voltage-dependent and voltage-
2+ 





channels using specific inhibitors, western blot analysis 
and tissue permeabilisation technique. 
4.	 To determine the relative role of mitochondria and cellular metabolism in 
contractions induced by the inhibition of KV channels using selective 
inhibitors. 
5.	 To identify species differences by comparing contractile responses to K
+ 




MATERIALS AD METHODS 
2.1 Isolation of blood vessels 
Male Wistar rats (weighing 250-300 g) and male CD mice (weighing 35-40 g), 
were killed by cervical dislocation in accordance with UK Home Office 
guidelines. The heart and lungs were removed en bloc after opening of the chest 
cavity from the diaphragm and cutting the rib cage. Subsequently the abdominal 
area was opened midline and the whole mesenteric bed was removed. All tissues 
were placed in 100 ml of Krebs solution and kept on ice for micro dissection. Rat 
rd 
intrapulmonary arteries (internal diameter 300-500 µm) and 3 order mesenteric 
arteries (internal diameter 250-400 µm) were micro dissected, cleaned of 
connective tissues whilst remaining intact in the organ. Mouse arteries were 
collected in the similar way except that the main intrapulmonary arteries (diameter 
250-350 µm) and 1
st 
order mesenteric arteries (internal diameter 150-250 µm) 
were collected. Arteries were cut into sections of ~2 mm length while maintaining 
in the ice cold Krebs solution in the dissection Petri dish. A piece of 40 µm 
diameter stainless steel wire (DMT/AS) was carefully inserted through the lumen 
of the piece of the artery which was subsequently mounted into the jaws of wire 
myograph following the procedure as described in details bellow. All of the above 
procedures were carried out using a microscope (Leica, Zoom 2000 or Meiji, 




A. Rat intra pulmonary arteries B. Mouse intrapulmonary arteries

Figure 2. 1 Micro-dissection of rat and mouse intra pulmonary arteries. 
A piece of ~ 2 mm long intra pulmonary artery was collected from the indicated 
area (1) and (2) from rat lung and area (3) from mouse lung. From the mouse lung 
the main intra pulmonary artery was taken instead of taking side branch because 
the diameter of the later was very small which made small vessel mounting more 
difficult with less reliable level of success. 
2.2 Myography 
The contraction was measured using small vessel wire myograph (Mulvany et al., 
1982;Mulvany, 1988;Mulvany & Aalkjaer, 1990;Buus et al., 1994;Mulvany, 
1999). The myograph is a form of organ bath which is composed of a horizontal 
stainless steel chamber containing two opposing stainless steel ‘jaws’. Each jaw 
has a pair of ‘teeth’ between which the arterial ring will be positioned with the 
help of two pieces of stainless steel wire. The jaw on the right is attached to a 
micrometer for adjusting the distance between the two jaws (Fig. 2.2). 
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Figure 2. 2 Jaws of myograph. 
Original photograph shows the 
arrangements of one pair of jaws of 
a wire myograph. One of the jaws is 
attached to the force transducer 
(left), and the other jaw (right) is 
attached to the micrometer which is 
manually adjusted to apply tension 
on the mounted vascular ring. 
These micrometers are manually operated for the normalisation procedure. The 
jaw on the left is attached to a force transducer via a steel rod that passes through 
a hole in the side of the chamber. The hole through which the rod passes is sealed 
with vacuum grease provided by Danish Myotechnology (Aarhus, Denmark). The 
ring of artery was mounted on two pieces of 40 µm stainless steel wire, attached 
to each of the two jaws. The detailed procedure of mounting the tissue is 
described below (section 2.2.2). The two vessel Mulvany-Halpern myograph (also 
called dual myograph) is equipped with two pairs of jaws enabling mounting of 
two pieces of arterial ring in the same bath solution at the same time. In my study 
I used one pulmonary and one mesenteric artery ring in parallel to investigate the 
differences in tissue responses being simultaneously challenged with the same 
substance under the same experimental conditions. In some experiments I also 
used multi myograph system (four channel myograph, Model 610M, Danish 
Myotechnology, Denmark). In that system two pulmonary and two mesenteric 
artery rings were mounted in four chambers and the rest of experimental 
conditions was identical. The responses were repeated in a dual chamber 
myograph and no significant difference in tissue responses was observed. I also 
used multi myograph system for the membrane permeabilisation experiments that 
I carried out at King’s College London, because this procedure required different 
approach (as described in Section 2.3 below). 
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2.2.1 Solutions used in myography















aCl 118 102 92 82 42 
aHCO3 24 24 24 24 24 
MgSO4 1 1 1 1 1 
aH2PO4 0.5 0.5 0.5 0.5 0.5 
KCl 4 20 30 40 80 
Glucose 11 11 11 11 11 
CaCl2 1.8 1.8 1.8 1.8 1.8 
pH = 7.35 
2.2.2 Vessel mounting procedure 
Before starting the mounting procedure myograph chamber(s) was filled with 10 
ml (dual myograph) or 5 ml (four-channel myograph) PSS at room temperature; 
chamber and solutions were continuously gassed with 95% O2/5% CO2 mixture. 
Pieces of stainless steel wire were freshly cut ready to be used for mounting the 
vessel. In the dissection Petri dish under low magnification the first wire was 
inserted through the lumen of the arterial ring with great care to avoid any damage 
to the lumen wall. Once the first wire was inserted the arterial ring was then 
transferred from Petri dish to the myograph chamber holding the two edges of the 
wire with blunt forceps. The first wire along with the arterial ring was attached to 
one of the two jaws. The wire was first hold tightly between the jaws and then one 
end was secured under one of two screws. The wire was placed under the screw 
such that when the screw is tightened, always in a clockwise direction, the wire 
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will be tighten up further by the movement of the screw (Fig 2.3 i). In the same 
way the other end of the wire was also secured under the other screw of the same 
jaw (Fig 2.3 ii). Care was taken so that both ends of the wire were secured tightly 
and that there was no slack in the wire. This was achieved by holding the free end 
of the wire tightly with blunt forceps and pulling it taut while manoeuvring it 
under the screw, and continuing to hold it taut while tightening the screw with the 
other hand. The wire was passed under the side of the screw that will result in the 
wire being pulled tighter when the screw is tightened clockwise (Fig 2.3 i and ii). 
Once the first wire was secured the jaws were opened and the second wire was 
then passed through the lumen of the artery already secured by the first wire (Fig 
2.3 iii). The wire was held in the middle with blunt forceps and held in such a way 
that it lied parallel to the bottom of the chamber and in parallel with the artery ring. 
By placing the tip of the second wire at the opening at either end of the mounted 
artery a simple wrist action was all that was required for this wire to pass through 
the lumen of the artery. Care was taken to keep the tip of the second wire straight 
and to keep it parallel with the first wire (Fig 2.3 iii). 
Once the second wire had been passed through the artery ring such that the artery 
sits roughly in the middle of it, the jaws were re-closed in order to clamp onto the 
second wire and render it immobile (Fig 2.3 iv). Then the two ends of the second 
wire were secured under the two screws of the second jaw. The first end was 
secured with the jaw closed; tightening the screw over the wire such that the wire 
was pulled tight as the screw was tightened (fig 2.3 vi-x). The jaws were then re-
opened just enough to loosen the hold over the second wire (Fig 2.3 vii), and as 
with the first wire, the free end was held tightly with forceps and pulled taut to 
take up all slack as it was passed under the remaining screw and as the screw is 
tightened (Fig 2.3 viii-x). If the two wires were not perfectly parallel, the 
elevation of one or the other at one end or the other was carefully adjusted with 
blunt forceps in order to properly align it with the other. While warming up the 
myograph before normalisation, the jaws were set slightly apart to prevent the two 
































Figure 2. 3 Step-by-step diagrams demonstrating vessel mounting procedure 
on a wire myograph. 
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2.2.3 ormalisation of the tension 
Tension was normalised using a normalisation protocol which also enables to 
obtain circumference, diameter of the vessel ring, and tension (mN/mm) under a 
specified transmural pressure. After mounting, the vessel rings were stabilised in 
Krebs with continuous bubbling with a gas mixture of 95% O2 and 5% CO2 at 37
o
C 
for 1h. The temperature was controlled and maintained by the built-in heater. 
Following stabilisation vessel rings were set to an internal circumference at which 
they were just held under tension. The micrometer was adjusted manually and the 
resting tension-internal circumference relation was determined using the custom 
written program called NORMALIZE (McPherson, 1985). The vessel rings set to a 
normalised tension by re-adjusting the micrometer in a position determined by the 
software. This software allows the calculation of transmural pressure for a vessel. By 
re-adjusting the level of stretch on a vessel by small increments, pressure was 
increased or decreased until the optimum physiological pressure was achieved which 
in rodent intra pulmonary artery is ~15 mmHg (Herget et al., 1978;MacLean & 
McCulloch, 1998;Boer et al., 2004;Baliga et al., 2008;Kelland et al., 2010) and 
small mesenteric artery is ~100 mmHg (Mulvany & Halpern, 1977;Madhani et al., 
2003;Baliga et al., 2008). 
2.2.4 General experimental procedure in myography 
Following a one hour stabilisation period the vessels were checked for viability 
using 80 mM KCl for 3 min each. At least three to four consecutive high K
+ 
(80 
mM KCl) applications were carried out to establish a contraction of reproducible 
maximal amplitude. Only vessels developing a tension of >3 mN for rPA and >6 
mN for rMA were deemed suitable for tension recording. For mouse tissue a 
slightly less tension with high K
+ 
(>2 mN for mPA and >4 mN for mMA) was 
deemed acceptable because of comparatively smaller diameter of mouse vessels. 
Because the main focus of this work was the role of ion channels in smooth 
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muscle cells, the endothelial function was suppressed by using 100 µM L-NAME 
ɷ
(N -nitro-L-arginine methylester) to block nitric oxide synthase and 10 µM 
indomethacin to inhibit cycloxigenase. To verify that endothelium is not 
interfering with the observed responses to 4-AP, these were compared with the 
responses obtained following the mechanical removal of the endothelium by a 
gentle rubbing of the endothelial lumen with a human hair. A single dose of 10 
µM acetylcholine was used to verify the lack of endothelium-dependent relaxation. 
As no difference was observed, all experiments were performed in the presence of 
L-NAME and indomethacin. 
In majority of experiments, the procedure composed of 3 steps: control, 
pretreatment with agonist and recovery; each are described in the relative chapters. 
In between different steps, tissue contractility and viability was re-established by 
regular wash-out with Krebs and 80 mM KCl (approximately every 10 to 15 min). 
Each subsequent experimental step was applied only when the amplitude of 
contraction to 80 mM KCl was established. The maximal contraction to 80 mM 
KCl response (measured at the end of 3 min for PA or as the peak contraction in 
MA) immediately prior to an experimental procedure was considered as 100%. 
Tension developed in the response to a vasoactive substance or an inhibitor was 
expresses as percentage of 80 mM KCl contraction (unless otherwise stated). 
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Table 2.2 Vasoactive mediators used in tension study









20 - 80 mM 
4-AP KV channel blocker 0.5 M 
(H2O) 
0.5-10 mM 
Linopirdine KCNQ channel blocker 10mM 
(Ethanol) 
10 µM 
Y-27632 Rho-kinase inhibitor 10mM 
(H2O) 
10 µM 




10 nM -1 µM 
L-AME e-NOS blocker 100mM 
(H2O) 
100 µM 










channel blocker 1mM 
(DMSO) 
1 µM 
ACh e-NOS stimulant, vasodilator 10mM 
(H2O) 
10 µM 







2.3 Membrane permeabilisation 
Vascular smooth muscle cell membrane permeabilisation is a valuable technique 
for the direct control of cytoplasmic solute composition and for understanding of 
contractile mechanism (Kitazawa et al., 1989;Kobayashi et al., 1989). In this 
study, two different methods of membrane permeabilisation, that produces 
different levels of membrane skinning, were carried out: α-toxin permeabilisation 
and β-escin permeabilisation. α-toxin permeabilisation was carried out with a 
commercially available α-toxin (Sigma-Aldrich Co. Ltd, Poole, UK). It is a 
widely used technique to study effects of drugs and action of transmitters in 
smooth muscle for exploring in a near-physiological condition as α-toxin makes 
cells permeable to low molecular weight solutes of upto 1000 Da (Ahnert-Hilger 
& Gratzl, 1988). β-escin permeabilisation was carried out with a commercially 
available agent called β-escin which is one of the saponin esters. β-escin 
permeabilisation yields smooth muscle preparations with an apparently intact, 
coupled receptor-effector cascade and a cell membrane that is permeable to higher 
molecular weight (at least 17,000 Da) compounds than does α-toxin (Kobayashi et 
al., 1989). 
2.3.1 Procedure of tissue permeabilisation 
Due to different experimental approach used, most notable differences in 
myography technique for permeabilised arteries compared to non-permeabilised 
vessels were: 1) experiments were conducted at 26ºC rather than 37ºC; 2) because 
external solutions were buffered with PIPES instead of bicarbonate, organ bath 
was gassed with compressed air and not with 5% CO2 and 95% O2. Arteries were 
mounted on a myograph as described in section 2.2.2. After obtaining three 
consecutive contractile responses to 80 mM KCl the arteries were equilibrated in 
normal relaxing solution (G10) containing 10 mM EGTA. Details of the solutions 
2+ 




solutions (expressed as pCa=-log[Ca ] in M) was achieved by mixing K2EGTA 
and CaEGTA in appropriate proportions. Due to high cost of α-toxin, a special 
technique was adopted for α-toxin permeabilisation in Jeremy Ward’s Lab. The 
solution in the myograph chamber was completely removed using a pressure 
suction tube (great care was taken not to touch the arteries during this procedure). 
-1 
Approximately 150 µl of pCa 6.5 solution containing 60 µg ml α-toxin was 
applied directly on the mounted artery; this volume was sufficient to form a large 
drop of solution around the artery with a stable surface tension. During the 
following 30 min, ~25 µl of the same permeabilisation solution was added to the 
drop every 10 min to prevent drying of arteries. The degree of permeabilisation 
was monitored by a slow development of tension. Permeabilisation process 
considered to be completed when tension reached a plateau level. The artery was 
then relaxed with two consecutive washes with the relaxing G10 solution (termed 
as it has very low pCa <10). When tension returned to the baseline level, 
submaximal contraction was brought about by application of a test solution with 
pCa 7.2 (in rPA) or with pCa 6.4 (in rMA). Vasoactive agents were added to the 
bathing solution once contraction in the test solution reached steady state level. 
Since β-escin is not an expensive chemical, it was added directly in the bath 
solution (50 µM) and left for 30 min to permeabilise the tissue. Both α-toxin and 
β-escin are washed off in G10. 
2.3.2 Solutions and chemicals used for membrane permeabilisation 
In membrane permeabilisation experiments three main solutions were used, the 
tissue relaxing solution G10 and pCa 4.5 (CaG), and other pCa solutions of 
different concentration. The stock solutions and recipe for G10 and pCa 4.5 are 
described in this section. Different concentration of pCa solutions were prepared 
by mixing CaG (pCa 4.5) and G10 solutions in the corresponding ratios shown in 
the table 2.5 at the end of this section. 
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Table 2.3 Stock solutions used for permeabilisation study

100 mM CaEGTA (500 ml) 
100 mM CaCO3 5.0 g 
100 mM EGTA 19.02 g 
195 mM KOH 5.47 g 
Ionic strength = 495 mM 
CaCO3 and EGTA were dissolved in ~450 ml doubled distilled water (ddH2O), 
stirred for 30 min. Then KOH was added and stirred slowly until solution turned 
into a clear one (1-2 hours). The solution left stand for CO2 to leave the solution. 
Finally the volume was made up to 500 ml with ddH2O and the pH was left as it 
was. Stored in the fridge. 
100 mM K2EGTA (500 ml) 
100 mM EGTA 19.02 g 
Ionic strength = 300 mM 
EGTA was dissolved in ddH2O and pH was adjusted to 7.1 by carefully adding 
KOH pellets. Stored at room temperature. 
200 mM PIPES, KOH (500 ml) 
200 mM PIPES 30.24 g 
Ionic strength = 400 mM 
PIPES was dissolved in ddH2O and pH was adjusted to 7.1 by carefully adding 





100 mM Mg(Ms)2 (500 ml) 
100 mM MgO 2.015 g 
200 mM methanosulfonic acid 9.61 g 
Ionic strength = 300 mM 
MgO was dissolved in ~400 ml ddH2O and then methanosulfonic acid was added 
and waited for MgO to dissolve slowly. Volume was made up to 500 ml with 
ddH2O but pH was left as it was. Stored at room temperature. 
1 M KMs (500 ml) 
1 M methanosulfonic acid 48.05 g 
1 M KOH 32.6 g 
Ionic strength = 2000 mM 
Methanosulfonic acid was dissolved in ~400 ml ddH2O and then a KOH was 
added and stirred slowly. Volume was made up to 500 ml with ddH2O but pH was 
left as it was. Stored at room temperature. 
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Table 2.4 Recipe for G10 and pCa 4.5

G10 (1L) pCa 4.5 (500 ml) 
PIPES (200 mM) 150 ml 75 ml 
Mg(Ms)2 (100 mM) 53 ml 26.5 ml 
KMs (1 M) 46.6 ml 23.3 ml 
K2EGTA (100 mM) 100 ml ---------
CaEGTA (100 mM) -------- 50 ml 
a2ATP 2.806 g 1.404 g 
a2creatinine phosphate 2.55 g 1.276 g 
pH adjusted with KOH pH 7.1 pH 7.1 
Storage 2-8 ºC (fridge) -20 ºC (freezer) 
To give total [Mg
2+
] = 5.3 mM 
To give total [Ca
2+
] = 10 mM (pCa 4.5 only) 
To give total [EGTA] = 10 mM 
To give total [ATP] = 5 mM 
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Table 2.5 Ionic strengths of G10 and pCa 4.5

G10 
400 (PIPES)*150/1000 = 60 + 
300 (Mg(Ms)2)*53/1000 = 15.9 + 
2000 (KMs)*46.6/1000 = 93.2 + 
300 (K2EGTA)*100/1000 = 30 + 
15 (Na2ATP) = 15 + 
30 (NaP-Cr) = 30 + 
Total ionic strength = 244.1 mM 
pCa 4.5 
400 (PIPES)*150/1000 = 60 + 
300 (Mg(Ms)2)*53/1000 = 15.9 + 
2000 (KMs)*46.6/1000 = 93.2 + 
495 (CaEGTA)*100/1000 = 19.5 + 
15 (Na2ATP) = 15 + 
30 (NaP-Cr) = 30 + 
Total ionic strength = 263.6 mM 
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Table 2.6 Ratios to obtain corresponding pCa solutions

pCa [CaG] [G10] 
20.0 0.00000 10.00000 
8.0 0.34935 9.65065 
7.5 1.02715 8.97285 
7.4 1.25961 8.74039 
7.3 1.53568 8.46432 
7.2 1.85938 8.14062 
7.1 2.23332 7.76668 
7.0 2.65792 7.34208 
6.9 3.13071 6.86930 
6.8 3.64585 6.35415 
6.7 4.19402 5.80598 
6.6 4.76288 5.23712 
6.5 5.33800 4.66201 
6.4 5.90434 4.09566 
6.3 6.44776 3.55224 
6.2 6.95638 3.03362 
6.1 7.42149 2.57851 
6.0 7.83787 2.16231 
5.9 8.20362 1.79638 
5.8 8.51963 1.48037 
5.7 8.78884 1.21116 
5.6 9.01551 0.98449 
5.5 9.20458 0.79542 
5.4 9.36119 0.63881 
5.3 9.49030 0.50970 
5.2 9.59655 0.40345 
5.1 9.68408 0.31592 
5.0 9.75658 0.24342 
4.9 9.81726 0.18273 
4.8 9.86896 0.13104 
4.7 9.91415 0.08585 
4.6 9.95506 0.04493 
4.5 9.99378 0.00622 
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2.4 Measurement of membrane potential (Em) 
rd 
A segment (~2 mm) of intrapulmonary or small (3 order) mesenteric artery was 
mounted in a two vessel Mulvany-Halpern myograph (Model 400A; Danish 
Myotechnology, Aarhus, Denmark) in Krebs solution containing (mM/L): NaCl, 
118.0; NaCO3, 25; KCl, 3.6; MgSO4
.
7H2O, 1.2; KH2PO4, 1.2; glucose, 11.0; 
CaCl, 2.5; and gassed with 95% O2 and 5% CO2 at 37ºC. The vessel was allowed 
to equilibrate for 1 hour and was then stretched to a tension equivalent to 15 
mmHg (pulmonary artery) or 70 mmHg (mesenteric artery) wall tension using a 
normalisation protocol as described above (in section 2.2.3). Smooth muscle 
tension and membrane potential (Em) were measured simultaneously as previously 
described (Garland & McPherson, 1992). The experiment was performed in a 
Faraday cage and on an anti-vibration table. A conventional glass microelectrode 
(borosilicate with filament, inside diameter 0.69 mm and outside diameter 1.2 mm, 
tip resistance 80-120 MΩ) filled with 2 mol/L KCl was used to impale individual 
smooth muscle cells in rat pulmonary and mesenteric arteries. The microelectrode 
was positioned by an EXFO 1W-812 Stepmotor driven by an 82000-1-0 series 
EXFO controller (Burleigh, USA). Once in position the electrode was impaled by 
gentle tapping on the anti-vibration table or by a pulse of negative capacitance that 
vibrates tip of electrode. Successful impalement was deemed as a sharp downward 
deflection on the recording followed by maintenance of a steady negative 
membrane potential and returned to near baseline upon removal of electrode. The 
measurement of resting membrane potential (RMP) was taken immediately before 
application of K
+ 
channel blockers and in some experiments also after wash out 
and recovery. Tension and membrane potential data were captured by using a 




2.5 Western blot analysis 
Western blot or Immunoblot is a method to detect a specific protein in a given 
sample of tissue homogenate or extract. This method depends on the use of a high 
quality antibody directed against a desired protein(s) that have been separated by 
gel electrophoresis according to their size. Tissues containing target protein are 
first broken mechanically using a homogeniser and then lysed using different 
buffers containing detergents, solubilising agents and different protease and 
phosphatase inhibitors. Detergents, salts and buffers are employed to enhance 
lysis of the cells and to solubilise proteins. Protease and phosphatase inhibitors are 
added to prevent the digestion of the sample by its own enzymes. To fully 
dissociate proteins of the sample into their polypeptide subunits, samples are 
heated with sodium dodecyl sulphate (SDS) and thiol reagent. SDS-PAGE (SDS 
polyacrylamide gel electrophoresis) maintains polypeptides in a denatured state 
once they have been treated with strong reducing agents to remove secondary and 
tertiary structure of protein and thus allows separation of proteins by their 
molecular weight. Sampled proteins become covered in the negatively charged 
SDS and move to the positively charged electrode through the acrylamide mesh of 
the gel. Smaller proteins migrate faster through this mesh and the proteins are thus 
separated according to their size. Following electrophoresis, separated proteins are 
transferred into a nitrocellulose membrane. The gel is placed next to the 
membrane and application of an electrical current induces the proteins in the gel 
to move to the membrane where they adhere. The membrane is thus turned into a 
replica of the gel’s protein pattern, and is subsequently probed with primary 
antibodies raised against specific proteins. Secondary antibodies, tagged with an 
enzyme called horseradish peroxide (HRP), are then added to bind specifically to 
the already bound primary antibodies. HRP-linked secondary antibody is used 
with a chemiluminescent agent (known as enhanced chemiluminescence or ECL) 
that produces luminescence in proportion to the amount of target protein. A 
photosensitive film, placed against the membrane, captures the exposure of light 
from the reaction and thus creates an image of the antibodies bound to the blot. 
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2.5.1 Treatment protocol and tissue preparation for Western blot 
Rat intrapulmonary and small mesenteric arteries were dissected and combined 
from a few animals to minimise individual variation and to maximise the amount 
of protein. Tissues were placed in 1.5 ml eppendorph tubes containing Krebs 
solution and subjected to the following treatment protocol (Table 2.7). The 
protocol was designed to mimic the experimental procedure used in myography 
experiments. To test the effect of tissue stretching main extra-pulmonary artery 
rings were mounted in the myograph and were treated with the same drugs as 
mentioned in the following protocol (Table 2.7). 
Table 2.7 Tissue treatment protocol for Western blot analysis 
Treatment group Treatment protocol 
Control Bubbling with carbogen (95% O2+5% CO2) in Krebs 
solution for 50 min. 
4-AP Bubbling with carbogen in Krebs solution for 10 minutes. In 
continued bubbling 10 µM linopirdine for 20 min followed 
by 10 mM 4-AP for 20 min. 
Y+4-AP In continued bubbling 10 µM Y-27632 for 10 min followed 
by 10 µM linopirdine for 20 min followed by 10 mM 4-AP 
for 20 min. 
After treatment, either non-stretched or stretched, the tissues were collected, snap 
frozen in liquid nitrogen, and stored at -80ºC until used. To prepare protein 
samples for Western blotting vascular tissue samples were mechanically 
homogenised using PowerGen 125 homogeniser (Fisher Scientific, UK) in 10 
volumes per weight (between 200-400 µl) of an ice-cold lysis buffer (Table 2.8). 
Homogenates were centrifuged at 14000 rpm at 4ºC for 15 minutes and 
supernatant was collected. 
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Table 2.8 Buffers used in Western blot analysis and their composition

Buffer Composition 
Lysis buffer 150 mM NaCl, 1 mM EDTA, 50 mM Tris HCl pH 7.5, 1% 
Nonidet-P40, 10% glycerol, 1 mM sodium orthovenadate, 10 




10% SDS, 200 mM Tris HCl pH 6.8, 50% glycerol, 0.01% 
bromophenol blue and 5% 2-mercaptoethanol (freshly added ) 
SDS-PAGE 
running buffer 




39 mM glycine, 48 mM Trizma base, 0.0375% SDS, 20% 
(v/v) methanol, ultrapure water 
Tris-buffered 
saline (TBS) 
20 mM Tris-HCl pH 7.5 and 150 mM NaCl 
TBS- TBS+0.05% Nonedate-P40 
2.5.2 Determination of protein concentrations in lysate samples 
To minimise the variation in loading of lysate samples on the electrophoresis gel 
the protein concentration in the samples must be identical. To achieve equal 
loading protein concentration was determined with the BioRad protein assay 
(BioRad, Hercules, USA); this is a modified form of Bradford protein 
quantification assay (Bradford, 1976;Zor & Selinger, 1996). Standard curve was 
-1 
constructed with a 1 µg µl solution of bovine serum albumin (BSA) at the 
-1 
concentrations ranging from 0 to 64 µg µl in a 96-well microtitre plate. 250 µl of 
1x Quickstart Bradford dye reagent (BioRad) was added in each well to be used. 
Then, standard BSA solutions (0-64 µl) or unknown lysate samples (2 µl) were 
added in triplicate in the microtitre plate. The volume in the wells used for BSA 
and unknown sample was adjusted by adding MiliQ water (e.g., in a well 
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containing 1 µl BSA: Bradford reagent 250 µl + BSA 1 µl + MilliQ 63 µl = 314 µl 
total volume; in a well containing 2 µl unknown sample: Bradford reagent 250 µl 
+ unknown sample 2 µl + MilliQ 62 µl = 314 µl total volume). Protein 
concentration was measured at 595 nm OD (optical density) using Versamax 
tunable microplate reader with the help of Softmax Pro software (Molecular 
Devices, USA). Protein concentration in each of the lysate samples was then 
calculated from the standard curve by linear regression. To equalise protein 
concentration between all samples, the volumes of samples containing higher 
levels of proteins were adjusted with a necessary amount of ice-cold lysis buffer 
that they will be equal to that in the lysate sample with the minimum 
concentration of protein. 
2.5.3 Sample preparation for gel electrophoresis 
Antibodies typically recognise a small portion of the protein of interest and this 
domain may reside within the 3D conformation. To enable the antibody to access 
to this portion of a certain protein, it is necessary to unfold or denature the protein; 
this can be done by heating with an anionic denaturing detergent such as SDS. 
The lysate samples were mixed with 5x SDS sample buffer at the ratio of 4:1 (e.g. 
25 µl sample buffer added in 100 µl lysate sample) in eppendorph tubes, incubated 
at 100ºC for 5 minutes using Techno dri-block DB-2A (Techno Cambridge Ltd., 
Cambridge, UK). Subsequently, eppendorph tubes containing the protein samples 
were placed on ice for 5-10 minutes and then stored at -20ºC until used for 
running into the gel. 
2.5.4 SDS-PAGE electrophoresis 
One dimensional SDS-PAGE electrophoresis (Sodium Dodecyl Sulphate 
PolyAcrylamide Gel Electrophoresis) was carried out using BioRad mini Protean 
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II gel electrophoresis with attached Powerpack 300 unit (BioRad Laboratories, 
Hemel Hempstead, UK). Using pre-cleaned glass plates gel chambers or cassettes 
were assembled according to the manufacturer’s guideline. This technique is a 
standard means for separating proteins according to their molecular weight. The 
separation of molecules within a gel is determined by the relative size of the pores 
formed within the gel. Smaller proteins migrate through the gel faster than larger 
protein. This dictates the composition of the gel; the smaller the size of the protein 
of interest, the higher the percentage of acrylamide in the gel to be used. 
Conversely, the bigger the size of the protein of interest, the lower the percentage 
of acrylamide in the gel should be used. For the proteins of interest in this study 
(MYPT1, 130 kDa; MLC20, 20 kDa) 7.5% gel was chosen (El-Awady et al., 2008). 
2.5.4.1 Preparation of SDS-PAGE gels 
The running or resolving gel was prepared with 7.5% and the stacking gel with 
5% acrylamide according to the following recipe (Table 2.9). The total volume of 
the running gel was sufficient for three 1 mm thick mini gels, while the stacking 
gel was sufficient for four 1 mm thick mini gels. Polymerisation is initiated by the 
addition of ammonium persulphate (APS) along with tetramethylethylenediamine 
(TEMED). A 50 µM APS (10% w/v) and 20 µl TEMED were added to running 
and stacking gel mixtures immediately before pouring them into the gel cassette. 
Table 2.9 Recipes for electrophoresis gels 
Running gel 7.5% Stacking gel 5% 
30% acrylamide/bis-acrylamide 3.75 ml 1.67 ml 
MilliQ water 5.6 ml 6.0 ml 
1 M Tris-HCl pH 8.8 5.6 ml -
1 M Tris-HCl pH 6.8 - 1.25 ml 
10% SDS 0.25 ml 0.15 ml 
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Pre-cleansed glass plates were fixed in the gel cassette holder and the running gel 
was poured between the glass plates. The top layer of the running gel was overlaid 
with MilliQ water to achieve a uniform line while preventing from drying out and 
left to polymerise for 40 minutes. After polymerisation of the running gel water 
was aspirated carefully and the stacking gel was poured on top with a 10-well 
comb inserted between the plates to create the wells for the loading of protein 
samples, and left for 20 minutes to polymerise. Following polymerisation of the 
stacking gel the comb was removed carefully and the wells were thoroughly 
cleaned with MilliQ water to remove any residual stacking gel that might distort 
the band. Then the wells in the stacking gel were filled with 1x SDS-PAGE 
running buffer (Table 2.8). Stacking gel is necessary to provide a series of 
separate lanes for loading of the standard and unknown protein samples. 
2.5.4.2 Loading samples and markers and running the gel 
Using special loading tips (1- 200 µl, Gel Saver II tip natural, Fisherbrand, UK) 
samples (25 µl per lane) were loaded into the mini-gel wells with one well loaded 
®
with 10 µl of pre-stained molecular weight marker (Precision Plus Protein
Standards; Bio-Rad, UK) to determine the protein size and also to monitor the 
progress of an electrophoretic run. Ready-to-run gels were then placed into a gel 
tank with 1x SDS-PAGE running buffer in the top and bottom reservoirs and 
electrophoresis were run at 80 volts until the bromophenol blue present in the 
lysate samples entered the running gel. At this point, the voltage was increased to 
180 volts. Gels were run until the bromophenol blue dye reached the bottom of 
the running gel or the desired separation of bands in reference to the molecular 
weight markers was achieved. Then the gels were carefully separated from the gel 
holders with a gel knife and placed into semi-dry transfer buffer (Table 2.8). 
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2.5.5 Transfer of protein to nitrocellulose membrane 
Transfer of protein from gel to nitrocellulose membrane was done by semi-dry 
transfer using BioRad Transblot SD cell (BioRad, USA). The membrane was 
placed next to the gel and the two were sandwiched between absorbent materials. 
To achieve an efficient and smooth transfer of protein to the membrane, the 
positive graphite electrode (bottom) was first dampened with semi-dry transfer 
buffer and then the sandwich was placed on it. The sandwich was made on the 
bottom positive electrode by placing four 3MM Whatman paper, a piece of 
nitrocellulose membrane, a gel and finally another four pieces of Whatman paper, 
all of the similar size as the gel and all pre-soaked in the semi-dry transfer buffer. 
After sandwiching the gel and membrane between papers air bubble between the 
gel and membrane was removed by gently rolling them out with a hand-roller. 
Then the upper negative electrode was dampened with transfer buffer and gently 
lowered into place to maintain a tight contact between the gel and membrane. The 
-2 
rate of transfer was set at 0.8 mA cm or 40 mA per gel for 1 hour 6 min. 
2.5.6 Visualisation of protein and antibody probing 
To check successful protein transfer, the membrane was washed with TBS-N 
(Table 2.8) and then Ponceau Red (1:10 dilution) was applied onto the membrane 
that revealed clear bands of proteins on it. The Ponceau Red stain was removed by 
washing the membrane with TBS-N and then the molecular weight standards were 
marked with a ball point pen. To block the non-specific background binding of 
the primary and/or secondary antibodies to the membrane, it was incubated with 
TBS-N containing 5% skimmed milk (Oxoid Ltd., Basingstoke, Hampshire, 
England) with gentle shaking on a Stuart rocking platform (Sterilin Ltd, 
Staffordshire, UK) for 1 hour at room temperature. After blocking, membranes 
were washed with TBS-N three times for 5 minutes each on a rocking platform at 
room temperature. The membranes were then incubated overnight at 4 ºC with 
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primary antibodies with gentle shaking. On the following morning, membranes 
were washed three times with TBS-N for 5 minutes each and then incubated for 1 
hour with HRP-conjugated secondary antibodies (1: 5000 dilution in TBS-N with 
2% skimmed milk, Dako, Glostrup, Denmark). The immunoreactive protein bands 
were illuminated with chemiluminescence substance ECL or advanced ECL kit 
(Amersham Biosciences, UK) and were developed on X-Ray film (Fujifilm 
Corporation, Tokyo, Japan) in a dark room. ECL kit was used for pan antibodies 
(e.g., MYPT1, MLC20) while advanced ECL kit was used for phospho antibodies 
(e.g., phospho-MYPT1, phospho-MLC20). The stable hard copy results on the film 
were quantified by densitometric analysis using ImageJ software (ImageJ 1.43, 
http://rsb.info.nih.gov/ij/). 
Table 2.10 Conditions of primary antibodies used 












MYPT1 Rabbit 130 1: 1000 1: 5000 
Phospho-MYPT1 
(Thr 850) 
Rabbit 130 1: 5000 1: 5000 
MLC20 Rabbit 20 1:1000 1:10000 
Phospho-MLC20 Rabbit 20 1:1000 1:10000 
All antibodies used were polyclonal. Primary antibodies were diluted in TBS-N 
with 0.01% (w/v) sodium azide to protect from microbial growth and applied 10 
ml per each membrane. Secondary antibodies were diluted in TBS-N with 2% 
skimmed milk and applied 10 ml per each membrane. 
2.5.7 Membrane stripping and re-probing 
After taking the images for a particular protein (e.g., phospho-MYPT1), 
membranes subjected to reuse to probe another protein (e.g., pan MYPT1) were 
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washed with TBS-N for 10 minutes at room temperature on a rocking platform. 
Before re-probing with another primary antibody all previous antibodies were 
striped from the membrane using a striping solution Re-Blot Plus (Chemicon, 
USA). To do so, the membranes were treated with 1x Re-Blot plus solution on a 
rocking platform for exactly 15 minutes at room temperature. After stripping the 
membranes were washed thoroughly with TBS-N for 5-6 times for 5 minutes each 
on a rocking platform at room temperature. Membranes were then blocked with 
5% skimmed milk and re-probed with primary and secondary antibodies as 
described before. This procedure of stripping and re-probing was used for 
P
examining equal loading of phospho proteins (e.g., MYPT1) using antibodies 
specific for their non-phospho proteins (e.g., MYPT1). It has been used to get the 
P
ratio of phospho over non-phospho proteins ( MYPT1/MYPT1) for quantification 
of changes in phosphorylation of that protein. 
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2.6 Calcium imaging with confocal microscopy 
2.6.1 Isolation of single cell 
Rat intrapulmonary and small mesenteric arteries were collected by the procedure 
described in section 2.1 in this chapter. For the isolation of pulmonary PASMCs 
and MASMCs the fragments of arteries were kept separately in HEPES buffered 
saline solution (HBSS) containing (mM): KCl 6, NaCl 119, MgCl2 1.2, CaCl2 2, 
D-glucose 12 and HEPES, 10; pH was adjusted to 7.3 with NaOH. The 
2+
fragments were then transferred into 1.5 ml plastic tube with nominally Ca -free 
HBSS containing 0.5 mg/ml protease type X and 1.5 mg/ml collagenase type IA. 
Tissue digestion was done in a water bath with gentle shaking for 15 min at 37 ºC. 
The tissue was then washed with warmed HBSS for 5 min and dispersed by gentle 
trituration with a blunt-ended, fire-polished glass Pasteur pipette. Dispersion was 
done in warmed nominally calcium free HBSS and the resulting suspension was 
pipetted onto glass coverslips, attached with vacuum grease to experimental 
chambers for viewing under confocal microscope. Cells were allowed to adhere 
for 30 min and the dispersion solution was then replaced several times with HBSS 
with gradually increasing concentration of CaCl2. All experiments were 
conducted in HBSS containing 2 mM CaCl2 at room temperature (20-23 ºC). 
2.6.2 Confocal imaging 
Confocal microscopy was performed using a Zeiss Axiovert 100M microscope 
attached to an LSM 510 laser scanning unit (Carl Zeiss, Oberkochen, Germany). 
An X40 oil immersion plan-neofluar objective (NA=1.3) was used to image cells. 
The pinhole was set to provide a confocal optical section (z resolution) of 0.8-1.0 
µM. Temporal changes in fluorescence were imaged by repeating x-y scanning of 
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either a whole confocal field. Zeiss LSM files (.lsm) were exported as tagged 
image files (TIFF; .tif) for further analysis of the data. 
2.6.2.1 Chamber system 
Figure 2. 4 Chamber system used for confocal microscopy. 
Arrows indicate the inflow and outflow of solutions. 
A circular chamber was used for confocal microscopy, which consisted of three 
separate plastic pieces assembled as outer ring, an inner placement ring, and the 
bath (Figure 2.4). The bath consisted of a ring closed by a circular glass coverslip 
attached with vacuum grease. The capacity of the bath was ~300 µl and a series of 
baths were prepared so that all the cell suspension could be aliquoted among them, 
straight after trituration. The bath seated at the bottom of the outer ring and was 
held in place by the placement ring above it. Several small sections of rigid tubing 
were stuck around the edge of outer ring to accommodate a solution 
application/suction system. For solution application thin tubing was connected at 
one end to a 1 ml syringe (with needle) and at the other end to a small length of 
pulled glass capillary tube, by which it was slotted into the outer ring tubing. A 
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separate syringe/tube/capillary was used for each different solution (e.g., one for 
normal bath solution, one for 4-AP, one for linopirdine). Suction was with a 
similar piece of tubing connected to length of capillary tubing at one end and an 
aquarium pump at the other (via an air pocket). 
2.6.2.2 Calcium imaging 
For calcium imaging PASMCs and MASMCs were incubated for 30 minutes at 
room temperature with 5 µM of cell permeant calcium sensitive fluorophore, fluo-
3AM (Abs/Em = 506 nm/526 nm) (Invitrogen, Paisley, UK). This was followed 
by a 30-min wash in HBSS to allow time for de-esterification. The fluo-3 AM was 
diluted from a stock solution containing 2 mM fluo-3 AM and 0.025% pluronic F-
127. Pluronic F-127 is normally used in such experiments since it prevents 
aggregation of fluo-3 AM in HBSS solution and helps uptake of the dye by cells. 
Further procedures were carried out at room temperature. After loading with this 
2+
Ca -sensitive indicator , fluo-3 fluorescence was excited by the 488 nm line of 
Argon ion laser (Siemens, Munchen, Germany) and changes in fluorescence (an 
indicator of intracellular free calcium) were detected by the confocal detector at 
wavelengths <515 nm. 
The response (fluorescence signal) was measured as the maximal change in 
fluorescence ∆F (F-F0, where F is the maximum level of fluorescence reached in 
the presence of the stimulus, and F0 is the initial fluorescence, immediately before 
the stimulus) divided by the initial fluorescence F0. Thus, the change in the 
fluorescence (∆F/F0) is an arbitrary unit. This normalisation approach removes 
variability due to any imprecision in loading of fluorescence indicator dye. x-y 
time-series imaging was performed. The final figures were produced using 




2.6.3 Solutions and chemicals

HEPES buffered saline solution (HBSS) 
Composition of HBSS (mM): 119 NaCl, 6 KCl, 1.2 MgCl2, 2 CaCl2, 10 D-glucose, 
10 HEPES, adjusted to pH 7.35 with NaOH. 
Table 2.11 Chemicals and drugs used in confocal imaging 





-sensitive dye 2 mM 
(DMSO) 
5 µM 
4-AP* KV channel blocker 0.5M 
(H2O) 
0.5-10 mM 
Linopirdine KCNQ channel blocker 10 mM 
(Ethanol) 
10 µM 




2.6 Data analysis and statistics 
Data are expressed as mean±standard error of mean (S.E.M.), where n equals 
2+ 
number of animals, except in confocal (Ca imaging) experiments, where n 
equals number of VSMCs from 3 to 4 animals. Vascular contraction and 
relaxation was calculated as % of maximum steady state contraction induced by 
80 mM KCl or other vasoactive agents (e.g., 4-AP) as described in details in 
relevant chapters. In some of the experiments the absolute tension (mN) produced 
with vasoactive agent was taken into consideration and compared with 
2+ 
standardised 80 mM KCl contraction. Unless otherwise stated, tension and Ca
imaging were compared between pulmonary and systemic mesenteric arteries. 
Significant differences between groups were determined using paired or unpaired 
Student’s t-test as appropriate. Multiple comparisons were performed with one 
way ANOVA followed by Bonferroni, Dunnett or Tukey-Kramer post-hoc test as 
appropriate. Bonferroni test was used when it was necessary to compare certain 
selected pairs of treatment groups. Dunnett test was chosen to compare control 
versus all treatment groups whilst Tukey-Kramer test was used for comparing all 




REGULATIO OF EXCITABILITY I THE RAT 
PULMOARY AD SYSTEMIC VASCULATURE: THE 
+
TALE OF TWO K CHAELS 
3.1 Introduction 
Under normal level of alveolar oxygen the pulmonary arterial circulation is a low-
pressure, low-resistance system that carries deoxygenated blood into the 
pulmonary microcirculation where gas exchange can occur. In hypoxic conditions, 
however, pulmonary arteries constrict thus diverting blood flow from poorly 
ventilated to better ventilated regions of the lung to match ventilation with 
perfusion. The control of pulmonary vascular resistance and hypoxic pulmonary 
vasoconstriction resides in small intra-pulmonary arteries and depends on the 
2+ 
level of intracellular Ca . 
Potassium channels are recognised as an important regulator of pulmonary 





(KV) channels. This interest was driven by 
the following main reasons: i) KV channels are inhibited by acute hypoxia in 
single PASMCs (Post et al., 1992;Yuan et al., 1993;Olschewski et al., 2002), ii) 
the selective inhibitor of the KV channels, 4-AP, caused membrane depolarisation 
(mimicking the depolarising effect of hypoxia) and attenuated HPV (Hasunuma et 
al., 1991;Karamsetty et al., 1998;Archer et al., 2004), iii) the inhibitors of KATP or 
BKCa channels did not alter basal tissue reactivity or HPV in intact pulmonary 
arteries and lungs (Hasunuma et al., 1991;Karamsetty et al., 1998), and iv) the KV 
channel current is the dominant K
+ 
current in PASMCs with a relatively little 
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component of BKCa or KATP currents (Smirnov et al., 1994;Smirnov & Aaronson, 
1994;Smirnov et al., 2002). 
Although the above mentioned findings overall support the proposal for the 
leading role of KV channels in the regulation of membrane potential in the 
pulmonary circulation, they are chiefly based on the evidence obtained in single 
isolated cells. In intact PA, the role of the KV channels alone in the regulation of 
the cell membrane potential at rest has been however challenged (Gurney et al., 
2002). One of the key arguments against KV channels is that their apparent 
threshold of activation (between -40 and -30 mV) measured in isolated myocytes 
is more positive than the resting potential in intact PAs (between -52 and -59 mV) 
(Casteels et al., 1977;Suzuki & Twarog, 1982;Bonnet et al., 2001). Additionally, 
there is a mismatch between the effect of 4-AP, a selective KV channel inhibitor, 
that produces contraction of intact isolated PA at concentrations typically above 5 
mM (Doggrell et al., 1999;Bonnet et al., 2002) while the EC50 for the inhibition 
of KV channels in single PASMCs ranges between 0.11 to 0.35 mM (Smirnov & 
Aaronson, 1994;Smirnov et al., 2002). 
The presence of background K
+ 
currents mediated by KCNQ channels has been 
recently demonstrated in vascular smooth muscles (Yeung & Greenwood, 
2005;Mackie et al., 2008), including PA (Joshi et al., 2006;Joshi et al., 2009). 
KCNQ channels are voltage-dependent K
+ 
channels, which activate at more 
negative membrane voltages (-60 to -80 mV) compared for KV channels. 
Activation of KCNQ channels is also slower than other KV channels, taking 
hundreds of milliseconds or even seconds to fully activate and they do not 
inactivate during sustained depolarisation (Gurney et al., 2010). Therefore, 
KCNQ channels are ideal for setting the resting potential in cells (Mackie & 
Byron, 2008;Gurney et al., 2010). Nevertheless, the large size of the KV channel 
currents measured in small resistance PASMCs (Smirnov et al., 2002) suggests 
that they can be also active at membrane potentials negative to -40 mV and be 
involved in the regulation of cell resting potential. The relative contribution of the 




In this chapter I have investigated the relative contribution of KV and KCNQ 
2+
channels to contraction, changes in membrane potentials and intracellular [Ca ]i 
in rat small PAs and isolated PASMCs using pharmacological tools, small vessel 
myography, microelectrode technique and confocal imaging. The tissue 
specificity of the responses was assessed using rat mesenteric artery recorded 
under identical experimental conditions. Single cells were isolated from the 




3.2.1 Role of KV and KCQ channels in the regulation of the basal tone 
in rat PA and MA 
The effect of increasing concentrations of 4-AP from 0.5 to 10 mM applied 
cumulatively for 5 min each on contraction of PA and MA is shown in Fig. 3.1 A 
and C, respectively. Overall, in 8 PA, increasing concentrations of 4-AP caused 
progressive increases in tension which becomes significant only at 10 mM 
(22.5±7.5%) of 4-AP (compared to 0.5 mM, p<0.001) (Fig. 3.2 A). Under the 
same experimental conditions, 4-AP did not cause significant contraction in 8 MA 
at any concentration (Fig. 3.2 C). 
To compare the effect of 4-AP in the depolarised condition which should promote 
a greater activation of 4-AP-sensitive KV channels, 20 mM KCl was added to the 
myograph chamber for 20 min. This produced a significant increase in contraction 
in PA, but not in MA, as it can be seen from representative traces in Fig. 3.1 B 
and D. In PA and MA, 20 mM K
+ 
caused 20.2±5.8% and 0.87±0.21% contraction, 
respectively. Fig. 3.2 summarises the effect of 4-AP in 8 PA and 8 MA in the 
absence and in the presence of 20 mm KCl. In the presence of 20 mM KCl, 
progressive increases in concentration of 4-AP caused further increases in tension 
at all concentration tested, becomes significant at 5 and 10 mM of 4-AP in PA 
(compared to 0.5 mM, 0.001<p<0.05; Fig. 3.2 B). This effect was not observed in 
MA, where 4-AP was able to significantly increase tension only at 10 mM 
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Figure 3.1 Effect of 20 mM KCl on 4-AP-dependent contraction in rat PA 
and MA. 
A-D, Representative traces from PA (A-B) and MA (C-D) compare contractile 
responses induced by increasing concentrations of 4-AP (0.5-10 mM) in the 
absence (A, C) and presence (B, D) of 20 mM KCl. PA and MA internal 
diameters (i.d.) were 422 and 270 µm, respectively. Horizontal and vertical scale 
bars represent 5 min and 1 mN, respectively. 
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To compare statistically the effect of 20 mM KCl on the 4-AP-induced responses 
in the same tissue and between two types of arteries, data were re-arranged and 
are presented in Fig. 3.3. This analysis show that in the presence of elevated K
+
, in 
PA, further contraction to increasing concentrations of 4-AP was substantially 
increased becoming significant at 5 and 10 mM compared to the control 
conditions (Fig. 3.3 A, filled circles). Significant potentiation of the 4-AP-induced 
contraction was also observed in MA, albeit only at 10 mM (Fig. 3.3 B, filled 
squares). Notably, as it can be seen from the comparison in Fig. 3.3 A and B, the 
4-AP-induced contraction was greater in PA than in MA (relative to the peak 80 
mM KCl responses). A significant difference in the 4-AP-induced contraction 
between these arteries (PA vs. MA) in the absence and presence of 20 mM KCl 
was observed only at 10 mM 4-AP (0.001<p<0.01) (Fig. 3.3 C and D, 
respectively). 
In contrast, no apparent enhancement of contraction in PA and MA by 20 mM 
KCl was observed for TEA concentration-responses (1, 2, 5, 10 and 20 mM) (n=2, 
Fig. 3.4). In both PA and MA responses to TEA were small suggesting 
insignificant contribution of TEA sensitive KV channels to contractility in these 
vessels. This observation is consistent with the key role of the 4-AP sensitive and 
TEA-insensitive KV channels (i.e. KV1.5), but rules out a significant contribution 
of TEA-sensitive K
+ 
conductances such as BKCa or TEA-sensitive KV channels 
(i.e. KV2.1) under this experimental conditions (Archer et al., 1996;Osipenko et 
al., 2000;Smirnov et al., 2002). 
The capability of 4-AP to significantly constrict PA is consistent with the 
recognised role of KV channels in the control of the pulmonary vascular tone 
(Sweeney & Yuan, 2000;Weir & Olschewski, 2006). On the other hand, the 
ability of 20 mM KCl to significantly enhance the tissue sensitivity to low 
concentrations of 4-AP suggests the presence of additional K
+ 
conductances 
which contribute to the control of the basal tone. Recently, background KCNQ 
channels have been proposed to play a critical role in this process in both PA and 
MA (Mackie et al., 2008;Joshi et al., 2009;Gurney et al., 2010). If this is the case 
under my experimental conditions, then the inhibition of KCNQ channels should 





. To check this hypothesis, the responses to different concentrations of 
4-AP were assessed in the absence and presence of 10 µM linopirdine, a specific 
inhibitor of the KCNQ channels. This concentration of linopirdine was chosen to 
induce maximal inhibition of the KCNQ channels in intact arteries based on 
previous studies (Joshi et al., 2006;Mackie et al., 2008;Joshi et al., 2009). 
It is noteworthy that in this study only linopirdine was used as a reliable and 
selective inhibitor which has been used previously in other studies specifically 
measuring tension in intact arteries (Joshi et al., 2006;Mackie et al., 2008;Joshi et 
al., 2009). Another reason for using a single KCNQ inhibitor was that inhibition 
of KCNQ channels served as an experimental tool to facilitate activation of KV 
channels in the whole tissue. However, it would be interesting and useful to 
investigate the effect of other inhibitors, for example XE991 which is considered 
to be more potent (Earl et al., 1998) than linopirdine, although its concentration 
range used in the experiments (Yeung & Greenwood, 2005;Yeung et al., 
2007;Yeung et al., 2008;Ng et al., 2010;Zhong et al., 2010b) is not that dissimilar 
to linopirdine used in my study. It is also notable that 4-AP was found to be 
ineffective on KCNQ currents tested for KCNQ1, KCNQ2, KCNQ3 and 
KCNQ2/KCNQ3 channels (Robbins, 2001). 
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Pulmonary artery Mesenteric artery 
Figure 3.2 Summary of the 4-AP responses in control and depolarised rat PA 
and MA. 
Column graphs summarise concentration-contraction relationship to 4-AP in the 
absence and presence of 20 mM KCl in PA (A-B) and MA (C-D). Responses to 1 
to 10 mM 4-AP were compared with that produced with 0.5 mM 4-AP in control 
conditions and under depolarised conditions (in 20 mM KCl) (One-way ANOVA 
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Comparison between conditions (for the same tissue) 
Comparison between tissues (under the same conditions) 
Figure 3.3 Summary of the potentiation of 4-AP contraction by 20 mM KCl 
in rat PA and MA. 
A-B, Comparison of concentration-contraction relationship to 4-AP in control and 
depolarised conditions in PA (A) and MA (B). C-D, comparison of concentration-
contraction relationship to 4-AP between PA and MA in the absence (C) and 
presence (D) of 20 mM KCl. Note that some error bars are smaller in size than 
corresponding symbols. Also note that graphs in C-D are the same as shown in A-
B. (**p<0.01 and ***p<0.001 indicates significant difference between graphs for 
the same concentration of 4-AP; tested by Bonferroni post-hoc test following one-
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Figure 3.4 TEA concentration-responses in control and depolarised rat PA 
and MA. 
A-D, Representative traces from PA (A-B) and MA (C-D) demonstrating the 
effect of increasing concentrations of TEA (1-20 mM) on contraction in the 
absence (A, C) and presence (B, D) of 20 mM KCl. PA and MA internal diameter 
were 340 and 175 µm, respectively. Horizontal and vertical scale bars represent 5 




Figure 3.5 A-D shows representative traces recorded from PA and MA in the 
absence and presence of 10 µM linopirdine applied for 20 min prior to application 
of increasing concentrations of 4-AP. As it can be clearly seen from these 
recordings, 4-AP-induced contraction was markedly increased in PA following 
the inhibition of KCNQ channels (Fig. 3.5 A and B), mimicking the effects 
observed in the elevated K
+
. It is noteworthy that linopirdine itself caused a small 
but significant (14.6±2.4%, n = 28, p<0.0001) contraction of the PA. No 
significant effect of linopirdine alone was observed in the MA (1.1±0.2%, n = 26, 
Fig. 3.5 C and D). Fig. 3.6 summarises the effect of linopirdine on the 4-AP-
induced contraction in 8 PA and 8 MA, demonstrating a significant enhancement 
of contraction to 5 and 10 mM 4-AP in PA in the presence of linopirdine 
compared to the control conditions (Fig. 3.6 A) and compared to MA measured in 
control conditions (Fig. 3.6 C) and in the presence of the KCNQ inhibitor (Fig. 
3.6 D). Linopirdine also enhanced 4-AP-induced contraction in MA only at 10 
mM (Fig. 3.6 B). 
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Figure 3.5 Effect of the KCQ channel inhibitor linopirdine on 4-AP-induced 
contraction in rat PA and MA. 
Representative traces obtained from PA (A-B) and MA (C-D) compare 
contractions in response to increasing concentrations of 4-AP (0.5-10 mM) in the 
absence (A, C) and presence (B, D) of 10 µM linopirdine (Lino). PA and MA i.d. 
were 412 and 242 µm, respectively. Horizontal and vertical scale bars represent 5 
min and 1 mN, respectively. 
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Comparison between conditions (for the same tissue) 
Comparison between tissues (under the same conditions) 
Figure 3.6 Summary of the potentiation of 4-AP contraction by linopirdine in 
rat PA and MA. 
A-B, Comparison of concentration-contraction relationship to 4-AP between the 
control conditions and after linopirdine treatment in PA (A) and MA (B). C-D, 
comparison of concentration-contraction relationship to 4-AP between PA and 
MA in the absence (C) and presence (D) of 10 µM linopirdine. Note that some 
error bars are smaller in size than corresponding symbols. Also note that graphs in 
C-D are the same as shown in A-B. (*p<0.05 and ***p<0.001 indicates 
significant difference between graphs for the same concentration of 4-AP; tested 
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3.2.2 Effect of the KV and KCQ channel blockade on the resting 
membrane potential in rat PA and MA 
The above described findings are consistent with the relatively greater 
contribution of the KV and KCNQ channels to the regulation of the resting 
potential in the PA than in the MA. To assess the effect of the inhibition of the KV 
and KCNQ channels on the resting membrane potential directly, changes in the 
membrane potential were measured using sharp microelectrodes in the presence of 
10 mM 4-AP, 10 µM linopirdine and the combination of the both inhibitors. Fig. 
3.7, A and B, show the effect of 10 mM 4-AP followed by the addition of 10 µM 
linopirdine on the tension (A) and membrane potential (B) in the PA. Application 
of 10 mM 4-AP caused slowly developing membrane depolarisation from the 
resting level of -58.3 mV to -50.0 measured after 10 min paralleled by the tension 
development. The addition of 10 µM linopirdine rapidly depolarised the 
membrane to -23.9 mV (Fig. 3.7 B). This depolarisation was associated with a 
significant contraction (Fig. 3.7 A). Interestingly, fluctuations in the membrane 
potential were observed (Fig. 3.7 B, inset). No fluctuation in tension was however 
seen. Such fluctuations in membrane potential were observed only in one other 
PA preparation. 
In the MA, 4-AP caused a small depolarisation from -67.8 mV to -66.3 mV with 
no significant development of contraction (Fig. 3.7 C and D). Addition of 
linopirdine caused further membrane depolarisation which was associated with 
regular bursts of the spike-like activity (Fig. 3.7 D). In contrast to the PA, these 
fluctuations in the membrane potential mirrored by oscillations in tension 
(compare the inserts in Fig. 3.7 C and D). These effects were consistently 
observed in all MA studied. Here it is worth mentioning that in my experimental 
set up the resting membrane potential measured in MA was more hyperpolarised 
compared to the values previously reported in MA [RMP ~-57 to -60 mV; 
(Mulvany et al., 1982;Garland & McPherson, 1992)]. This could be due to 
difference in the methods, especially applying different levels of resting tone. In 
my experiments the vessel was set at a tension equivalent to that generated at 0.9 
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times the diameter of the vessel at 70 mmHg. In the previous studies which 
showed more depolarised resting membrane potential of rat small mesenteric 
artery (~-57 mV to -60 mV), the vessel was set at 100 mmHg as the effective 
transmural pressure (Mulvany et al., 1982;Garland & McPherson, 1992). 
The mean changes in the membrane potential in 5-10 PA obtained from 6 rats and 
in 3-8 MA from 4 animals are compared in Fig. 3.8, A and B, respectively. In PA, 
10 µM linopirdine evoked depolarisation from -57.8±3.9 mV to -53.3±5.1 mV and 
10 mM 4-AP depolarised from -57.8±3.9 to -45.2±6.3 mV while combination of 
10 µM linopirdine and 10 mM 4-AP caused significant depolarisation from -
57.8±3.9 to -31.2±5.6 mV. In MA, on the other hand, 10 µM linopirdine 
depolarised very little from -67.8±1.8 mV to -67.0±2.5 mV, 10 mM 4-AP 
depolarised from -67.8±1.8 to -57.0±3.3 mV while combination of 10 µM 
linopirdine and 10 mM 4-AP resulted significant depolarisation from -67.8±1.8 to 
-47.0±4.3 mV. Combination of 10 µM linopirdine and 10 mM 4-AP significantly 
depolarised both tissues although the extent of depolarisation was greater in the 
pulmonary (~46%) than in the mesenteric artery (~31%). Fig. 3.9 A and B 
compare the correlation between the relative changes in the membrane potential 
(measured as the difference of the average membrane potential before addition 
and in the presence of the inhibitors) and the force of contraction. In both PA and 
MA, a significant correlation between the two parameters was found: correlation 
coefficient equal to 0.77 (p<0.0005) and 0.55 (p<0.033), respectively. This 
regression analysis suggests that the amount of contraction is proportional to 
membrane depolarisation and is independent of the way (i.e. type of K
+ 
channel 
blocker) this depolarisation was produced. It does also support the additive role of 




Pulmonary artery Mesenteric artery 
Figure 3.7 Effects of KV and KCQ channel blockers on tension and 
corresponding membrane potential in rat PA and MA. 
A, C- Contraction traces obtained from PA (A) and MA (C) of 379 And 315 µm 
i.d. showing contraction in response to 10 mM 4-AP followed by 10 µM 
linopirdine (15 min each). B, D- Membrane potential traces obtained from PA (B) 
and MA (D) showing changes in the membrane potential upon application of 10 
mM 4-AP followed by 10 µM linopirdine (15 min each). Inserts show oscillations 
of contraction in MA (inset in C), and fluctuations of membrane potentials in PA 
(inset in B) and MA (insert in D) at the expanded time scale. Note that in the 
panels B and D the discontinuation in the traces indicates the time when 










































































































Pulmonary artery Mesenteric artery 
Figure 3.8 Summary of the effects of KV and KCQ channel blockers on 
membrane potential in rat PA and MA. 
A-B, Mean depolarisations induced by KCNQ channel inhibitor linopirdine (10 
µM) alone, KV channel blocker 4-AP (10 mM) alone or combination of these two 
are shown in PA (A) and MA (B). LIN, linopirdine. Differences between groups 
were tested by Tukey-Kramer post-hoc test following one-way ANOVA; n values 
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Pulmonary artery Mesenteric artery 
Figure 3.9 Correlation between membrane potential and contraction induced 
by KV and KCQ channel blockers in rat PA and MA. 
A and B compare the correlation between the relative changes in the membrane 
potential and the force of contraction in PA (A) and MA (B). Each open symbol 
represents the result of an individual experiment, whereas filled symbols represent 
the mean values for each group of treatment. The regression analysis was 
performed using individual values. Correlation coefficient for PA and MA is 
equal to 0.77 (p<0.0005) and 0.55 (p<0.033), respectively. 
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3.2.3 Effect of the KV and KCQ channel inhibitors on intracellular 
2+ 
Ca in single myocytes from rat PA and MA 
The correlation between the membrane depolarisation and the force of contraction 
in the presence of KV and KCNQ channel inhibitors, 4-AP, linopirdine and their 
combination, directly supports the combined role of the two channel types in the 
regulation of the resting membrane potential. The ability of the KV and KCNQ 
2+
channel inhibitors to change [Ca ]i was evaluated in single myocytes isolated 
from rat PA and MA using confocal imaging. Figure 3.10, A and C, shows 
representative images of 2 PASMCs and 2 MASMCs loaded with Fluo-3. Figure 
3.10, B and D, depicts recordings of fluorescent intensities before and after 
application of 2 and 10 mM 4-AP in the above mentioned 2 PASMCs and 2 
MASMCs, respectively. In PASMCs application of 2 mM 4-AP caused a 
2+
moderate sustained increase in [Ca ]i. In one cell (marked a) this response was 
further enhanced by 10 mM 4-AP; this represents typical responses seen in most 
PASMCs. In another cell (marked b) 10 mM 4-AP caused slow transient 
2+
responses. In MASMCs, oscillations in [Ca ]i were typically observed in both 
concentrations of 4-AP. The effects of 4-AP were completely reversible in both 
cell types. Figure 3.11, A and B, summarises the time course of this experiment in 
22 PA and 41 MA myocytes. The sustained averaged response in MA could be 
explained by the lack of synchronicity in oscillations between individual 
myocytes. 
2+
Figure 3.12 statistically analyses the effects of 2 and 10 mM 4-AP on [Ca ]i in 
PASMCs and MASMCs. Fig. 3.12, A and C, compares the effects of 4-AP on the 
mean intensities, whilst Fig. 3.12, B and D, compares the mean area under the 
curve (AUC). Both types of analysis show that 4-AP causes significant increases 
2+
in [Ca ]i in the two cell types. 
When similar experiments were performed in the presence of 10 µM linopirdine 
2+
and 2 mM 4-AP (Fig. 3.13), similar significant changes in [Ca ]i in PASMCs 




Figure 3.10 The effect of 4-AP on changes in [Ca
2+
]i in isolated PASMCs and 
MASMCs. 
A) Shows a series of 5 x-y confocal optical slices of two PASMCs loaded with 
Fluo-3 before (1) and at different times following the addition of 2 and 10 mM 4-
AP as indicated. B) Shows the time course of changes in the fluorescence 
intensities for the two cells shown in A. Note that only cell b demonstrate a slow 
oscillations. Likewise, C and D represent a series of confocal x-y optical slices 
and corresponding time courses for fluorescence intensities, respectively, for 2 
isolated MASMCs. Fluorescent intensity was expressed as ∆F/F0 where ∆F= F-F0 
(F is fluorescence intensity at a given time point and F0 is baseline fluorescence). 
a.u., arbitrary units. WO, wash out. 
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Figure 3.11 Comparison of the effect of 4-AP on [Ca ]i in isolated PASMCs 
and MASMCs. 
Relative fluorescent intensities, expressed as ∆F/F0, and recorded in each cell 
using the experimental protocol shown in Fig.3.10 were averaged for 22 PASMCs 
(A) and 41 MASMCs (B). Vertical bars represent S.E.M. Note that in MASMCs 
2+
individual cell oscillations summate causing sustained elevation of [Ca ]i. 
2+
Interestingly, in MASMCs, [Ca ]i was also significantly increased in 10 µM 
linopirdine and 2 mM 4-AP (Fig. 3.13, C and D), the effect was smaller than in 
PASMCs. Indeed, the difference in changes in fluorescence (∆F/F0) in the 
presence of both 10 µM linopirdine and 2 mM 4-AP was significantly greater in 
PASMCs than in MASMCs (p<0.00001). Because fluorescence intensities are 
presented as ∆F/F0, i.e., normalised in respect to the baseline, changes in 
2+




Figure 3.12 Comparison of the effect of KV channel inhibitors on [Ca
2+
]i in 
isolated PASMCs and MASMCs. 
To analyse the differences statistically two approaches were used. Firstly, 
fluorescent intensities (averaged at the end of each treatment in each cell) were 
averaged and statistically compared for 22 PASMCs (A) and 41 MASMCs (C). 
Secondly, fluorescent intensities were taken as area under the curve (AUC) in 
each cell for the duration of each treatment, averaged and compared in B and D 
for PASMCs and MASMCs, respectively. Note that the two types of analysis gave 
similar results. 
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Figure 3.13 Comparison of the effect of KV and KCQ channels inhibitors on 
[Ca
2+
]i in isolated PASMCs and MASMCs. 
The experimental protocol was identical to that described in Fig. 3.10 and 3.11 
except that 10 µM linopirdine and 2 mM 4-AP were respectively used instead of 2 
and 10 mM 4-AP. To analyse the differences statistically two approaches were 
used in a same way as described in Fig. 3.12, using averaged fluorescent 
intensities (A and C) and the mean area under the curve (AUC) (B and D) for 42 
PASMCs and 65 MASMCs, respectively. Note, no qualitative differences were 
observed between the two types of analysis. 
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Figure 3.14 Comparison of the contractions induced by low concentration of 
4-AP in the presence of linopirdine between rat PA and MA. 
A and B compare the effect of pretreatment with 10 µM linopirdine on 2 mM 4-
AP-induced contractions in intact PA and MA, respectively. Tension produced by 
2 mM 4-AP alone and 10 µM linopirdine alone are also shown for comparison. 
LIN, 10µM linopirdine. Differences between groups were tested by Tukey-
Kramer post-hoc test following one-way ANOVA, n = 8. 
Functional studies of intact artery rings using wire myograph reveals that the 
effect of linopirdine pretreatment on low concentration (2 mM) of 4-AP-induced 
contraction matches the above imaging data specifically in the PA (Fig. 3.14 A). 
In intact MA however the pretreatment with linopirdine did not potentiate the 
contraction induced by 2 mM 4-AP (Fig. 3.14 B), which may be due to the fact 
that isolated cells are generally more depolarised, than intact tissue preparations. 
123

3.2.4 Time-dependent potentiation of 4-AP responses: a comparison 
between rat PA and MA 
During experiments with repetitive applications of 4-AP, time-dependent 
potentiation of 4-AP-induced contraction was observed specifically in MA and 
rd 
not in PA. This effect was consistently observed, for example, during 3
application of 4-AP (recovery) compared to the first application (control) in the 
studies of the effect of L-VOCC blocker and Rho-kinase inhibitor where 3 
consequent applications of 4-AP (in combination with 20 mM KCl or 10 µM 
linopirdine) were used: control, during treatment and recovery. Time-dependent 
potentiation was independent on the way the tissue was preconstricted and 
observed for both 20 mM KCl + 10 mM 4-AP (Figures 3.15 and 3.16) and 10 µM 
linopirdine + 10 mM 4-AP (Figures 3.17 and 3.18). This effect was not due to 
drug treatment, as in a separate series of experiments (n = 2) where 3 subsequent 
applications of linopirdine+4-AP or 20 mM KCl+4-AP were assessed, similar 
potentiation of the 4-AP-induced contraction was observed. 
In this section I characterise this effect and compare the effect of 4-AP during its 
1
st 
(control) and during its 3
rd 
(recovery) application in the presence of either 20 
mM KCl (Fig. 3.15) or 10 µM linopirdine (Fig. 3.17) were compared with those 
following the recovery. Figures 3.16 and 3.18 summarise and statistically 
compare the responses. The effect of 10 mM 4-AP alone in both tissues is also 
shown for comparison. Although the exact reason(s) for this phenomenon is not 
clear, one may speculate that availability of KV channels is becoming greater with 
time (perhaps due to tissue depolarisation). This is supported by the observation 
that the effects of 20 mM KCl and 10 µM linopirdine were not significantly 
different. Further studies with membrane voltage (Vm) measurements will be 
needed to clarify this question. 
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Figure 3.15 Time-dependent potentiation of 4-AP responses in the 
presence of 20 mM KCl in rat PA and MA.  
Representative traces obtained from PA of 593 µm i.d. (A-B) and MA of 
270 µm i.d. (C-D) show the control and recovery responses to 4-AP in the 
presence of 20 mM KCl. Note, a significant potentiation in the recovery 
response in MA (D) and not in PA (B). Horizontal and vertical scale bars 
represent 5 min and 1 mN, respectively. 
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Figure 3.16 Comparison of the time-dependent potentiation of 20 mM 
KCl and 4-AP-induced responses between rat PA and MA. 
The graphs summarise and compare the time-dependent potentiation of 4-
AP responses in PA and MA in the presence of 20 mM KCl. No 
potentiation, rather significant decrease in recovery tension was observed in 
PA (A) while significant potentiation in recovery tension was observed in 
MA (B). The mean response to 10 mM 4-AP alone is shown for 
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Figure 3.17 Time-dependent potentiation of 4-AP responses in the 
presence of 10 µM linopirdine in rat PA and MA. 
Representative traces obtained from PA of 324 µm i.d. (A-B) and MA of 
259 µm i.d. (C-D) show the control and recovery responses to 4-AP in the 
presence of 10 µM linopirdine. Note, a significant potentiation in the 
recovery response in MA (D) and not in PA (B). Horizontal and vertical 
scale bars represent 5 min and 1 mN, respectively. 
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Figure 3.18 Comparison of the time-dependent potentiation of 
linopirdine and 4-AP-induced responses between rat PA and MA. 
The graphs summarise and compare the time-dependent potentiation of 4-
AP responses in PA (A) and MA (B) in the presence of 10 µM linopirdine. 
No potentiation was observed in PA (A) but only in MA (B). The mean 
response to 10 mM 4-AP alone is shown for comparison. Unpaired 




The main findings of this chapter can be summarised as: 
1)	 KV and KCNQ channels differently contribute to the regulation of the 
basal tone in pulmonary and systemic mesenteric arteries, with 
significantly less contribution in the latter. In pulmonary artery, both KV 
and KCNQ channels play role to maintain low resistance and low 
contractile state in rest. 
2)	 In the regulation of resting membrane potential, KV and KCNQ channels 
play a greater role in pulmonary than in mesenteric artery. Significant 
correlation between membrane potential and force of contraction was 
observed in both pulmonary and mesenteric artery. 
3)	 Consistent with the ability of the KV and KCNQ channel inhibitors to 
produce more depolarisation in pulmonary than in mesenteric artery, it 
was observed that the inhibition of KV and KCNQ channels leads to a 
2+
significantly higher level of [Ca ]i increases in isolated PASMCs than in 
MASMCs. 
4)	 Time-dependent potentiation of 4-AP-induced responses was absent in 





Figure 3.19 Physiological interaction between KV and KCQ channels in 
pulmonary artery. 
A) Both KV and KCNQ are active at rest keeping the cell membrane 
hyperpolarised. B) Inhibition of KCNQ channels alone (e.g. with linopirdine) will 
promote activation of KV channels, which in turn will maintain the cell membrane 
hyperpolarised. Likewise, inhibition of KV channels alone (e.g. with low 
concentrations of 4-AP) may not be sufficient to cause significant contraction due 
to the background activity of KCNQ channels. C) Inhibition of both KV and 
KCNQ channels removes these key hyperpolarising forces, causing depolarisation 
leading to nearly maximal contraction of the artery. Further explanations are in 
the text. 
The results presented in this chapter demonstrate that both KV and KCNQ 
channels are important in the regulation of the basal tone in PA. Although this has 
been hypothesised previously (Gurney et al., 2010), here, for the first time, I 
demonstrated the reciprocal interaction between the KV and KCNQ channels in 
controlling pulmonary vascular contractility. This is summarised in Fig 3.19. At 
rest, the activity of KV and KCNQ channels keep the cell membrane 
hyperpolarised and the tissue is relaxed (Fig. 3.19 A). Inhibition of only KCNQ 
channels (e.g. with linopirdine as shown in Fig. 3.19 B) or, likewise, inhibition of 
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only KV channels (e.g. with 4-AP) will cause only small, if any, depolarisation 
which may or may not be accompanied by a small contraction. This is likely to 
occur because the additional activation of KV or KCNQ channels (both are 
voltage-dependent) will tend to stabilise the cell membrane at hyperpolarised 
levels. However, the combined inhibition of both KV and KCNQ channels will 
eliminate these two key K
+ 
conductances leading to the development of nearly 
maximal contraction in PA (Fig. 3.19 C). Any depolarising stimulus (e.g. low 
concentrations of KCl used in this study or activation of Cl 
-
or non-selective 
cation conductance) will cause greater activation of KV channels thus increasing a 
potency of the KV channel inhibitors. Such interaction between the two types of 
K
+ 
channels will keep the cell membrane hyperpolarised, thus maintaining 
pulmonary arteries relaxed and pulmonary vascular resistance low, which is one 
of the main features of the pulmonary circulation. 
The above proposed model, however, is not fully applicable for MA. The possible 
reasons could be: i) relatively small expression of KV channel current in MA 
compared to that in PA (Firth et al., 2009a), ii) KV channels in MA are activated 
at more positive potentials compared to PA (Firth et al., 2009a), iii) relatively 
small contribution of KCNQ channels (Joshi et al., 2006), and iv) other K
+ 
conductance (e.g., BKCa) can be activated in the presence of combined action of 
KCNQ and KV inhibitors (Asano & Nomura, 2002). All these factors keep MA in 
more hyperpolarised state resulting in lesser responsiveness to 4-AP and 
linopirdine compared to PA. Interestingly, with time the effect of 4-AP is 
enhanced in MA (the phenomenon of time-dependent potentiation of contraction), 
and in that case the proposed model is becoming applicable for MA too. It is may 
be possible that with time and during consecutive contractions, KV channel 
activation is shifted to more negative potentials, leading to greater availability of 
KV channels and hence greater contraction. 
The above stated reciprocal relationship between the two channels is supported by 
the lack of each inhibitor to cause a significant contraction in intact PA when 
applied alone (Figures 3.5 and 3.6). Conversely, when added together, they 
induced the contraction which was comparable to that produced by 80 mM KCl. 
In addition, combination of the two inhibitors produced larger membrane 
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depolarisation compared to that produced by each blocker alone (Fig. 3.8). The 
ability of linopirdine to enhance the effect of a low concentration of 4-AP on 
2+
[Ca ]i and tension development (Fig. 3.13 and 3.14, respectively) is also 
supportive. On the other hand, the important contribution of the KV channels to 
the regulation of the resting tone in PA is supported by the ability of high 
concentrations of 4-AP to cause significant contraction (Figures 3.1 A and 3.2 A). 
The ability of 20 mM KCl (which would be expected to cause depolarisation of 
the cell membrane by ~39.66 mV according to the Goldman equation) to enhance 
the contraction to various concentrations of 4-AP in a similar manner as does 
linopirdine is also consistent with the presence of active 4-AP-sensitive KV 
channels. Finally, 4-AP at 10 mM alone caused larger membrane depolarisation 
2+
(Fig. 3.8 A) and larger increases in [Ca ]i (Fig. 3.12) compared to that seen with 
the KCNQ channel inhibitor alone. 
The role of both channels in the regulation of the cell resting potential is also 
supported by the electrophysiological measurements of the KCNQ and KV channel 
currents at negative voltages in PASMCs indicating that they might be 
comparable in sizes. For example, using selective KCNQ activator retigabine a 
significant increase of 24 pA in the whole-cell current in PASMCs was observed 
in the negative voltages between -60 and -40 mV (Joshi et al., 2009). Smirnov et 
al. has previously demonstrated similar size of KV current in normoxic PASMCs 
(Smirnov et al., 1994). 
It is noteworthy that the level of contraction caused by 10 µM linopirdine 
(0.53±0.07 mN or 14.6±2.4% of 80 mM KCl) in PA is overall substantially lower 
than that reported by Joshi et al. in similar preparation (~2 mN or ~85% of 50 mM 
KCl) (Joshi et al., 2006). This discrepancy is likely due to differences in the 
experimental conditions used in my and Joshi et al.’s study. Firstly, the resting 
tension was set at 5 mN (Joshi et al.) compared to 1-2 mN (my study). It is 
possible that high resting tension can activate stretch-activated non-selective 
channels (Kirber et al., 2000) promoting greater depolarisation. Secondly, Joshi et 
al. used HEPES-based buffer, whereas bicarbonate buffer was used in my 
experiments. Indeed when I used HEPES buffer in one experiment 10 µM 
linopirdine caused contraction as big as 65% of 80 mM KCl, which is comparable 
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to that reported by Joshi et al. It is apparent that both factors are contributive to 
the difference, between the two studies, however further experiments are 
necessary to clarify the exact mechanisms behind these differences. 
In MA, used in this study as a representative of the systemic circulation, 
increasing concentrations of 4-AP had a significantly smaller effect than in PA 
either in the control conditions or in the presence of 20 mM KCl or linopirdine 
(Figures 3.1-3.3 and 3.5-3.6), suggesting that it is not only due to the lack of 
KCNQ channels in MA but also due to relatively less contribution of 4-AP 
sensitive KV channels. One of the contributing factors could be the differences in 
the expression of functional KV channels in MA compared to PA (Firth et al., 
2009a). In addition, the KV current in rat MASMCs is activated at more positive 
voltages than that in PASMCs (Firth et al., 2009a). Another factor could be 
activation of other K
+ 
conductances, e.g. BKCa channels (Asano & Nomura, 2002). 
The latter might be activated by membrane depolarisation in the presence of either 
inhibitor (Fig. 3.8) thus limiting vasoconstriction in MA compared to PA. 
Interestingly, in MA subsequent applications of 10 mM 4-AP either in the 
presence of 20 mM KCl or 10 µM linopirdine resulted in time-dependent 
increases in 4-AP-induced contraction. Such potentiation however was not 
observed in PA (Figures 3.15-3.18). The phenomenon of potentiation of 4-AP-
induced contraction is interesting and to the best of my knowledge has not been 
previously reported. As the relaxation of 4-AP-induced contractions to diltiazem 
and Y-27632 was not apparently affected with time, it is likely that the number of 
KV channels becoming increasingly available in this tissue with time. Further 
work is required to identify the exact mechanisms responsible for this potentiation. 
Although the exact mechanism for this effect is currently not known, it may 
contribute to the increased sensitivity of isolated MASMCs to 4-AP in calcium 
measurements (Fig. 3.12) compared to contractile responses measured in intact 
arteries (Figures 3.1-3.3 and 3.5-3.6). The less significant effect of 4-AP in the 
presence of linopirdine in MA is also consistent with previous observations where 




The proposed model of interaction between the two channels could also explain 
an increased sensitivity of intact PA isolated from chronic hypoxic animals to low 
concentrations of 4-AP (Doggrell et al., 1999;Bonnet et al., 2002). It is well 
documented that chronic hypoxia is associated with membrane depolarisation 
which will lead to augmented availability of 4-AP-sensitive KV channels despite 
the fact that the expression of KV channels is decreased under such conditions 
(Smirnov et al., 1994;Osipenko et al., 1998;Platoshyn et al., 2001). 
One of the critical points could be the use of 4-AP as the inhibitor of KV channels. 
4-AP is considered as non-selective inhibitor which may cause other effects 
(Petkova-Kirova et al., 2000). However, the use of the same experimental design, 
when recordings were made from both PA and MA simultaneously under the 
same experimental conditions, argues against such possibility. Similar correlation 
between the force of contraction and membrane depolarisation depicted in Fig. 3.9 
also argues against the non-specificity of 4-AP in my experimental settings. 
Furthermore, tissue pretreatment with 10 µM diltiazem virtually eliminated 4-AP-
induced contractions in both preparations. I have also used correolide, a selective 
KV1 type channel inhibitor, at concentrations up to 20 µM. However it was able to 
produce only ~0.2 mN force in PA (n = 2; data not shown). This value is similar 
to that seen at 100 µM correolide in resistance PA reported previously by Archer 
and colleagues (Archer et al., 2004). No significant effect of correolide on 
contraction was observed in MA in my experimental conditions. One of the 
reasons for the difference between 4-AP and correolide could be in the time 
course of the onset of their action. Depolarisation increases the effectiveness of 4-
AP because 4-AP is an open channel blocker and will effectively and potently 
inhibit all open KV channels (Armstrong & Loboda, 2001). This notion is also 
supported by my experimental evidence. Correolide however is a slow acting 
blocker (Koo et al., 1999) and does not completely eliminate KV channel currents 
in PASMCs even at 10 µM (Dr. Smirnov’s unpublished observations). Thus, very 
slow onset of action (>20 min) and recovery made this blocker unsuitable for the 
purpose of this study in characterisation of KV channels. Therefore, 4-AP 
represents an adequate and useful pharmacological tool to investigate the role of 
KV channels in intact preparations. 
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The proposed model of the interaction between two channel types, in addition to 
providing the basic understanding of pulmonary function, can also serve as a 
useful experimental tool to investigate a relative contribution of the two types of 
channels in the HPV response. 
In this chapter it has been established that both KCNQ and KV channels are 
essential for maintenance of PA in low contractile state. Using this experimental 
approach, I have then tested the hypothesis whether KCNQ channels are inhibited 




THE ROLE OF KV AD KCQ CHAELS I 
HYPOXIA-IDUCED RAT PULMOARY AD 
SYSTEMIC VASOCOSTRICTIO 
4.1 Introduction 
In resistance intra pulmonary artery of the rat, acute hypoxic response is biphasic 
in nature consisting of an initial transient contraction (phase-I) followed by a 
slowly developing sustained contraction (phase-II) (Kovitz et al., 1993;Leach et 
al., 1994;Lazor et al., 1996;Leach et al., 2000;Robertson et al., 2000a;Robertson 
et al., 2000b;Dipp et al., 2001). The phase-II contraction is entirely dependent on 
the presence of intact endothelium (Leach et al., 1994;Robertson et al., 2003) but 
was not inhibited by nitric oxide synthase (NOS) inhibitors (Leach et al., 1994). 
In isolated rat small MA, which is widely used as a representative of the systemic 
circulation, the transient phase-I contraction was observed in response to hypoxia 
under similar experimental conditions followed by vasodilation instead of 
contraction observed in contrast to the PA (Leach et al., 1994). 
2+
It is generally agreed that HPV is triggered by an increase in [Ca ]i in the 
vascular smooth muscle cells via multiple mechanisms (Ward & Aaronson, 
1999;Weissmann et al., 2001;Gurney, 2002;Ward & McMurtry, 2009). The 
2+ 2+ 
hypoxia-dependent increase in [Ca ]i has two components: an initial Ca release 
2+ 
from intracellular stores followed by Ca influx from the extracellular 
compartment via voltage -dependent and -independent mechanisms (Means, 
1994;Abe et al., 1996;Ward & McMurtry, 2009). The importance of the elevated 
2+
[Ca ]i for HPV is supported by the observation that a small degree of pretone 
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(which is independent of the type of vasoconstrictor used, e.g., high K
+
, PGF2α or 
U-46619) was often required to obtain a reproducible HPV response (Leach et al., 
1994;Ward & Robertson, 1995;Ozaki et al., 1998;Robertson et al., 2000b). 
2+
Although the exact reason is not clear, moderate elevation of [Ca ]i is apparently 
necessary for initiation of the HPV response, hence the requirement for a pretone. 
2+ 
A significant body of evidence suggest that hypoxia-induced Ca release from 
intracellular stores is an early and essential event required for initiation of HPV 
2+ 
(Jabr et al., 1997;Dipp et al., 2001;Morio & McMurtry, 2002). Ca being 
2+ 
released from intracellular stores activates SOCCs and capacitative Ca entry 
(CCE) in PASMCs (Robertson et al., 2000b;McDaniel et al., 2001;Wilson et al., 
2001;Snetkov et al., 2003;Wang et al., 2004). 
On the other hand, it is well known that blockers of L-VOCCs suppress HPV as 
2+
well as the associated rise in [Ca ]i (Salvaterra & Goldman, 1993;Vadula et al., 
1993;Cornfield et al., 1994;Leach et al., 1994), supporting the hypothesis that L-
VOCCs play an important role in the initiation of the HPV response. Membrane 
depolarisation can be triggered by the inhibition of K
+ 
channels; as well as by 
2+
activation of non-selective cation channels involved in CCE and by Ca -activated 
chloride channels. Hypoxia-dependent inhibition of KV channels is well 
documented (Weir & Archer, 1995;Olschewski et al., 2002;Archer & Michelakis, 
2002). KV channels are the most abundant type of K
+ 
channels and an important 
contributor to the resting membrane potential in the pulmonary vasculature 
(Archer et al., 1993;Smirnov et al., 1994;Yuan, 1995;Smirnov et al., 
2002;Olschewski et al., 2002;Archer et al., 2004). The KV channel currents in 
PASMCs are also inhibited by hypoxia (Post et al., 1992;Archer et al., 1993;Weir 
& Archer, 1995;Olschewski et al., 2002;Archer & Michelakis, 2002;Platoshyn et 
al., 2006) and therefore can contribute to membrane depolarisation and activation 
of L-VOCCs. 
Another type of voltage-gated K
+ 
channels, KCNQ, is recently recognised to be 
also important in the regulation of resting membrane potential in vascular smooth 
muscle cells (Yeung & Greenwood, 2005;Brueggemann et al., 2007;Yeung et al., 
2007;Yeung et al., 2008;Mackie et al., 2008) including PASMCs (Osipenko et al., 
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1997;Joshi et al., 2006;Joshi et al., 2009). However, whether KCNQ channels can 
contribute to the HPV response has not been yet demonstrated. Furthermore, 
although the inhibition of KV channels in the isolated pulmonary arterial cells has 
been well documented as mentioned above, their role in hypoxia-induced 
responses in intact pulmonary arteries remains largely unknown. 
As described in the previous chapter, the combined use of linopirdine, a selective 
KCNQ channel blocker, and 4-AP, a selective KV channel inhibitor, in intact 
tissue preparation allows the investigation of the contribution of KV and KCNQ to 
excitability and contractility of intact pulmonary and mesenteric arteries. Here, I 
employed this approach to investigate the role of KV and KCNQ channels in 
hypoxia-induced responses in intact pulmonary and mesenteric arteries of rat. 
The main objectives of this chapter were: 
•	 To investigate the relative sensitivity of KV and KCNQ channels to 
hypoxia-induced responses in PA and MA. 
•	 To compare the nature and extent of hypoxia-induced responses between 




Contraction was measured using dual wire myograph as described in detail in 
Chapter 2. Hypoxia was induced by switching from the oxygen rich gas mixture 
of 95% O2/5% CO2 to nitrogen rich gas mixture of 95% N2/5% CO2 for 20 min 
followed by reoxygenation (when the effect of hypoxia was studied in the 
presence of vasoconstrictor or channel inhibitor) or by washing out the chamber 
with oxygenated PSS. The level of hypoxia was measured using an ISO2 oxygen 
meter (WPI Incorporation, USA) in a separate set of experiments. The mean level 
of PO2 was 30±3 mmHg (n = 6, with variation ranging from 22-40 mmHg). 
During hypoxia experiments the chamber was covered with a plastic cover to 
minimise diffusion of ambient O2. All experiments were performed in the 
presence of 100 µM L-NAME and 10 µM indomethacin. In a separate set of 
experiments with K
+ 
channel blockers hypoxia was continued for 60 min to 
investigate the effect of prolonged hypoxia on PA and MA under conditions when 
KCNQ and KV channels were inhibited. Tissue was allowed at least 60 min to 
recover between hypoxic challenges (Leach et al., 1994;Robertson et al., 1995). 
Contractile responses were expressed as a percentage of the maximum tension 
obtained in response to 80 mM KCl (3 min) applied prior to the application of 




4.3.1 Biphasic nature of hypoxia-induced vasoconstriction in isolated 
+
rat arteries in the presence of K channel blockers 
Following the application of KCNQ and KV channel blockers (10 µM linopirdine 
and 2 mM 4-AP, respectively) the PA and MA were challenged simultaneously 
with hypoxia for 60 min. In this and the subsequent experiments (unless otherwise 
stated) low concentration of 4-AP (2 mM) was used instead of 10 mM to elicit a 
small pretone and thus leaving a potential room to observe further contraction in 
response to hypoxia for the investigation of its nature and extent. In both tissues, 
hypoxia produced two distinct phases of contraction: the initial transient phase-I 
contraction developed within first 5 to 6 minutes and then tissue was relaxed 
maximally in 10 to 15 minutes followed by a slowly developing phase-II 
contraction until the end of 60 min. The tissue was immediately relaxed to the 
pretone level upon re-oxygenation. The trend of hypoxic contraction in both PA 
and MA was similar although the level of contraction in MA was much less than 
that observed in PA. Also contraction during phase-II in MA was often associated 
with oscillations both in short exposure (20 min) to hypoxia (9 out of 13 
experiments) as well long exposure to hypoxia (60 min). In both cases (short and 
long exposure) the oscillations usually started after the transient phase-I was 
subsided (i.e. 10-12 min after exposure to hypoxia). Such an oscillatory response 
is exemplified in Fig. 4.1 B. Here, however, I will be focussing mainly on phase-I 
where the role of K
+ 
channels has been implicated and also comparing the 
hypoxia-induced responses between PA and MA. Since the phase-I of hypoxic 
contraction subsided within 15 min; in the subsequent experiments the duration of 























Figure 4.1 Typical biphasic responses of hypoxia-induced vasoconstriction in 
rat PA and MA.  
Both in PA (A) and MA (B), hypoxia produced two distinct phases of contraction: 
the initial sharp contraction of phase-I followed by a slow and sustained phase-II. 
Representative traces were obtained from PA and MA of 276 and 242 µm internal 
diameters (i.d.), respectively. Lino, linopirdine (10 µM); 4-AP, 4-aminopyridine 
(2 mM); 80K+, 80 mM KCl. Horizontal and vertical scale bars represent 5 min 




4.3.2 Effects of KV and KCQ channel blockers on hypoxia-induced 
contraction in rat PA and MA 
To evaluate the role of KV and KCNQ channels, the effect of hypoxia was 
assessed in intact arteries in three different conditions: i) in the presence of 10 µM 
linopirdine to completely block the KCNQ channels, ii) in the presence of 2 mM 
4-AP to partially inhibit KV channels while leaving KCNQ channels intact, and 
iii) in the presence of both 10 µM linopirdine and 2 mM 4-AP to block both 
channel types in order to induce depolarisation and some level of constriction 
(pretone). In the presence of 2 mM 4-AP the balance between KV and KCNQ 
channels will be shifted towards KCNQ channels (as described in the previous 
chapter). Thus, one would expect, if KCNQ channels are inhibited by hypoxia, 
then the HPV response will be greater in the presence of low concentration of 4-
AP compared to the control. 
Representative traces obtained from PA and MA are shown below in the Fig. 4.2. 
The mean absolute and normalised hypoxia-induced contractions in PA and MA 
are statistically compared in Fig. 4.3 A-D. In PAs, hypoxia alone produced a 
small sustained contraction which was only 0.4±0.1 mN (n = 8) (Fig. 4.3 A). A 
similar effect (0.4±0.05 mN, n = 4) was observed when hypoxia was applied 
following the pretreatment of the tissue with 2 mM 4-AP for 15 minutes (Fig. 4.3 
A). Interestingly, the pretreatment of PA with 10 µM linopirdine for 20 min 
caused a transient hypoxia-induced contraction which was 3 times greater 
(1.2±0.3 mN, n = 4, Fig 4.3 A) compared to those measured in the absence of the 
inhibitors and in the presence of 4-AP, although this difference was not significant 
(one-way ANOVA). However, when the artery was pre-treated with a 
combination of linopirdine (10 µM for 20 min) followed by 4-AP (2 mM for 15 
min), hypoxia caused a transient contraction with a peak of 4.4±0.7 mN (n = 6, 
Fig. 4.3 A), i.e., a response which was comparable to that evoked by 80 mM KCl 
(Fig. 4.2 D). 
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Figure 4.2 Effect of KV and KCQ channel blockers on hypoxia-induced 
vasoconstriction in rat PA and MA.  
Representative traces showing the effect of hypoxia at different treatment 
conditions in PA (A-D) and MA (E-H). After obtaining the control hypoxia-
induced responses (A and E), inhibitors were applied cumulatively as shown by 
arrows followed by hypoxia. A and B is from the same PA with an i.d. 309 µm 
while C and D is from a different PA with an i.d. 389 µm. Similarly, E & F is 
from the same MA with an i.d. 309 µm while G and H is from a different MA 
with an i.d. 314 µm. Hyp, hypoxia; 4-AP, 4-aminopyridine (2 mM); Lino, 
linopirdine (10 µM). Horizontal and vertical scale bars represent 5 min and 1 mN, 
respectively. 
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This effect was significantly greater than the responses measured in the control 
conditions (an increase by 12-fold, p<0.001), in the presence of 2 mM 4-AP (an 
increase by 11-fold, p<0.001), or 10 µM linopirdine (an increase by 4-fold, 
p<0.001) (Fig 4.3 A). 
In MAs, on the other hand, hypoxia alone induced very little contraction of 
0.03±0.02 mN (n = 8) (Fig. 4.3 C). However, in the presence of 2 mM 4-AP and 
10 µM linopirdine alone, and linopirdine+4-AP, hypoxic response was increased 
to 1.3±0.7 mN (n = 4), 1.7±0.6 mN (n = 4) and 2.2±0.5 mN (n = 6), respectively 
(Fig. 4.3 C). Only in the combined presence of 4-AP and linopirdine, hypoxia 
caused a significant increase in tension compared to that in the absence of the 
inhibitors (p<0.05, Tukey-Kramer post-hoc test following one-way ANOVA; Fig. 
4.3 C). 
The MA has an ability to produce much greater contraction than PA, therefore a 
comparison between PA and MA based on normalised (to 80 K
+
) contraction can 
provide a more valid assessment. When the tension was normalised to 80 K
+ 
to 
account for the difference between different treatments, similar differences were 
observed in PA but no difference was observed in MA (Fig. 4.3 B and D, 
respectively). 
Notably, when comparing the hypoxic responses between PA and MA, statistical 
analysis (Bonferroni post-hoc test for comparison between selected pairs 
following one-way ANOVA) revealed that in the presence of 10 µM linopirdine 
and 2 mM 4-AP hypoxia produced significantly bigger responses in PA than in 
MA in both absolute (4.4±0.7 vs. 2.0±0.5 mN, respectively; n = 6, p<0.01) as well 




Pulmonary artery Mesenteric artery 
Figure 4.3 Effect of KV and KCQ channel blockers on hypoxia-induced 
vasoconstriction in rat PA and MA. 
Absolute (A and C) and normalised (B and D) hypoxia-induced contractions in 
PA (A-B) and MA (C-D) in the presence of K
+ 
channel inhibitors. Lino, 
linopirdine; 4-AP, 4-aminopyridine. Differences between groups were tested by 






































































4.3.3 Effect of pre-exposure to hypoxia on linopirdine and 4-AP-
induced contraction in rat PA and MA 
To investigate the effect of hypoxia on contraction under conditions when both 
KCNQ and KV channels were virtually inhibited, linopirdine (10 µM) and 4-AP 
(10 mM) were used to block KCNQ and KV channels, respectively. As the 
application of both inhibitors caused nearly maximal contraction, the following 
experimental protocol was applied. Both arteries were first treated with 10 µM 
linopirdine (20 min) followed by 10 mM 4-AP (15 min). The contraction thus 
recorded was used as a control response. Inhibitors were washed out until the 
baseline was restored. Both arteries were exposed to hypoxia for 20 min followed 
by the addition of the inhibitors in the same sequence and contraction was 
recorded as a hypoxic response. After at least 60 minutes of recovery period the 
first step was repeated and the response was recorded as a recovery response. Fig. 
4.4 shows representative traces obtained from PA (A-C) and MA (D-F). Fig. 4.5 
summarises the absolute and normalised results for PA (A-B) and MA (C-D). In 
PA, a combined application of 10 µM linopirdine and 10 mM 4-AP produced 
5.0±0.9 (n = 6) mN tension in control which was reduced to 1.7±0.5 (n = 6) mN in 
hypoxia. Following wash-out and reoxygenation, the effect of hypoxia was nearly 
completely recovered (4.0±0.5 mN, n = 5). In this artery, hypoxia significantly 
reduced the contraction induced by the inhibitors compared to the control and 
recovery conditions (Fig 4.5 A). Similar significance was reached when the 
tension was normalised to 80 mM KCl contraction (Fig 4.5 B). 
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Figure 4.4 Effect of hypoxia on tension resulted from the inhibition of KCQ 
and KV channels in rat PA and MA.   
Representative traces obtained from PA (A-C) of 305 µm i.d., and MA (D-F) of 
199 µm i.d. show linopirdine+4-AP-induced contraction in control (A and D), in 
the presence of hypoxia (B and E) and after recovery from hypoxia (C and F). 
Note that as time of the exposure to inhibitors was limited (20 min for linopirdine 
and 15 min for 4-AP), some traces (e.g., C, D and F) did not reach a steady-state 
level. Lino, linopirdine (10 µM); 4-AP, 4-aminopyridine (10 mM); Hyp, hypoxia. 
Horizontal and vertical scale bars represent 5 min and 1 mN, respectively. 
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Under similar experimental conditions, the absolute tension in MA was also 
significantly reduced by hypoxia compared to the control run (from 7.4±1.3 mN 
to 1.3±0.5 mN, n = 6) (Fig. 4.5 C). The size of the contraction was recovered fully 
(7.4±2.0 mN, n = 5). The phenomenon termed ‘time-dependent potentiation’ 
described in previous chapter, could have contributed for the full recovery in this 
artery. Overall, in MA pre-exposure to hypoxia had a similar effect to that 
observed in PA on 4-AP-induced contraction, reducing significantly both absolute 
and normalised tension (Fig 4.5 C-D). 
Interestingly, hypoxia potentiated linopirdine-induced contraction specifically in 
PA (Fig. 4.4 B). Pre-exposure to hypoxia for 20 min significantly potentiated 
linopirdine-induced contractions in PA from 1.4±1.1% (control) to 6.2±1.8% 
(hypoxic) (n = 6, p<0.05). However, in MA, no significant effect was observed 
(0.27±0.06% vs. 0.78±0.35% in control and hypoxic conditions, respectively; n = 
6, p>0.05) (Fig. 4.6). As KCNQ channels should be completely blocked by 10 µM 
linopirdine, the increased in tension in the presence of KCNQ channel blocker is 
likely to be due to a greater availability of the KV channels which are known to be 
blocked by hypoxia (Post et al., 1992;Archer et al., 1993;Weir & Archer, 




Pulmonary artery Mesenteric artery 
Figure 4.5 Hypoxia significantly blocks vasoconstriction induced by KCQ 
and KV channel blockers in rat PA and MA. 
Graphs summarise and compare data obtained in control, hypoxic and recovery 
conditions in PA (A-B) and MA (C-D). A and C represent absolute tension, B and 
D represent normalised tension. Data were normalised to maximum contraction 
produced by 80 mM KCl applied prior to addition of inhibitors or hypoxia and 
expressed as a percentage of 80 mM KCl contraction. Differences between groups 
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Figure 4.6 Effect of pre-exposure to hypoxia on linopirdine-induced contractions 
in rat PA and MA. 
Each column represents the mean value obtained in 6 arteries where tissue responses 
to linopirdine were compared in the absence and presence of hypoxic challenge for 20 
min. Lino, linopirdine (10 µM); rPA, rat pulmonary artery; rMA, rat mesenteric 
artery. Note that hypoxia produced significantly higher contractions to 10 µM 
linopirdine in PA, but not in MA. Paired Student’s t-test (n = 6). 
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4.3.4 Hypoxia-induced contraction in the presence of thromboxane A2 
analogue U-46619 in rat PA and MA 
Since I have demonstrated above that hypoxia in the presence of linopirdine and 
low concentration of 4-AP (which act via the voltage-dependent pathway) caused 
a transient hypoxic vasoconstriction in both PA and MA (Fig. 4.2 and 4.3), the 
effect of hypoxia was investigated in the presence of the stable thromboxane A2 
analogue U-46619 which is known to activate contraction via both voltage-
2+ 
independent and voltage-dependent pathways as well as by releasing Ca from 
2+ 
intracellular Ca stores (Wilson et al., 2005;Alapati et al., 2007;McKenzie et al., 
2009). 
Since a small degree of pretone of the intact tissue is known to enhance hypoxia-
induced contraction (Leach et al., 1994;Ward & Robertson, 1995;Ozaki et al., 
1998) and, also, the level of pretone has significant effect on the size of the 
subsequent hypoxic constrictor response (Rodman et al., 1989;Ward & Robertson, 
1995), it is therefore important to maintain the level of pretone constant by 
adjusting concentrations of agonist to provide adequate comparison between 
different protocols. In this set of experiments where U-46619 was used to elicit 
pretone, both diltiazem (used to block the voltage-dependent component of 
contraction to U-46619) and Y-27632 (used to inhibit a component of U-46619-
2+ 
induced contraction due to Ca sensitisation) reduced the level of pretone. To 
adjust for that and to maintain a constant level of pretone, concentration of U-
46619 was increased from 10 nM to 50 nM in experiments involving the use of 
diltiazem or Y-27632. 
The experimental protocol was similar to that described in section 4.3.2. Hypoxia 
was applied for 20 min after obtaining a stable pretone with U-46619 applied for 
20 min. Representative traces of such experiments are depicted in Fig. 4.7. It is 
noteworthy that hypoxia caused a transient contraction in both PA (Fig. 4.7 A) 




To explore a possible role of L-VOCC-mediated Ca influx in these hypoxic 
responses in the presence of U-46619, arteries were pre-treated with the L-VOCC 
blocker diltiazem (10 µM) for 10 min prior to application of U-46619. Diltiazem 
was preferred to nifedipine because the former is readily reversible compared to 
the later. Diltiazem caused a significant attenuation of the peak hypoxic 
vasoconstriction by 47% in PA (mean 31.3±5.4 %, n = 5, p<0.05) compared to the 
control hypoxic response, whereas in MA this degree of inhibition was much 
greater, i.e. 90% (mean 85.1±2.8 %, n = 5, p<0.05) (traces in Fig. 4.7 B and E, 
respectively; summarised in Fig. 4.8). 
2+ 
The role of Rho-kinase in Ca sensitisation is well known in vascular smooth 
muscle cells (Sauzeau et al., 2000;Swärd et al., 2000;Somlyo & Somlyo, 
2003;Kizub et al., 2010) and has also been implicated in HPV (Leach et al., 
1994;Robertson et al., 1995;Robertson et al., 2000a;Wang et al., 2001;McMurtry 
et al., 2003;Wang et al., 2003b;Fagan et al., 2004). To investigate whether Rho-
kinase is involved in hypoxia-induced responses in the presence of U-46619, the 
specific inhibitor of Rho-kinase Y-27632 (10 µM) was applied for 10 minutes 
prior to addition of U-46619 followed by 20 min hypoxia. The effect of Y-27632 
significantly reduced the hypoxic response by 67% (mean 75.6±3.4 %, n = 5, 
p<0.001) in PA and by 84% (mean 86.8±2.2 %, n = 5, p<0.05) in MA (traces in 
Fig. 4.7 C and F, respectively; summarised in Fig. 4.8). 
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Figure 4. 7 Effect of hypoxia on U-46619-induced constriction: Role of Rho-
2+
kinase-mediated sensitisation and L-VOCC-mediated Ca  entry in rat PA 
and MA.  
Representative tension recordings were obtained from PA (A-C) of 380, 377 and 
380 µm i.d. and MA (D-F) of 243, 294 and 209 µm i.d., respectively. U-4, U-
46619 (10 nM in A, D; 50 nM in B, C, E and F); Dil, diltiazem (10 µM); Y-2, Y-
27632 (10 µM); Hyp, hypoxia. Horizontal and vertical scale bars represent 5 min 


































Figure 4.8 Statistical comparison of the hypoxia-induced contraction in the 
presence of diltiazem and Y-27632 in rat PA and MA. 
Data obtained in three conditions: hypoxia in the presence of U-46619 alone 
(control), diltiazem+U-46619 or Y-27632+U-46619. Data expressed as a 
percentage of 80 mM KCl applied for 3 min before each protocol. Differences 
between groups were tested by Tukey-Kramer post-hoc test following one-way 
ANOVA, n = 5. 
The average results are summarised and statistically compared in Fig. 4.8. It can 
be seen that, in PA, the inhibition of Rho-kinase had apparently a greater effect on 
hypoxic vasoconstriction compared to the inhibition of the L-VOCC, albeit non-
significant (although significant with t-test when compared between the two 
treatment groups only). In contrast, in MA, no apparent differences between the 
two inhibitors were found. Overall, however, both inhibitors significantly 
suppressed hypoxia-induced transient contraction in both arteries, suggesting the 
2+ 




4.3.5 Effect of hypoxia in the presence of different concentrations of 
KCl in rat PA and MA 
The results presented above suggest that hypoxia can induce a significant transient 
contraction in both types of arteries under conditions when the KCNQ channels 
and to a lesser degree the KV channels are inhibited. The effect of hypoxia was 
significantly greater in PA than in MA. However, when both types of channels 
were completely blocked causing maximum depolarisation and contraction, pre-
exposure to hypoxia caused significant attenuation of contraction induced by both 
the inhibitors. In the previous chapter I demonstrated that low concentration of 
KCl (20 mM) selectively potentiated 4-AP dependent contraction. Increasing 
concentrations of KCl will progressively depolarise the cell membrane, activate 
L-VOCCs and cause progressively increasing contraction. I therefore investigated 
the effect of hypoxia in the presence of increasing concentrations of KCl to induce 
contraction solely via the voltage-dependent pathway. 
To quantitatively compare the effects produced by hypoxia in the presence of 20, 
30, 40 and 80 mM KCl hypoxia-induced contractions (when occurred) and 
relaxations were expressed as percentage of the pretone measured before changing 
to hypoxia in each concentration of KCl (new baseline). Hypoxia-induced 
relaxations which were observed particularly when pretone was increased were 
measured by calculating the difference between the peak of the transient hypoxic 
contraction and the response measured at the end of the hypoxic challenge. 
Representative traces obtained from PA and MA show hypoxia-induced effects in 
the presence of increasing concentrations of KCl in PA (Fig. 4.9 A-D) and MA 
(Fig. 4.9 E-H). 
155

In PA, at low concentration of KCl (20 mM and 30 mM), hypoxia caused 
transient contraction of 108±30% (n = 5) and 11±4% (n = 4), respectively 
(calculated as percentage of the pretone elicited by KCl). The amplitude of 
contraction was decreased with increased concentration of KCl (7±4%, n = 3 and 
1±1%, n = 3 in 40 and 80 mM KCl, respectively). The contraction in each case 
was followed by gradual relaxation of 120±32% (n = 5), 29±2% (n = 4), 32±8% 
(n = 3) and 25±7% (n = 3) for 20, 30, 40 and 80 mM KCl, respectively (Fig 4.9 A-
D; summarised in Fig.4.10). 
In MA, the effect of hypoxia in increasing concentrations of KCl was associated 
predominantly with hypoxia-induced relaxations of 97±19% (n = 5), 91±14% (n = 
4), 83±15% (n = 3) and 81±6% (n = 3) % in 20, 30, 40 and 80 mM KCl, 
respectively (Fig. 4.9 E-H). Note, that in MA, low concentration of KCl (20 mM) 
failed to induce any significant contraction (Fig. 4.9 E). 
Fig. 4.10 summarises the relationship between KCl concentration and hypoxia-
induced contraction and relaxation in PAs and MAs. As can be seen from this 
comparison, hypoxia caused significant contraction only in PA, where the 
hypoxia-induced contractions were maximal at low KCl concentrations and were 
decreased when KCl concentration was increased (Fig. 4.10 A, filled bars). In MA, 
hypoxia did not cause significant contraction at any KCl concentration tested (Fig. 
4.10 A, open bars). 
At lower KCl concentration hypoxia-induced relaxation was prevailed, and 
hypoxia-induced relaxations in PA were quantitatively comparable to those 
observed in MA (Fig. 4.10 B, filled bars). At higher concentrations of KCl, 
however, hypoxia-induced relaxation in MA was significantly greater than that 
observed in PA (Fig. 4.10 B, open bars). 
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Figure 4.9 Hypoxia-induced contraction and relaxation at progressively 
increased pretone produced by different concentrations of KCl in rat PA and 
MA. 
Representative traces were obtained from rat pulmonary (A-D) and mesenteric (E-
H) arteries of 321 µm and 303 µm i.d., respectively. 20K, 30K, 40K and 80K 
indicate extracellular concentration of KCl in mM. Hyp, Hypoxia. Horizontal and 




































B. Hypoxic relaxations 
Figure 4.10 Dependence of hypoxia-induced contractions and relaxations on KCl 
concentration in rat PA and MA. 
Each column represents the mean value obtained in 3-5 arteries. Statistical 
comparison between the two arteries was performed with paired Student’s t-test. 
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4.3.6 Hypoxia-induced relaxation depends on the type of a 
preconstrictor agent 
The results described in the previous section showed that, when the maximal 
contraction was achieved with 80 mM KCl, both arteries (PA and MA) were 
predominantly relaxed by hypoxia. However, the relaxation was significantly 
greater in MA than in PA. This may indicate that hypoxia-induced relaxation in 
PA and MA could involve different mechanisms. To investigate this phenomenon 
directly, the effect of hypoxia was studied in the presence of 80 mM KCl (to 
2+ 
depolarise the cell membrane and maximally stimulate L-VOCC-mediated Ca
entry), 10 µM linopirdine+10 mM 4-AP (to inhibit both types of voltage-gated K
+ 
channels contributing to the membrane potential and cause contraction via L-
VOCC-dependent pathway) and 1 µM U-46619 (a thromboxane A2 analogue to 
activate contraction via receptor-mediated pathway) under conditions when 
maximal contraction was developed and maintained. 
In this set of experiments arteries were first preconstricted using agents described 
above for 20 min to achieve a sustained level of contraction. Hypoxia was then 
applied for 20 min, followed by reoxygenation for 20 min. Relaxation responses 
were measured as a percentage of contraction induced by the preconstricting agent 
immediately prior to the hypoxic challenge. 
The representative traces shown in Fig. 4.11 indicate that in PA the degree of 
relaxation to hypoxia depends on the way tissue was preconstricted. Thus, the 
hypoxic challenge relaxed KCl-induced contraction by 39%, linopirdine+4-AP-
induced contraction by 69% and U-46619-induced contraction by 88% (Fig. 4.11 
A-C). In contrast, hypoxia caused more complete and similar relaxation in 
preconstricted MA, causing 84%, 99% and 100% relaxation in the presence of 
KCl, K
+ 
channel inhibitors (linopirdine+4-AP) and U-46619, respectively (Fig. 
4.11 D-F). Notably, the degrees of hypoxia-induced relaxations in MA under all 
three conditions were similar to that observed in PA in the presence of U-46619. 
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Figure 4.11 Effect of hypoxia on agonist-induced contractions in rat PA and 
MA.  
Traces show relaxation effect of hypoxia on the maximal contraction induced by 
80 mM KCl (A, D), the K
+
 channel inhibition (B, E) and the thromboxane A2 
analogue U-46619 (C, F) in PA (left panel) and MA (right panel). Representative 
traces were obtained from PA of 313 µm (A) and 375 µm (B and C) i.d., and MA 
of 198 µm (D) and 277 µm (E and F) i.d. Area under dotted line indicates 
exposure to hypoxia. Lino, linopirdine (10 µM); 4-AP, 4-aminopyridine (10 mM); 
U-4, U-46619 (1 µM).   Horizontal and vertical scale bars represent 5 min and 1 
mN, respectively.  
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80K+ Lino+4-AP U-46619 
B. 
Figure 4.12 Hypoxia-induced relaxation depends on the type of agonist in rat 
PA and not in MA. 
Relaxation to hypoxia was measured in the presence of 80 mM KCl (80K
+
), 10 
µM linopirdine+10 mM 4-AP (Lino+4-AP) and 1 µM U-46619 in PA (A) and MA 
(B). Relaxation response was calculated as described in the text. Differences 
between groups were tested by Tukey-Kramer post-hoc test following one-way 
ANOVA (n = 3). 
Fig. 4.12 compares the hypoxia-induced relaxation obtained in all three conditions. 




inhibitors (both causing the contraction via the voltage-dependent Ca entry 
pathway) was significantly smaller than that in the presence of U-46619 (which 
causes contraction predominantly via voltage-independent mechanisms) (Fig. 4.12 
A). On the other hand, in MA, the relaxation effect of hypoxia was independent 
on mechanism of preconstriction (Fig. 4.12 B). The comparison of hypoxia-
induced relaxation between PA and MA demonstrates that, relaxation is 
significantly greater in MA than in PA in all three conditions (Fig. 4.13). Despite 
being significant (Fig. 4.13, p<0.01) the hypoxia-induced relaxations observed in 
U-46619-preconstricted arteries might have little functional significance as their 
degree of relaxation is similar between two arteries. 
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Figure 4.13 Comparison of hypoxia-induced relaxation between rat PA and 
MA. 
Hypoxia-induced relaxation is significantly greater in MA irrespective of 




The main observations described in this Chapter can be summarised as following: 
1) Complete inhibition of KCNQ channels with 10 µM linopirdine, but not 
KV channels with low (2 mM) concentration of 4-AP, stimulated a transient 
contraction to a short hypoxic challenge which was similar to the phase-I of HPV. 
This contraction was significantly greater when both inhibitors were used together. 
Interestingly, a transient contraction to hypoxia was also observed in systemic 
mesenteric arteries, although proportionally the effect was smaller than in 
pulmonary arteries. 
2) The transient hypoxia-induced contraction was observed at the low 
level of pretone and was independent on the type of vasoconstrictor used (the K
+ 
channel inhibitors, low concentrations of KCl or U-46619) or tissue type. 
3) When submaximal contraction was achieved with high concentrations 
of vasoconstrictor agents, hypoxia caused vasodilatation in both types of artery. In 
the pulmonary artery, the hypoxia-induced vasodilatation was dependent on the 
type of vasoconstrictor, and was less prominent in the presence of 80 mM KCl 
and the K
+ 
channels inhibitors (acting via the voltage-dependent Ca
2+ 
entry 
pathway) than U-46619 (acting predominantly via the voltage-independent 
pathway). No such differences were observed in the mesenteric arteries. This 
could indicate the presence of a hypoxia-resistant component in contraction 
evoked by depolarisation which is specific to the pulmonary artery. 
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4.4.1 Role of KV and KCQ channels in hypoxia-induced contraction 
The current view on the role of the KV channels in the HPV response is that their 
inhibition by hypoxia and subsequent membrane depolarisation contribute to the 
2+
initial rise of [Ca ]i during the first phase of HPV [recently reviewed in (Moudgil 
et al., 2006;Weissmann et al., 2006b;Ward & McMurtry, 2009)]. This hypothesis 
is mainly based on the well documented observation that hypoxia inhibits KV 
channel currents in single isolated PASMCs (Post et al., 1992;Archer et al., 
1993;Archer et al., 1996;Olschewski et al., 2002;Platoshyn et al., 2006). This 
effect is considered to be specific to PASMCs because hypoxia does not affect KV 
currents in systemic arteries (Yuan et al., 1993;Michelakis et al., 2002a). 
Surprisingly, the involvement of KV channels in the initiation of HPV response in 
intact PA has not been studied previously. There could be two major reasons for 
the lack of studies in the intact tissues: i) the absence of commercially available 
specific inhibitors of the KV1.5 channel isoform [the main isoform which encodes 
KV channel currents in PAs (Archer et al., 1998;Archer et al., 2001;Smirnov et al., 
2002;Brevnova et al., 2004;Platoshyn et al., 2006)] and ii) the ability of the 
selective but non-specific KV channel inhibitor 4-AP (the most widely used KV 
channel inhibitor to study the role of KV currents in the vasculature) to cause a 
significant contraction of isolated PAs in adult normoxic animals typically at 
concentrations of 5-10 mM (Priest et al., 1998;Doggrell et al., 1999;Doi et al., 
2000;Bonnet et al., 2001;Bonnet et al., 2002). Such low sensitivity of the intact 
preparations to 4-AP is in disagreement with electrophysiological findings where 
KV channel currents are more sensitive to 4-AP in isolated PASMCs with an EC50 
ranging between 0.11 to 0.35 mM (Smirnov & Aaronson, 1994;Smirnov et al., 
2002). The main reason for this discrepancy between single cells and whole tissue 
preparations is due to activity of the KCNQ channels at the resting condition and 
has been resolved in this study (see Chapter 3). 
The understanding of the relationship between these two voltage-dependent K
+ 
channels provides an important opportunity to address the role of each type of 
channel in HPV response which was one of the main aims of this Chapter. As 
shown in Fig. 4.2 and 4.3, a partial inhibition of KV channels with 2 mM 4-AP did 
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not enhance the HPV response in PAs. Under such conditions it could be expected 
that KCNQ channels are activated completely and in control of the resting 
potential. If hypoxia caused a significant inhibition of KCNQ channels, this would 
have lead to membrane depolarisation and contraction. This was not the case, 
leading to a suggestion that KCNQ channels in PASMCs are not significantly 
affected by hypoxia. On the other hand, when KCNQ channels were inhibited by 
10 µM linopirdine (which should promote a greater activation of the KV channels 
to enable control of the resting potential) the HPV response was augmented. 
Furthermore, both observations are in line with the above mentioned hypothesis 
that KV channels are inhibited by hypoxia. The lack of significant differences is 
likely to be due to variation between the tissue responses which can be explained 
by the observations that hypoxia enhances the KV current in the negative voltage 
range, whereas the current is inhibited at more positive potentials (Dr. SV 
Smirnov’s unpublished observations). Such effect was also previously 
demonstrated (but not discussed) in canine PASMCs [Fig.7 in (Post et al., 1992)] 
and in rat PASMCs [Fig.7 in (Archer et al., 1993)]. Interestingly, this effect on the 
KV channel current is very similar to that seen in the presence of mitochondrial 
inhibitors (Firth et al., 2008). The implications of such dual effect of hypoxia on 
the KV channels could be that enhanced KV current at negative voltages stabilises 
the resting potentials. When the cell membrane is depolarised further, however the 
inhibitory effect on the KV current will prevail leading to membrane 
depolarisation and contraction. This notion is supported by the observation that in 
the presence of 10 µM linopirdine and 2 mM 4-AP (the combination which will 
promote such depolarisation) hypoxia caused a significantly greater contraction 
(Figs. 4.2 and 4.3). Also, hypoxia significantly enhanced the contraction in the 
presence of 10 µM linopirdine specifically in PA (Fig. 4.4 B and Fig. 4.6). 
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4.4.2 Tissue specificity of HPV response 
Interestingly, in MAs hypoxia was also able to induce a transient contraction in 
the presence of KV channel inhibitors (Figs. 4.2 F-H and 4.3 C-D). The ability of 
systemic vessels to transiently constrict in response to acute hypoxia is not new 
and has been previously observed in porcine mesenteric (Nankervis & Miller, 
1998) and coronary (Shimizu et al., 2000) arteries, canine basilar (Elliott et al., 
1989) and sheep middle cerebral (Klaas & Wadsworth, 1989) arteries. Transient 
contraction to hypoxia was also observed in rat small MA (Leach et al., 
1994;Robertson et al., 2003). The ability to compare the effect of hypoxia in 
pulmonary and systemic arteries under the same experimental conditions 
represents one of the main advantages of this study. Such comparison clearly 
demonstrates that the transient contractile effect of hypoxia is present in both 
types of arteries and importantly, this contraction is independent on the way the 
tissue is stimulated; either with K
+ 
channel inhibitors (Fig. 4.2) or with a receptor 
agonist U-46619 (Fig. 4.7). The independence of the hypoxic vasoconstriction on 
the type of stimulant was previously reported only in PAs (Rodman et al., 1989), 
but no direct comparison between PAs and systemic arteries has yet been reported. 
In this Chapter I also showed for the first time that, although the transient hypoxic 
contraction in MA was qualitatively similar to that seen in PA, it was significantly 
smaller than in PAs under my experimental conditions. The hypoxia-induced 
responses between PA and MA although qualitatively look similar, statistical 
comparison of these data indicates that in the presence of linopirdine and 4-AP 
hypoxia produced significantly bigger responses in PA than in MA in both 
absolute as well as the normalised tension (Fig. 4.3). This suggests that the ability 
of MA to contract in response to hypoxia is less than that of PA. This conclusion 
does not therefore contradict the common notion that PA more readily contract in 
response to hypoxia although both PA and MA may share the mechanism 
responsible for the initial transient hypoxic contraction. 
One critical difference in my study, however, is the observation of similar pattern 
of biphasic nature of HPV (a transient phase I followed by a slow and sustained 
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phase II) both in PA and MA (Fig. 4.1). The presence of the sustained phase II 
with occasional oscillations in MA was somewhat unexpected since most previous 
studies reported the relaxation of systemic arteries during prolonged effect of 
hypoxia (Leach et al., 1994;Robertson et al., 2000b;Robertson et al., 2003). One 
possible reason for such discrepancy could be due to differences in the 
experimental approach. The previous studies employed PGF2α to produce pretone 
whilst in my experiments linopirdine and 4-AP were used to stimulate the arteries. 
However, it is currently not known if this sustained phase of contraction is only 
the result of using K
+ 
channel blockers, or other factors may be involved. 
Although 100 µM L-NAME and 10 µM indomethacin were present in the 
myograph solutions in all experiments, the role of endothelium in this process is 
not clear. Whether endothelium-derived constricting factors (EDCF), which are 
released in response to various stimuli (Vanhoutte et al., 1991) and are considered 
to be mediators of HPV (Holden & McCall, 1984;Rubanyi & Vanhoutte, 1985), 
are also involved in MA need to be addressed further in a separate study. 
The presence of oscillations in contractions in MA is also interesting. In almost 
two third of the experiments, where application of linopirdine and 4-AP was 
followed by hypoxia, oscillations were observed in MAs, but not in PAs. 
Oscillations in contraction is known to be associated with oscillations of smooth 
2+
muscle membrane potential (Gustafsson et al., 1993) and of [Ca ]i (Peng et al., 
1998), whilst K
+ 
channels play a modulatory role in this mechanism (Gustafsson 
et al., 1994;Edwards & Griffith, 1997). In this study, simultaneous recordings of 
membrane potential and vessel contraction demonstrated oscillations both in Vm 
and contraction in MA more frequently than in PA (Chapter 3). Also it has been 
reported that oscillation was promoted after removal of the endothelium (or 
inhibition of NO synthase) in the rabbit mesenteric (Omote et al., 1993) and rabbit 
ear arteries (Griffith & Edwards, 1993), rat aorta (Marchenko & Sage, 1994) and 
rat mesenteric arteries (Sell et al., 2002). Thus, it cannot be excluded that in my 
experiments the use of L-NAME and indomethacin are triggering such 
oscillations when tissue is stimulated. The absence of oscillations in PAs could be 
due to difference in the gap junctions and variation in synchronised oscillatory 
mechanisms between PAs and MAs (Aalkjaer & Nilsson, 2005). 
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4.4.3 Differences in hypoxia-induced relaxation in rat PA and MA 
The results shown in Fig. 4.9 (A-D) and 4.10 (A) clearly demonstrate that the 
degree of the transient hypoxic contraction of PA strongly depends on the level of 
pretone which was elicited by increased concentrations of KCl and decreases as 
KCl-induced tension increases. The transient contraction was followed by 
relaxation, which progressively increased as pretone was increased. Similar 
biphasic effects of hypoxia were previously reported in large extra-pulmonary 
arteries of the rat (Bennie et al., 1991;Jin et al., 1992;Shigemori et al., 1996) and 
rabbit (Bonnet et al., 1989) preconstricted with KCl or an agonist. In the phase-II 
of HPV this initial relaxation will be followed by a slow contraction if hypoxia is 
persisted and the endothelium is intact (Bennie et al., 1991;Jin et al., 1992;Leach 
et al., 1994). It is however worth mentioning that although hypoxia-induced 
relaxation was focus of many studies in systemic arteries, in PA it has not been 
widely investigated. Reduction in intracellular ATP during hypoxia leading to an 
increase in outward KATP current (Noack et al., 1992) may be responsible for 
relaxation caused by U-46619 and linopirdine+4-AP, as was proposed for agonist 
(e.g. U-46619, angiotensin II, 5-HT and noradrenaline) induced contraction in PA 
(Wanstall & O'Brien, 1996), but would not explain relaxation in high K
+ 
which 
render these channels inactive. This mechanism may be responsible for the 
difference between hypoxia-induced relaxation in PA and MA in 80 mM KCl. 
Experiments using KATP inhibitors like glibenclamide could answer the question 
whether KATP channels are involved in any of those responses. In any case, the 
dependence of the relaxation to hypoxia on the way tissue is preconstricted in PA, 
but not as much in MA, could indicate differences in the way contraction is 
maintained in the two artery types. 
In systemic arteries preconstricted with agonists or high K
+
, hypoxia is known to 
cause relaxation (Namm & Zucker, 1973;Klaas & Wadsworth, 1989;Marriott & 
Marshall, 1990;Otter & Austin, 1999;Bruce et al., 2004). The exact mechanism of 
hypoxia-dependent relaxation in systemic circulations remained unresolved and a 
range of mechanisms including the release of vasodilator metabolites, such as 
adenosine from hypoxic tissues (Berne, 1980), opening of glibenclamide-
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sensitive KATP channels leading to K
+ 
efflux and hyperpolarisation (Daut et al., 
1990;Bonnet et al., 1991;Mellemkjaer & Nielsen-Kudsk, 1994), inhibition of L-
VOCCs (Herrera & Walker, 1998), possible dependence on cellular metabolism 
2+ 
(Otter & Austin, 1999), the inhibition of non-voltage-dependent Ca entry and 
2+ 
intracellular Ca release or the enhanced activity of SERCA (Guibert et al., 2002) 
have been proposed. As in case of HPV, multiple factors such as the tissue type, 
the type of vasoconstrictor, the presence of endothelium and others are likely to 
contribute to hypoxic systemic vasodilatation. 
Since the functional responses to hypoxia in the pulmonary and systemic 
circulations are different, comparison of hypoxia-induced relaxation in addition to 
hypoxia-induced contractions between PA and MA recorded under the same 
experimental conditions can reveal important differences in the responses of the 
two different types of arteries. Indeed, as shown in Figs. 4.11 and 4.12, the 
hypoxia-induced relaxation in PAs was dependent on the way tissue was pre-





channel inhibitors and the strongest in the presence of U-46619. On the 
other hand, no significant differences in hypoxia-induced relaxation were 
observed in MAs in the three groups. Furthermore, the relative degree of 
relaxation was significantly smaller in PAs than in MAs (Fig. 4.13), suggesting 
that the ability of MAs to relax to hypoxia is significantly greater than that of PAs. 
Interestingly, the weakest relaxation in PAs was observed under conditions when 
K
+ 
fluxes across the cell membrane were impaired, i.e. in 80 mM KCl or in the 
presence of linopirdine and 4-AP. This may indicate that the differential effect of 
hypoxia in PA compared to MA is most pronounced when K
+ 
channels (KV in 
particular) are inhibited. These differences are unlikely to be due to the use of 
95% O2 as normoxia (this level of oxygen was chosen because of the joint use of 
PA and MA in the same chamber) because previous study demonstrated that there 
is no significant difference in HPV responses in PAs between 95%O2/5CO2 and 
air/5%CO2 (Leach et al., 1994). 
The greater susceptibility of the phase-I of HPV measured in the presence of U-
46619 to both the L-VOCC blocker diltiazem and the Rho-kinase inhibitor Y-
27632 in MA, compared to PA (Fig. 4.7 and 4.8), may indicate the crucial 
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involvement of these two pathways in the differential regulation of contractility in 
these two types of vessels. The investigation of the relationship between the 
2+ 
voltage-dependent pathway and Ca sensitisation in the control of PA and MA 






IDEPEDET MECHAISMS OF 4-AP-IDUCED 
COTRACTIO I RAT PULMOARY AD 
SYSTEMIC MESETERIC ARTERIES 
5.1 Introduction 
The contractile response of intact artery rings is the result of vascular smooth 
2+ 
muscle contractions, which are primarily due to elevation of intracellular Ca
2+ 
concentration. This occurs as a result of activation of either the release of Ca
2+ 
from the intracellular stores or due to Ca influx from the extracellular space in 
the voltage-dependent and voltage-independent manner (Karaki et al., 1997). The 
voltage-dependent Ca
+ 
entry depends on membrane potential which in turn is 
determined by K
+ 
efflux (Standen & Quayle, 1998). Changes in the cell 
2+
membrane potential lead to changes in [Ca ]i and ultimately to the changes in the 
contractile state of the cell. A body of evidence suggests that, in PASMCs, KV 
channels play a significant role in regulating the resting membrane potential 
(Yuan, 1995;Yuan et al., 1998c;Mauban et al., 2005). Under resting conditions, 
some KV channels are active resulting in an efflux of K
+ 
ions, which contributes to 
the negative resting membrane potential. Membrane depolarisation caused by the 
2+ 
inhibition of KV channels (i.e., by hypoxia or 4-AP) causes Ca influx through L-
2+
VOCCs, which increases [Ca ]i resulting in vascular smooth muscle cell 
contraction and thus increasing in pulmonary tone (Weir & Archer, 
1995;Sweeney & Yuan, 2000). 
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The results presented in this chapter, could however, suggest that contraction 
produced as a result of application of the KV channel blockers in intact pulmonary 
arteries may be at least partly voltage-independent. The important questions are: i) 
whether any difference in the levels of voltage-dependent and voltage-
independent components of contraction exists between the pulmonary and 
systemic blood vessels; and ii) what possible mechanism might be involved in the 
2+ 
voltage-independent component? It is well documented that Ca sensitisation due 
to activation of the RhoA/Rho-kinase pathway is responsible for the augmented 
vascular contraction in animal models (Uehata et al., 1997;Mukai et al., 
2001;Chrissobolis & Sobey, 2001;Weber & Webb, 2001;Kitazono et al., 2002;Jin 
et al., 2006;Hilgers et al., 2007) as well as in humans (Masumoto et al., 
2001;Seasholtz et al., 2006). Therefore, the contraction of the vascular smooth 
2+ 
muscle is subjected to the dual regulation by the Ca signal and alteration of the 
2+ 
Ca sensitivity. This has been well documented for the sustained phase of 
agonist-induced smooth muscle contraction which is dependent on Rho-kinase 
activation and the phosphorylation of myosin phosphatase regulatory subunit 
(MYPT1) of MLCP (Swärd et al., 2000;Dimopoulos et al., 2007). Notably, 
2+ 
simultaneous measurements of the force and intracellular Ca in canine coronary 
arteries revealed a possibility that KCl depolarisation could increase contractility 
2+	 2+ 
of this tissue via Ca sensitisation (Yanagisawa & Okada, 1994). Ca
sensitisation was also implicated in the KCl-dependent augmentation of 
endothelin-1-induced contraction in the same preparation (Okada et al., 1992). 
Therefore, this chapter will be focussed on the investigation of the effects of KV 
channels inhibition using a combination of 4-AP and linopirdine and membrane 
depolarisation using high K
+ 
on isometric tension in isolated PA and MA to test 
the following questions: 
1)	 Whether contraction induced by blockers of K
+ 
channels and high K
+ 
involves voltage-dependent and voltage-independent pathways? 
2+ 





5.2.1 Effect of L-VOCC blocker (diltiazem) and a specific Rho-kinase 
inhibitor (Y-27632) on 4-AP-induced contraction in rat PA and MA 
Contractile responses to 10 mM 4-AP were produced in PA and MA in the 
presence of 10 µM linopirdine to completely block KCNQ channels and to 
maximise 4-AP responses. In this and the subsequent experiments 10 mM 4-AP 
was always preceded by 10 µM linopirdine unless otherwise stated. When 4-AP-
induced contraction reached the steady state level (20 min), 10 µM diltiazem, an 
L-VOCC blocker, was applied for 10 min followed by the application of 10 µM 
Y-27632, a selective inhibitor of Rho-kinase. The relaxation to both inhibitors 
was then calculated as the percentage of the maximal steady state 4-AP 
contraction. Representative examples of such experiments are shown in Fig. 5.1. 
It can be clearly seen that diltiazem alone blocked the 4-AP contraction only 
partly by 46% in PA (fig. 5.1 A), but contraction in MA was blocked nearly 
completely by 98% (Fig. 5.1 C). Although application of Y-27632 in the presence 
of diltiazem further reduced 4-AP-induced contraction in PA, it failed to block it 
completely (Fig. 5.1 A). This contrasts to the effect of Y-27632 in MA which was 
completely relaxed to the basal level in the presence of the inhibitor (Fig. 5.1 C). 
Application of the inhibitors in the reversed order showed that Y-27632 (when 
applied first) was a relatively less effective relaxant compared to the diltiazem, 
relaxing 4-AP-induced contraction by 31% in PA (Fig. 5.1 B) and by 65% in MA 
(Fig. 5.1 D). Notably, the effect of Y-27632 was greater in MA than in PA. 
Consecutive application of diltiazem completely relaxed the 4-AP-induced 
contraction in MA (Fig. 5.1 D), whereas the combined effect of Y-27632 and 
diltiazem in PA was similar to that when applied in the reversed order, causing 
only partial relaxation in PA. 
Fig. 5.2 summarises and statistically compares the relaxatory effects of the two 
inhibitors. On average, in the PA, the 4-AP-induced contraction was reduced by 
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48.6±2.3% (n = 11) in the presence of diltiazem. In the presence of diltiazem, 
application of Y-27632 further suppressed the contraction by approximately two-
thirds (62.0±5.4%, n = 6) (Fig. 5.2 A and B). Although the change of the Y-
27632-dependent relaxation was less than that by diltiazem (31.7±8.7%, n = 6), 
the resulting effect of the two inhibitors when applied together was virtually the 
same in PA, leaving about 35% of contraction which was insensitive to diltiazem 
and Y-27632. In MA, Y-27632 alone relaxation mounted to 77.2±4.0% (n = 6), 
which was significantly greater than that in PA (p<0.001, n = 6). The combination 
of both inhibitors completely relaxed MA independent on the order of their 
application (Fig. 5.2 C and D). Because diltiazem blocks contraction via 
inhibition of L-VOCCs whilst Y-27632 selectively inhibits intracellular Rho-
2+ 
kinase responsible for Ca sensitisation and due to their additiveness (at least in 
PA), the diltiazem- and Y-27632- sensitive components will be referred to as the 
voltage-dependent and voltage-independent components, respectively. 
The above comparisons clearly show that 4-AP contracts both arteries in a 
complex manner involving voltage-dependent and voltage-independent 
components in the maintenance of the sustained contraction. The distinguishing 
features between the pulmonary and systemic artery are a lesser sensitivity to 
Rho-kinase inhibition and the presence of the additional component of contraction 
2+ 2+ 
(in PA) which is apparently insensitive to voltage-dependent Ca entry and Ca
sensitisation. 
2+ 
It is worth mentioning here that removal of extracellular Ca blocked 4-AP-
induced contraction and cyclopiazonic acid also did not prevent the contraction to 
2+ 
4-AP (data not shown) indicating that this additional component is not due to Ca
2+ 
release from the intracellular Ca stores. 
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Figure 5.1 Effects of diltiazem and Y-27632 on 4-AP-induced contraction in 
rat PA and MA. 
Traces show the effects of L-VOCC blocker (diltiazem) or a specific Rho-kinase 
inhibitor (Y-27632) or combination of these two inhibitors on relaxation of 4-
AP-induced contraction in PA and MA. Representative traces were obtained 
from PA of 392 and 263 µm i.d. (A and B, respectively) and MA of 286 and 198 
µm i.d. (C and D, respectively). Lino, 10 µM linopirdine; 4-AP, 10 mM 4-
aminopyridine; Y, 10 µM Y-27632; Dil, 10 µM diltiazem. Horizontal and 
vertical scale bars represent 5 min and 1 mN, respectively. 
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Pulmonary artery Mesenteric artery 
Figure 5.2 Comparison of the inhibitory effects of diltiazem and Y-27632 
alone or in combination on 4-AP-induced contraction in rat PA and MA. 
A and C, Statistical comparisons of the effects of diltiazem and diltiazem+Y-
27632 on 4-AP-induced contraction in PA (A) and MA (C). B and D, Statistical 
comparisons of the effects of Y-27632 and Y-27632+diltiazem on 4-AP-induced 
contraction in PA (B) and MA (D). All 4-AP responses were carried out in the 
presence of 10 µM linopirdine applied for 20 min prior to 4-AP. Note that the 
order of the drugs listed on x-axis indicates the order of their application in the 
experiment. Lino, linopirdine (10 µM); 4-AP, 4-aminopyridine (10 mM); Y, Y-
27632 (10 µM); Dil, diltiazem (10 µM). Differences between groups were tested 
by Tukey-Kramer post-hoc test following one-way ANOVA; n values are shown 































































































5.2.2 Effect of the pretreatment with diltiazem, Y-27632 or 
combination on the 4-AP-induced contraction in rat PA and MA 
The results presented in the previous section demonstrate that in PA, in contrast to 
MA, the 4-AP-induced contraction was: i) less sensitive to either diltiazem or Y-
27632; ii) not completely blocked by the combined application of diltiazem and 
Y-27632; and iii) significantly less sensitive to Y-27632. To further investigate a 
2+ 2+
causal relationship between the voltage-dependent Ca entry and Ca -dependent 
sensitisation in the 4-AP-induced contraction the following experimental protocol 
was used for the two types of arteries: a) contraction was induced by 10 mM 4-AP 
(control); b) arteries were treated with 10 µM Y-27632 for 10 min prior to the 
addition of 4-AP (Y+4-AP); c) arteries were treated with 10 µM diltiazem for 10 
min prior to the addition to 4-AP (Dil+4-AP); and d) 10 mM 4-AP was applied 
alone after wash-out of the inhibitors (recovery). All the experiments were 
performed in the presence of 10 µM linopirdine in order to maximise the 4-AP-
induced responses. 
Representative traces from the first set of experiments are shown in Fig. 5.3. As 
can be seen in this Figure, in PA, the 4-AP-induced contraction was blocked 
partly by the pretreatment with Y-27632 or diltiazem with the effect being smaller 
in the presence of Y-27632 (~61%) compared to diltiazem (~85%). Under same 
conditions, in MA, the contraction caused by 10 mM 4-AP was blocked more 
profoundly by Y-27632 (~74%) or by diltiazem (~97%) (Fig. 5.3 F and G, 
respectively) compared to PA. Complete recovery of the 4-AP-induced 
contraction was observed in both tissues. A greater recovery in MA was due to 
potentiation phenomenon described in details in Chapter 3. The greater inhibition 
of the 4-AP-induced contraction in the presence of diltiazem in both tissues is 
2+ 
consistent with the depolarisation-induced Ca entry required for the initiation of 
tension. 
The results of the experiments where both arteries were pretreated with 
diltiazem+Y-27632 (10 µM each) are shown in Fig 5.4. As can be seen from the 
representative traces the 4-AP-induced contraction was completely abolished by 
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the pretreatment with diltiazem+Y-27632 in both PA (Fig. 5.4 A-C) and MA (Fig. 
5.4 D-F). These effects were fully reversible. It is worth noting that combination 
of diltiazem and Y-27632 was able to completely block the 4-AP response in PA 
when applied prior to induction of the contraction, conversely, when the 
contraction induced by 10 mM 4-AP was already developed combination of both 
inhibitors failed to completely relax PA (Fig. 5.1 A-B; and Fig. 5.2 A-B), 
2+ 
suggesting the necessity of the elevated intracellular Ca . 
The normalised responses obtained in these two sets of experiments are 
statistically compared in Fig.5.5. As can be seen from this comparison, all the 
effects of the L-VOCC blocker or Rho-kinase inhibitor on 4-AP-induced 
contraction were significantly different from the control and recovery responses 
(Fig. 5.5 A and B). In MA significant differences were only observed between the 
test data and the recovery for 10 µM Y-27632 and diltiazem pretreatments due to 
less consistent amplitude of 4-AP-induced contraction in control conditions (Fig. 
5.5 C). Although, in principle, this can be overcome by increasing the number of 
experiments, however, this was not considered practical due to prolonged duration 
of these experiments. Moreover, consistent results showing complete blockade of 
4-AP responses with L-VOCC blocker diltiazem and Rho-kinase inhibitor Y-
27632 pretreatment also provided evidence in favour of additiveness of these two 
inhibitors. Since the combination of the diltiazem and Y-27632 completely and 
consistently blocked contraction in MA (Fig. 5.5 D), the difference reached 
significance between the test and both the control and the recovery sets of data, 
despite a relatively smaller control contractions. It is important to note that, in the 
MA, the contraction in the presence of Y-27632 reduced by 69% (from 33±9% to 
10±2%) which is similar to that observed in the PA. Notably, the 4-AP-induced 
contraction in PA was inhibited more effectively by the pretreatment with Y-
27632 by 61% (from 104±4% in the control to 41±12% in the presence of the 
inhibitor). This was two times greater than the effect of Y27632 on the steady 
state 4-AP-induced contraction compared in Fig.5.2 B. In contrast, in MA, the 
effects of the Rho-kinase inhibitor were similar in both conditions. 
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Figure 5.3 Effect of pretreatment with Y-27632 or diltiazem on 4-AP-induced 
contraction in rat PA and MA.  
Representative traces were obtained from PA (A-D) of 263 µm i.d. and MA (E-H) 
of 198 µm i.d. Lino, linopirdine (10 µM); 4-AP, 4-aminopyridine (10 mM). 
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Figure 5.4 Effect of pretreatment with a combination of Y-27632 and 
diltiazem on 4-AP-induced contraction in rat PA and MA.  
Representative traces were obtained from PA (A-C) of 330 µm i.d. and MA (D-
F) of 203 µm i.d. Lino, linopirdine (10 µM); 4-AP, 4-aminopyridine (10 mM). 







Pulmonary artery Mesenteric artery 
Figure 5.5 Comparison of the inhibitory effects of single and combined 
pretreatment with Y-27632 and diltiazem on the subsequent contraction 
elicited by 4-AP in rat PA and MA. 
A and C, pretreatment with 10 µM Y-27632 alone or 10 µM diltiazem alone 
blocked 4-AP response only partly in PA (A) while in MA (C) the same 
concentration of Y-27632 alone blocks 4-AP response partly but diltiazem alone 
blocks this response completely. B and D, pretreatment with the combination of 
Y-27632 and diltiazem (10 µM each) completely blocked 4-AP response in both 
tissues. All 4-AP responses were carried out in the presence of 10 µM linopirdine 
applied for 20 min prior to 4-AP. Note that the order of the drugs listed on x-axis 
indicates the order of their application in the experiment. 4-AP, 4-aminopyridine; 
Y, Y-27632; Dil, diltiazem. Differences between groups were tested by Tukey-
Kramer post-hoc test following one-way ANOVA; n values are shown on the 






















































































5.2.3 Dependence of the effect of Y-27632 on the level of 4-AP-induced 
contraction in rat PA and MA 
The results described in the previous two sections may suggest that the relaxatory 
effect of Y-27632 depends on the level of 4-AP-induced contraction. To 
investigate this possibility, the effect of Y-27632 (10 µM) was compared in the 
presence of increasing concentrations of 4-AP (0.5, 1, 2.5, 5 and 10 mM) applied 
in the presence of 10 µM linopirdine. Fig. 5.6 shows representative traces 
recorded with this protocol in PA (Fig. 5.6 A-E) and MA (Fig. 5.6 F-J). In PA, Y-
27632 completely relaxed 4-AP at contractions between 0.5 and 2.5 mM, while 
had only partial effect at 5 and 10 mM. Although similar trend was observed in 
MA, the effect of Y-27632 was always greater in MA than in PA, becoming 
significantly different at 10 mM of 4-AP contraction (p<0.05, n = 4) (Fig. 5.7). 
It is notable that contractions produced by low concentrations of 4-AP (i.e., 0.5 
and 1.0 mM) in PA was completely ablated by 10 µM Y-27632. On the other hand, 
consistently with the observations described in Chapter3, similar low 
concentrations of 4-AP produced no contraction in MA. Therefore, the degree of 
Y-27632-induced relaxation was compared between PA and MA only for the 
higher concentrations of 4-AP (i.e., 2.5, 5 and 10 mM) (Fig. 5.7). 
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Figure 5.6 Inhibition by Y-27632 of contractions induced by different 
concentrations of 4-AP in rat PA and MA.  
Representative traces obtained from PA (A-E) of 388 µm i.d. and MA (F-J) of 243 
µm i.d. showing relative relaxation by 10 µM Y-27632 on contraction produced 
with different concentrations of 4-AP. All 4-AP responses were carried out in the 
presence of 10 µM linopirdine applied for 20 min prior to 4-AP. The time of 
application and the concentration of 4-AP in mM are shown by arrows. Lino, 
linopirdine (10 µM); 4-AP, 4-aminopyridine; Y; Y-27632 (10 µM). Horizontal 
and vertical scale bars represent 5 min and 1 mN, respectively. 
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rPA (n=4) rMA (n=4) 
p<0.05 
Figure 5.7 Statistical comparisons of the inhibitory effects of Y-27632 on 4-
AP-induced responses in rat PA and MA. 
Data expressed as a percentage of the inhibition of 4-AP responses by 10 µM Y-
27632. All 4-AP responses were carried out in the presence of 10 µM linopirdine 
applied for 20 min prior to 4-AP. Mean data are compared with paired Student’s 
t-test, n = 4. 
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5.2.4 Effect of Y-27632 on 4-AP-induced phosphorylation of myosin 
phosphatase target subunit (MYPT1) and MLC20 
In the section 5.2.1 of this chapter I demonstrated that in PA combined application 
(post-treatment) of diltiazem and Y-27632 or Y-27632 and diltiazem blocked the 
4-AP response only partly, leaving nearly one third of the contraction insensitive. 
Moreover, in the section 5.2.2 I also demonstrated that pretreatment with Y-27632 
alone blocked 4-AP response by ~61% (p<0.01, n = 3). Thus, I hypothesised that 
2+ 
4-AP was associated with Ca sensitisation which indirectly support the idea that 
the myosin phosphatase target subunit (MYPT1), the downstream effector 
component of Rho-kinase, could have been phosphorylated in response to the 
treatment with 4-AP. Therefore, 4-AP might increase levels of phosphorylated 
MYPT1 and pretreatment of the vascular tissue with Y-27632 might reduce the 
phosphorylation. Freshly isolated pieces of PA and MA were divided into three 
groups: i) the control (no inhibitor), ii) treated with 10 mM 4-AP, and iii) treated 
with 10 mM 4-AP+10 µM Y-27632. Pieces of arteries were incubated in Krebs 
solution under continuous gassing. Following the incubation, arteries were 
subjected to Western blot analysis to measure level of phosphorylated MYPT1 as 
described in Chapter 2. In the 4-AP treated groups, 10 µM linopirdine was also 
present to match the contraction experiments. Rho-kinase phosphorylates MYPT1 
at two different sites including Thr695 and Thr850 (mammalian sequence), and 
the later site is reported to be preferred by Rho-kinase (Muranyi et al., 2005). I, 
therefore, used antiphospho MYPT1 (Thr850) antibody in this study. 
Although pretreatment of the arterial tissues with 4-AP failed to show an increase 
in phosphorylation of MYPT1 the level of phosphorylated MYPT1 in Y-27632+4-
AP treated groups was significantly reduced in PA (p<0.05, n = 3; Fig. 5.8 A). 
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aA. Pulmonary artery B. Mesenteric artery 
Figure 5.8 Effect of Rho-Kinase inhibitor Y-27632 on the level of 
phosphorylated MYPT1 in rat PA. 
A combined pretreatment with 10 mM 4-AP and 10 µM Y-27632 significantly 
reduced phosphorylated MYPT1 in PA (A) and not in MA (B). Differences 
between control versus treatment groups were tested by Dunnett post-hoc test 
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The above results showing the absence of 4-AP-induced phosphorylation of 
MYPT1 does not fit with the observation that 4-AP evokes contraction in intact 
PA and MA and that the 4-AP-induced contraction is sensitive to the Rho-kinase 
inhibitor Y-27632. One of the possible explanations could be the differences in 
the experimental conditions and that, in the contraction experiments arteries were 
under certain level of tension. It was previously shown that mild stretching of 
blood vessels resulted in vasoconstriction mediated by RhoA/Rho-kinase pathway 
(McGregor et al., 2002). To test this hypothesis main extra PA rings were 
mounted in myograph under 5 mN of tension (hence termed stretched) and 





by leaving it with normal Krebs solution for an equal duration of the other 
treatment groups (control); ii) following normalisation and stimulation, tissue was 
treated with 10 µM linopirdine (20 min) and 10 mM 4-AP (20 min) (4-AP); iii) in 
addition to the treatment with 4-AP in this group, tissue was exposed to 10 µM 
Y-27632 for another 10 min (Y+4-AP ). Similar treatment was given to another 3 
groups without mounting them on the myograph hence termed non-stretched. At 
the end of each treatment protocol tissues were collected and snap frozen for 
Western blot analysis. For these non-stretched and stretched tissues, protein 
P
expression of phosphorylated 20 kDa myosin light chain ( MLC20) was measured 
P
by Western blot as MLC20 is the ultimate indicator of tissue contraction. 
P 19
Pretreatment with 4-AP showed a greater increase in the MLC20 (Ser ) levels in 
the stretched PA in comparison to non-stretched preparations (Fig. 5.9 B). 
P 19
Pretreatment with Y-27632, however, tends to decrease the MLC20 (Ser ) levels. 
However, neither in the stretched nor in the non-stretched tissue these differences 
were significant (Fig. 5.9 A and B, respectively). More experiments are necessary 
to determine if the difference exists in the phosphorylation levels under these 
conditions. 
Also, the experiments with the stretched tissue were carried out in main PA rings 
[external diameter ~2 mm (Hislop & Reid, 1978)] whereas contraction studies 
were performed in small resistance arteries. Although the mechanism of 
contraction and Rho-kinase-dependent sensitisation supposed to be similar, the 
sensitivity to 4-AP could differ between the two tissues (conduit vs. resistance). 
The observation of two subtypes of K
+ 
currents, 4-AP sensitive and 4-AP 
insensitive in arteries isolated from the main PA (Smirnov et al., 2002) supports 
this possibility. 
Finally, phosphorylation of MYPT1 of a different site (Thr695) also cannot be 
entirely excluded. Future focussed work will help to identify the exact molecular 
pathway involved in the 4-AP-induced contraction. 
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A. on-stretched pulmonary artery B. Stretched pulmonary artery 
Figure 5.9 Effect of tissue stretching on 4-AP-induced phosphorylation 
of MLC20 in rat main PA. 
Pretreatment with 10 mM 4-AP changed phosphorylation of MLC20 in 
stretched PA (B), but not in non-stretched PA (A). Data were not significant 



























5.2.5 Effects of diltiazem and Y-27632 on high K (80 mM KCl)-
induced contraction in rat PA and MA 
The previous sections characterised vascular response to 4-AP which acts via 
inhibition of KV channels thus causing membrane depolarisation and contraction. 
On the other hand, use of 4-AP was criticised due to lack of its complete 
specificity. High concentrations of extracellular K
+ 
cause contraction via similar 
mechanism: depolarising the cell membrane due to decrease of K
+ 
gradient across 
the cell membrane and thus impairing the activity of all K
+ 
channels independent 




contraction engages Ca -sensitisation in addition to the established voltage-
dependent mechanism similar to that observed with 4-AP in my experimental 
conditions, the effect of the L-VOCC blocker diltiazem and Rho-kinase inhibitor 
Y-27632 on the steady-state contraction induced by high concentration of K
+ 
was 
assessed in PA and MA. 
Arteries were exposed to 80 mM KCl for 15 min to obtain sustained contraction 
followed by addition of 10 µM diltiazem, 10 µM Y-27632, or their combination 
for 10 min each in a similar fashion as described for 4-AP in the previous sections. 
In PA, diltiazem alone blocked high K
+
-induced contraction by 89% (mean 
84±3.6%, n = 10, p<0.001). Subsequent application of Y-27632 completely 
abolished the tension (Fig. 5.10 A). In MA, on the other hand, diltiazem alone 
completely blocked the total contraction (mean 99.7±0.3%, n = 10, p<0.001) 
produced with high K
+ 
(Fig. 5.10 C). When the application sequence was reversed, 
10 µM Y-27632 blocked high K
+ 
contraction only by 35% (mean 35.4±2.1%, n = 
11, p<0.001) in PA (Fig. 5.10 B), and by 85% (mean 90.6±1.4%, n = 11, p<0.001) 
in MA (Fig. 5.10 D). In both tissues, however, the tension was totally abolished in 
the presence of the two inhibitors added together (Fig. 5.11 A-D). 
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 Pulmonary artery Mesenteric artery 



















Figure 5.10 Effects of diltiazem or Y-27632 or combination of these two 
+
drugs on high K -induced contraction in rat PA and MA.  
Representative traces were obtained from PA of 294 and 363 µm i.d. (A and B, 
respectively) and MA of 262 and 194 µm i.d. (C and D, respectively). 80 K
+
, 80 
mM KCl; Y, Y-27632 (10 µM); Dil, diltiazem (10 µM). Horizontal and vertical 





The average results of the effect of diltiazem and Y-27632 on KCl-induced 
contraction in 11 PA and 10 MA are statistically compared in Figure 5.11. This 
comparison and those reported in the previous sections demonstrate principal 
similarity between the relaxation induced by the two inhibitors in the presence of 
high K
+ 
and 4-AP. Notably, the degree of inhibition of the steady state contraction 
by Y-27632 was very similar in high K
+ 
(35.4±2.1%, n = 11) and 4-AP 
2+ 
(31.7±8.7%, n = 6), suggesting that the levels of Ca sensitisation are similar in 
both conditions. Also, similar to 4-AP, MA showed greater sensitivity to both 
diltiazem and Y-27632 in the presence of high K
+ 
in comparison to PA. On the 
other hand, the combination of both inhibitors completely relaxed high K
+
-
induced contraction in PA, whereas a significant component of 4-AP-induced 
contraction was insensitive in their presence in this preparation. Also, in MA, the 
degree of relaxation to diltiazem alone was very similar and nearly complete in 
high K
+ 
as well as in 4-AP-induced contractions. However, surprisingly Y-27632 
completely relaxed high K
+
-induced contraction (in MA), but only partially the 4-
AP-induced contraction in this artery (compare Fig. 5.2 D with Fig. 5.11 D). 
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Pulmonary artery Mesenteric artery 
Figure 5.11 Comparison of the inhibitory effects of diltiazem and Y-27632 
on high K
+
-induced contraction in rat PA and MA. 
A and C, Statistical comparisons of the effects of diltiazem and diltiazem+Y-
27632 on high K
+
-induced contraction in PA (A) and MA (C). B and D, 
Statistical comparisons of the effects of Y-27632 and Y-27632+diltiazem on high 
K
+
-induced contraction in PA (B) and MA (D). A combination of diltiazem and 
Y-27632 (10 µM each) ablated high K
+ 
response completely in both tissue types. 
Note that the order of the drugs listed on x-axis indicates the order of their 
application in the experiment. 80 K, 80 mM KCl; Y, Y-27632; Dil, diltiazem. 
Differences between groups were tested by Tukey-Kramer post-hoc test 




























































































5.2.6 Effect of pretreatment of PA and MA with diltiazem, Y-27632 or 
+
their combination on high K -induced contraction 
To investigate whether the pretreatment of arteries with the two inhibitors (alone 
or in combination) will affect high K
+
-induced contraction in a similar fashion as 
it did for the 4-AP-induced responses, diltiazem and Y-27632 at 10 µM each 
were applied for 10 min prior to the addition of 80 mM K
+
. The effect of the drugs 
was compared with both the control and the recovery responses. Fig. 5.12 shows 
traces from a representative experiment. Interestingly, in PA, while a partial block 
of high K
+ 
contraction (56%) following the pretreatment with Y-27632 alone (Fig. 
5.12 B) is expected based on the previous findings, an incomplete inhibition of 
high K
+ 
response by diltiazem (70%, Fig. 5.12 C) is somewhat unusual. 
Conversely, in MA, pretreatment with either of the inhibitors blocked high K
+ 
response almost completely (Fig 5.12 F and G), suggesting that the difference 
between PA and MA are unlikely to arise from a less potent action of diltiazem in 
PA, since both arteries were exposed to the same concentration of the L-VOCC 
blocker. 
Interestingly, in the presence of Y-27632, contraction to high K
+ 
in MA was 
2+ 
transient, suggesting that Ca sensitisation is important for maintaining of 
contraction in this tissue. In PA, however, the amplitude of contraction was 
reduced, without significant changes in the time course. Similar to the 4-AP-
induced contraction, the pretreatment with a combination of Y-27632 and 
diltiazem (10 µM each) virtually completely blocked high K
+ 
response both in PA 
(96.9±1.1, n = 3, Fig. 5.13 B) and in MA (100%, n = 3, Fig. 5.13 E). 
The normalised average results statistically compared in Figure 5.14, 
demonstrating significant difference between the control responses and those in 
the presence of the inhibitors. 
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Pulmonary artery Mesenteric artery

+
Figure 5.12 Effects of pretreatment with Y-27632 or diltiazem on high K -
induced contraction in rat PA and MA. 
Representative traces obtained from PA (A-D) of 390 µm i.d. and MA (E-H) of 
240 µm i.d. showing response to 80 mM KCl in control, in the presence of 10 µM 
Y-27632 or 10 µM diltiazem and recovery. 80 K
+
, 80 mM KCl. Horizontal and 
vertical scale bars represent 5 min and 1 mN, respectively. 
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Pulmonary artery Mesenteric artery

Figure 5.13 Effect of pretreatment with a combination of Y-27632 and 
+
diltiazem on high K -induced contraction in rat PA and MA. 
Representative traces obtained from PA (A-C) of 294 µm i.d. and MA (D-F) of 
262 µm i.d. showing response to 80 mM KCl in control, in the presence of Y-
27632+diltiazem (10 µM each) and recovery. 80 K
+
, 80 mM KCl. Horizontal 




Pulmonary artery Mesenteric artery 
Figure 5.14 Summary of the effects of pretreatment with Y-27632 and 
diltiazem alone or a combination of the two inhibitors on high K
+
-induced 
contraction in rat PA and MA. 
A and C, Statistical comparisons of the effects of pretreatment with Y-27632 or 
diltiazem alone on high K
+
-induced contraction in PA (A) and MA (C). B and D, 
Statistical comparisons of the effects of pretreatment with Y-27632+diltiazem on 
high K
+
-induced contraction in PA (B) and MA (D). Note that the order of the 
drugs listed on x-axis indicates the order of their application in the experiment. 
80 K, 80 mM KCl; Y, Y-27632 (10 µM); Dil, diltiazem (10 µM). Differences 
between groups were tested by Tukey-Kramer post-hoc test following one-way 
ANOVA (n = 3). Note that, as the pretreatment of the tissues with Y-
27632+diltiazem resulted in the complete inhibition of contraction no further 





































































5.2.7 Effects of Y-27632 on increasing levels of KCl-induced 
contractions in rat PA and MA 
In the section 5.2.3 I have demonstrated that the effect of Y-27632 on the 4-AP-
induced contraction depends on the level of preconstriction. It was, therefore, 
logical to check if a similar dependency exists for contractions induced by high K
+
. 
In this set of experiments, increasing concentrations of KCl (20, 30, 40 and 80 
mM) were applied for 15 min to obtain various levels of contractions followed by 
application of 10 µM Y-27632. Fig. 5.15 A-D shows representative traces in PA, 
where Y-27632-dependent relaxation was comparatively larger at lower than at 
high concentrations of KCl. In MA, on the other hand, the effect of Y-27632 was 
equally potent at all levels of KCl contractions (Fig. 5.15 E-H). 
The statistical analysis of these differences recorded in 4 PA and 4 MA is shown 
in Fig. 5.16. This comparison clearly shows that the ability of the Rho-kinase 
inhibitor to reduce contraction depends on the level of tone in PA but not in MA. 
This dependence is even more pronounced than the similar trend seen at different 
levels of 4-AP-induced contraction (Fig. 5.7), suggesting that this effect may be 
specific for PA and is independent on the way the contraction is initiated. The 
differences between PA and MA may therefore indicate towards the different role 
2+ 




Pulmonary artery Mesenteric artery

Figure 5.15 Inhibition of contraction induced by various concentrations of 
KCl by Y-27632 in rat PA and MA. 
Representative traces obtained from PA (A-D) of 374 µm i.d. and MA (E-H) of 
230 µm i.d. showing relative relaxation by 10 µM Y-27632 on contractions 
produced with gradual increase in concentration of KCl. A-D, in PA, Y-27632 
relaxed contraction to 20 mM KCl completely, while contraction elicited by 30 
mM or higher concentrations of KCl, Y-27632 only partly blocked the response. 










concentration of KCl in mM; Y, Y-27632 (10 µM). Horizontal and vertical scale 
bars represent 5 min and 1 mN, respectively. 
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rPA (n=4) rMA (n=4) 
p<0.001 p<0.01 p<0.001 
Figure 5.16 Statistical comparisons of the inhibitory effects of Y-27632 on 
KCl-induced contractions in rat PA and MA. 
Data expressed as a percentage of the inhibition of KCl contractions by 10 µM Y-




5.2.8 Effects of Y-27632 and diltiazem on U-46619-induced contraction 
in rat PA and MA 
The thromboxane A2 mimetic U-46619 is a potent vasoconstrictor acting via 
thromboxane prostanoid (TP) receptor that triggers smooth muscle contraction via 
2+
Ca /calmodulin/MLCK pathway and RhoA/Rho-kinase pathway (Wilson et al., 
2005;Alapati et al., 2007). U-46619-induced vasoconstriction also has a voltage-
2+ 
dependent component as it is reported that entry of extracellular Ca was 
inhibited by nicardipine, an L-VOCC blocker (Wilson et al., 2005). I, therefore, 
investigated the contractile responses to 1 µM U-46619 (15-20 min) in the 
absence and following pretreatment of the tissue with the L-VOCC blocker 
diltiazem (10 µM). In the first set of experiments performed without pretreatment 
with diltiazem, after a steady level of contraction with 1 µM U-46619 was 
achieved, 10 µM Y-27632 alone or Y-27632+diltiazem (10 µM each) were 
applied in PA and MA to assess a relative proportion of Rho-kinase-sensitive and 
voltage-sensitive components in the contraction resulting from the action of U-
46619. 
Figures 5.17 and 5.18 respectively show the representative traces and the 
summary of the results obtained in 3 PA and 3 MA. In the absence of diltiazem, in 
PA, 10 µM Y-27632 blocked U-46619-induced contraction by ~68% (mean 
43.9±11.8%, n = 3), and Y-27632+diltiazem (10 µM each) blocked by ~77% 
(mean 58.6±9.6%, n = 3) (Fig. 5.17 A); while in MA, 10 µM Y-27632 blocked U-
46619-induced contraction by ~86% (mean 89.3±2.0%, n = 3), and Y-
27632+diltiazem (10 µM each) blocked by ~99% (mean 99.4±0.2%, n = 3) (Fig. 
5.17 C). 
When the experiment was repeated after pretreatment of the tissue with 10 µM 
diltiazem, in the PA the U-46619-induced contraction was diminished by ~19 %, 
however the effect of Y-27632 was similar to that in the absence of diltiazem. 
Notably, as one would expect, the additional effect of diltiazem was absent (Fig. 
5.17 B and D). In MA, Y-27632 in the presence of diltiazem completely relaxed 
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U-46619-induced contraction without further effect of diltiazem (Fig. 5.17 D).  
Notably, the presence of the third component of U-46619-induced contraction 
which was insensitive to both diltiazem and Y-27632 in PA, but not in MA, 
echoes the effect of these inhibitors on the 4-AP-induced contraction in both 
arteries described in the previous sections. 
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Figure 5.17 Effects of Y-27632 and diltiazem on U-46619-induced contraction 
in rat PA and MA in the absence (A, C) and presence (B, D) of diltiazem. 
Representative traces obtained from PA of 362 (A) and 423 (B) µm i.d. and MA 
of 274 (C) and 370 (D) µm i.d. showing relaxation of 1 µM U-46619-induced 
contraction by 10 µM Y-27632 alone or Y-27632+diltiazem (10 µM each). U, U-
46619; Y, Y-27632; Dil, diltiazem. Horizontal and vertical scale bars represent 5 
min and 1 mN, respectively. 
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Figure 5.18 Effect of Y-27632 and diltiazem on U-46619-induced contraction 
in rat PA and MA in the absence and presence of diltiazem. 
Graphs summarise and compare normalised tensions produced with 1 µM U-
46619 alone, remaining tension after application of 10 µM Y-27632, or Y-
27632+diltiazem (10 µM each). (-) Diltiazem, experiments were carried out in 
absence of diltiazem; (+) Diltiazem, experiments were carried out in the presence 
of 10 µM diltiazem added before the application of U-46619. U, U-46619, Y, Y-
27632, Dil, Diltiazem. Top panel (A) one-way ANOVA with Tukey-Kramer post-
hoc test (n = 3), bottom panel (B) no statistics done (n = 2). 
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5.2.9 Effects of pretreatment with Y-27632 and diltiazem on U-46619-
induced contraction in rat PA and MA 
In the previous section I demonstrated that a combination of Y-27632 and 
diltiazem was unable to block the sustained U-46619-induced contraction in PA 
indicating the presence of a third component. I have also shown that the 
pretreatment with two inhibitors together completely blocked 4-AP- and high K+-
induced contraction. It is therefore logical to evaluate the effect of the combined 
addition of Y-27632 and diltiazem (10 µM each) on the subsequent contractile 
response to U-46619. 
Figures 5.19 and 5.20 respectively show the examples of the representative 
experiments and statistical comparison of the averaged data obtained in 4 PAs and 
4 MAs. Pretreatment with a combination of Y-27632 and diltiazem (10 µM each) 
blocked U-46619-induced contraction in PA by 63% (mean 61.1±11.9%, n = 4) 
with one third of contraction being insensitive to this treatment (Fig. 5.19 B). In 
contrast, in MA, the contraction was blocked by 95% (mean 95.8±1.2%, n = 4) 
(Fig. 5.19 E). In both cases, the complete recovery of the U-46619-induced 
responses was observed. 
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Figure 5.19 Effect of pretreatment with a combination of Y-27632 and 
diltiazem on U-46619-induced contraction in rat PA and MA.  
Representative traces obtained from PA (A-C) of 362 µm i.d. and MA (D-F) of 
274 µm i.d. showing contraction elicited by 1 µM U-46619 in the control, in the 
presence of  Y-27632+diltiazem (10 µM each), and following the recovery. U, U-
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5.20 Comparison of the effect of pretreatment with Y-

27632+diltiazem on U-46619-induced contraction between rat PA and MA. 
Graphs summarise and compare normalised tension obtained from PA (A) and 
MA (B) with 1 µM U-46619 alone (control), with 1 µM U-46619 following the 
pretreatment with Y-27632+diltiazem (10 µM each) and the recovery. Pre-
testament with a combination of Y-27632+diltiazem (10 µM each) was unable to 
completely block U-46619 response in PA (A) but it blocked U-46619 response 
entirely in MA (B). Note that the order of the drugs listed on x-axis indicates the 




5.2.10 Dependence of the effects of Y-27632 on the level of U-46619-
induced contraction in rat PA and MA 
The findings described in the previous sections suggest that the effect of Y-27632 
was dependent on the level of preconstriction induced by 4-AP and high K
+ 
specifically in PA. I therefore investigated if similar dependency exists for 
contractions caused by different concentrations of U-46619. The experiments 
were carried out under two conditions: 1) in the presence of 10 µM diltiazem in 
order to eliminate voltage-dependent component, and 2) in the absence of 
diltiazem. In both cases 10, 20, 100 and 1000 nM of U-46619 were used to obtain 
increasing levels of contractions; the agonist was applied for 10-15 min to obtain 
a sustained contraction which was followed by addition of 10 µM Y-27632. 
Figures 5.21 and 5.22 respectively show the representative recordings in the 
presence and in the absence of diltiazem. The statistical comparison of the mean 
values obtained under both conditions is shown in Fig. 5.23. This analysis clearly 
shows that Y-27632 caused a greater relaxation at low concentrations of U-46619 
in PA in both conditions. In MA, however, the effect of Y-27632 was independent 
on the degree of preconstriction in the presence of diltiazem (Fig. 5.21 E-H and 
Fig. 5.23 A). In the absence of the L-VOCC blocker diltiazem, Y-27632 was less 
effective at high concentration of U-46619 (Fig. 5.22 E-H and Fig. 5.23 B) and 
2+ 
the remaining contraction is likely to be mediated by the Ca entry via L-VOCC 
as it can be blocked by subsequent application of diltiazem (Fig. 5.17 C). 
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Figure 5.21 Effect of Y-27632 on the levels of U-46619-induced contraction 
(in the presence of diltiazem) in rat PA and MA.  
Representative traces obtained from PA (A-D) of 309 µm i.d. and MA (E-H) of 
300 µm i.d. showing relaxation at different levels of U-46619-induced 
contractions with a 10 µM Y-27632. A-D, in PA, Y-27632 relaxed U-46619 
contractions completely at a concentration of 10 and 20 nM while contraction 
elicited with 100 nM or higher concentrations of U-46619, Y-27632 only partly 
blocked the response. E-H, in MA, on the other hand, Y-27632 nearly completely 
blocked any level of U-46619-induced contraction. The numbers next to the 
arrows indicate concentration of U-46619 in nM. Y, Y-27632 (10 µM). Horizontal 
and vertical scale bars represent 5 min and 1 mN, respectively. 
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Figure 5.22 Effect of Y-27632 on the levels of U-46619-induced contraction 
(in the absence of diltiazem) in rat PA and MA.  
Representative traces obtained from PA (A-D) of 3338 µm i.d. and MA (E-H) of 
215 µm i.d. showing relaxation at different levels of U-46619-induced 
contractions with a 10 µM Y-27632. A-D, in PA, Y-27632 relaxed U-46619-
induced contractions incompletely at any concentration of U-46619 with an 
increasing insensitivity to Y-27632 with the increase of contraction. E-H, in MA, 
on the other hand, Y-27632 completely blocked U-46619-induced contractions at 
10 and 20 nM while contractions elicited with 100 nM or higher concentrations of 
U-46619, Y-27632 only partly blocked the contraction. The numbers next to the 
arrows indicate concentration of U-46619 in nM. Y, Y-27632 (10 µM). Horizontal 
and vertical scale bars represent 5 min and 1 mN, respectively. 
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Effect of Y-27632 on U-46619 responses in PA and MA 
Figure 5.23 Statistical comparisons of the inhibitory effects of Y-27632 on U-
46619-induced contractions in rat PA and MA in the presence (A) and 
absence (B) of diltiazem. 
Data expressed as a percentage of inhibition of U-46619-induced contractions by 
10 µM Y-27632. Mean data compared between PA and MA with paired 
Student’s t-test (n = 3). (+) Diltiazem, experiments were carried out in the 
presence of 10 µM diltiazem added before addition of U-46619; (-) Diltiazem, 



















































































rPA (n=3) rMA (n=3) 
p<0.05 




The main observations described in this chapter is that in both pulmonary and 
systemic arteries contraction elicited by the membrane depolarisation either via 
inhibition of K
+ 
channels with 4-AP and linopirdine or using high K
+ 
has two 
components: 1) voltage-dependent and 2) voltage-independent; the latter involves 
2+ 
Rho-kinase dependent Ca sensitisation component. There are however several 
differences between the two type of arteries. Firstly, the voltage-dependent and 
voltage-independent components of 4-AP- or high K
+
-induced contractions are 
additive in PA, but not in MA. Secondly, the Rho-kinase-dependent sensitisation 
has a significantly greater dependence on the pretone in PA than in MA. Thirdly, 
in PA, an additional third component is present in the 4-AP-induced contraction, 
which is absent in MA. Interestingly, three additive components of contraction 
elicited by the thromboxane A2 receptor agonist U-46619 (as distinguished using 
diltiazem and Y-27632) also exists in PA, and not in MA. Although this may 
imply the similarity between the contractions caused by 4-AP and U-46619, 
however the third component of contraction was preserved following the 
pretreatment with diltiazem and Y-27632 in response to U46619 (Fig. 5.20 A), 
whereas 4-AP-induced contraction was completely abolished under such 
conditions (Fig. 5.5 B). This suggests that cellular mechanisms responsible for the 
third component (which is insensitive to the L-VOCC blockade and to the 
inhibition of Rho-kinase) in the 4-AP- and U-46619-induced contractions may be 
different. Previously, it was demonstrated that activation of TP receptors in PA 
2+ 
involved both intracellular Ca release and activation of non-voltage-dependent 
2+ 
Ca entry (Liu et al., 1997;Snetkov et al., 2006); both mechanisms could 
contribute to the described third component of the U-46619-induced contraction. 
The novel and most interesting observation presented here is that relaxation of the 
high K
+ 
and 4-AP-induced contractions to diltiazem and Y-27632 are additive in 
PA, but not in MA. This finding provides an important insight into the principal 
difference between the voltage-dependent and voltage-independent cellular 
mechanisms which are responsible for maintenance of contraction in the two 
2+ 




and Ca -sensitisation via Rho-kinase pathway operates in parallel in the PA, 
hence termed the parallel hypothesis. In the MA, they run in sequence, hence 
termed sequential hypothesis. The two diverse hypotheses are depicted in Fig. 
2+ 
5.24. In both hypotheses Ca entry is essential in order to maintain the sustained 
contraction because the contraction is completely abolished by the pretreatment 
with diltiazem and Y-27632. 
Pulmonary artery Mesenteric artery 
Figure 5.24 Working model to explain the ‘parallel’ and ‘sequential’ 
hypothesis. 
Parallel hypothesis: in PA, the inhibition of KV channels follows a parallel 
mechanism of vasoconstriction in which Ca
2+ 
influx via L-VOCCs and Ca
2+ 
-
sensitisation take place simultaneously. Sequential hypothesis: in MA, elevated 
Ca
2+ 
(via voltage-dependent pathway) and Ca
2+
-sensitisation act mainly in 
































It is worth mentioning that the overall effects of Rho-kinase inhibition described 
in this study are consistent with previously published works. Several groups 
demonstrated that Rho-kinase is activated in response to KCl-induced 
depolarisation (Yuan, 1995;Sakurada et al., 2001;Sakurada et al., 2003). Rho-
kinase phosphorylates myosin phosphatase target subunit 1 (MYPT1) and thus 
2+
downregulates MLCP activity, resulting in Ca -sensitisation (Somlyo & Somlyo, 
2003;Hilgers & Webb, 2005). In my study, I did not find a significant effect of 4-
AP on phosphorylation of MYPT1. However, Y-27632 significantly reduced 
phosphorylation of MYPT1. The results where 4-AP effect was studied on MLC20 
phosphorylation were more promising when tissue was stretched but still not 
conclusive. More experiments will be required to achieve a clearer view regarding 
phosphorylation of MYPT1 as well as MLC20. There is a significant functional 
difference in terms of sensitivity to Y-27632 between pulmonary and systemic 
arteries. For example, agonist-induced contractions in the systemic arteries are 
more susceptible to Y-27632 (Batchelor et al., 2001;Chan et al., 2009;Freitas et 
al., 2009) than that in the pulmonary arteries (Alapati et al., 2007;McKenzie et al., 
2009). One of the weaknesses of my study is the focus on measuring MLC20 
phosphorylation, the ultimate indicator of smooth muscle contraction, only in PA. 
Therefore, it will be important to determine the phosphorylation of MYPT1 in 
stretched PA and MA in the future works. 
The thromboxane A2 mimetic U-46619 acts via TP receptors (Yang et al., 2004) 
2+
which leads to an increase in [Ca ]i and sensitisation of the contractile proteins to 
2+ 
Ca (Tosun et al., 1998;Janssen et al., 2001;Somlyo & Somlyo, 2003). One of the 
signalling molecules activated downstream of the TP receptor in smooth muscle 
cell is Rho-kinase (Somlyo & Somlyo, 2003) and the involvement of Rho-kinase 
pathway in U-46619-induced sustained contractile response was demonstrated in 
PA (Alapati et al., 2007). A study by Cogolludo et al. (2003) established a 
possible link between the TP receptor, KV channels and Rho-kinase in rat 
PASMCs. This study provided evidence that U-46619 acting via TP receptor 
inhibits KV channel activity and causes membrane depolarisation, leading to 
2+
opening of L-VOCCs, increase in [Ca ]i, and contraction of PASMCs (Cogolludo 
et al., 2003). This opens the possibility that U-46619 may share, at least partly, 
mechanisms similar to those activated in the presence of 4-AP. The similarity 
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between the effect of the L-VOCC blocker and the Rho-kinase inhibitor on the U-
46619 and 4-AP-induced contractions does not contradict this notion. 
In this study, diltiazem was exclusively used because it showed complete 
reversibility upon the removal of the inhibitor. In a separate set of experiments, 1 
µM nifedipine was also used (n = 2, data not shown) demonstrating similar results. 
Diltiazem also blocked completely linopirdine-induced contraction in depolarised 
PA and MA (n = 2, data not shown). Similar effects was also observed in previous 
studies where 1 µM nifedipine was able to completely block linopirdine (10 µM) 
responses in rat PA (Joshi et al., 2006). 
It is worth noting that MA always showed greater sensitivity to either diltiazem 
or Y-27632, in comparison to PA irrespective of the way how contraction was 
generated (either with 4-AP, high K
+ 
or U-46619) (Fig. 5.2, 5.11 and 5.20). It is 
also notable that for the same tissue there is a significant difference in the 
sensitivity to Rho-kinase inhibitor Y-27632 depending on the agonist used for 
inducing sustained contraction as summarised in Fig. 5.25. The present finding is 
also consistent with the previous report that the relative inhibitory effects of the 
Rho-kinase inhibitors depends on the agonists used (Chan et al., 2009). The 
reason for this difference is likely to be inherent to each tissue and could be due to 
the differences in the kinetics of contraction. It is noteworthy that PA and MA has 
different kinetics of response to high K
+
; PA shows a slow and sustained (‘tonic’) 
response whereas MA shows a comparatively fast (‘phasic’) onset of contraction, 
which then can decrease with time. This could be due to differences in the role 
2+ 2+
Ca channels and the Ca -entry pathways between these two arteries (Zheng et 
al., 2008). The data presented in this study however do not allow answering the 
question of what cellular mechanisms are involved in the onset of contraction. 

























































Figure 5.25 Relative inhibitory effects of Y-27632 on agonist-induced 
contractions in rat PA and MA. 
Bar graphs statistically compare the level of inhibition by 10 µM Y-27632 
between agonists. rPA, rat pulmonary artery, rMA, rat mesenteric artery, U, U-
46619. Differences between all groups were tested by Tukey-Kramer post-hoc test 
following one-way ANOVA; n values are shown on the graphs in brackets. 
To address the differences in the sensitivity to Rho-kinase inhibitor Y-27632 
between PA and MA at the molecular level, immunohistochemical techniques can 
be applied in the future works. Immunohistochemical localisation can be 
performed in PA and MA segments by using specific polyclonal and monoclonal 
antibodies to Rho-kinase (e.g. ROKα) (Yoon et al., 2010). Comparison of the 
immunohistochemical expression of ROKα between PA and MA could reveal the 
possible reason for difference in the sensitivity to Y-27632. 
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Another observation which demonstrate that contractions induced by 4-AP, high 
K
+ 
or U-46619 were attenuated by the Rho-kinase inhibitor Y-27632 to a greater 
extent at low levels of pretone in PA than in MA is consistent with previous work 
which showed that Y-27632 inhibited more effectively contractions induced by 
low concentrations of KCl in rabbit aorta (Sakurada et al., 2003) and by low 
concentrations of phenylephrine in rabbit femoral artery (Ratz et al., 2005). Such 
differences in my experiments are unlikely to be due to variation in the expression 
of RhoA/ROK as was demonstrated for tonic smooth muscle (which had 
characteristically higher levels of RhoA/ROK) compared to phasic smooth muscle 
(Patel & Rattan, 2006), because the degree of relaxation was similar at low level 
of contraction and was consistently greater in MA (showing ‘phasic’ type of 
responses). An increase in the receptor-induced activation of RhoA and associated 
MYPT1 phosphorylation with increased level of contraction (Sakurada et al., 
2001;Mizuno et al., 2008) is also unlikely, as both KCl- and U46619-induced 
contractions demonstrated such dependence in PA (Figs. 5.16 and 5.23). One 
2+
possible explanation could be Ca -dependence of the Rho-kinase activity, which 
2+
is somehow decreased when [Ca ]i is increased. Since there is currently no 
2+
evidence that Rho-kinase is inhibited by increased [Ca ]i, these findings therefore 
provide a foundation for further studies focussed in this direction. 
There is also another important implication of the results described in this study 
related to the specificity of the action of 4-AP, which is often criticised in the 
literature. In my experimental settings a number of observations strongly suggest 
that 4-AP acts specifically causing contraction via inhibition of KV channels in 
both types of arteries. These include: 1) the similarity between the effects of the 
L-VOCC blocker and the Rho-kinase inhibitor on the 4-AP, KCl- and U-46619-
induced responses; 2) the ability of diltiazem+Y-27632 pretreatment to 
completely inhibit 4-AP-induced contractions; 3) the differences between the 
effects of 4-AP in PA and MA measured simultaneously and in identical 
experimental conditions; and 4) the ability of linopirdine to significantly 
potentiate the effect of 4-AP specifically in the PA. This set of evidence strongly 
supports the notion in favour of 4-AP as specific inhibitor of KV channels in the 
concentration range used in this study. 
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One of the unanswered questions is: what is the residual component of the 4-AP-
induced contraction in PA? It is interesting that this residual component was 
ablated by pretreatment with a combination of diltiazem and Y-27632. However, 
once the contraction is developed ~30% of 4-AP-induced contraction was not 
sensitive to the combination of both inhibitors. Similar effects of both inhibitors 
was observed for the contraction induced by U-46619 only in PA, the main 
difference between the effects of the L-VOCC and Rho-kinase inhibitors in the 
two cases was the presence of the residual component of the U-46619-induced 
contraction following the pretreatment with inhibitors in contrast to the 4-AP-
induced contraction. 
rd 
To explore the insensitive 3 component of 4-AP response in PA several attempts 
have been taken. To check the possibility if ROS are involved the effect of tiron, a 
membrane permeable ROS scavenger, on 4-AP-induced contraction was tested. 
Pretreatment of both arteries with 10 mM tiron did not alter 4-AP-induced 
responses in either of the two tissue types (data not shown). Similarly, tissue 
pretreatment with 100 µM pinacidil, a KATP channel opener, did not affect the 4-
AP-induced contraction (data not shown), suggesting that KATP channels are not 
involved. Also 100 µM tyrphostin, a widely used tyrosine kinase blocker, alone 
or even in combination with diltiazem and Y-27632 applied after 4-AP-induced 
contraction was developed failed to ablate 4-AP responses in PA (data not shown), 
suggesting that tyrosine kinase is unlikely to be involved. 
rd 
These differences between PA and MA clearly indicates that the 3 component of 
4-AP-induced contraction is specific for 4-AP, an inhibitor of the KV channels. 
Recently, Firth et al. showed that KV channels are functionally and structurally 
associated with mitochondria specifically in PASMCs (Firth et al., 2008;Firth et 
al., 2009a). On the basis of these previous reports, I speculated that the insensitive 
component of 4-AP-induced contraction might be associated with 
compartmentalisation of KV channels and mitochondria. 
Whether the voltage-independent and Rho-kinase insensitive component of the 4-
AP-induced contraction is linked to compartmentalisation phenomenon involving 
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mitochondria, I investigated the effect of 4-AP in α-toxin and β-escin 
permeabilised (skinned) tissues. The effect of mitochondrial uncouplers to inhibit 
mitochondria function was also assessed in the skinned and intact tissue 




ITERACTIO OF MITOCHODRIA WITH KV 
CHAELS AD ITS ROLE I THE METABOLIC 
REGULATIO OF COTRACTIO I RAT 
PULMOARY AD MESETERIC ARTERIES 
6.1 Introduction 
The results presented in the previous chapter clearly demonstrated the presence of 
the additional component in the 4-AP-induced contraction, which was insensitive 
to the inhibition by both L-VOCC and Rho-kinase inhibitors specifically in the 
PA, and not in the MA. Although similar component was also observed in 
contraction evoked by U-46619, it was not sensitive to the pretreatment with 
diltiazem+Y-27632, whereas that seen with the KV channel blocker 4-AP was 
completely ablated (compare Fig. 5.5 B and 5.20 A). Also this component of 
2+ 
contraction was not significantly affected by CPA, suggesting that Ca release 
from the sarcoplasmic reticulum is unlikely to be responsible. This component 
was not observed in contractions induced by high K
+
, which will impair the 
overall K
+ 
efflux indiscriminately through all K
+ 
channels, but will not inhibit 
them. The 4-AP specificity of this phenomenon therefore strongly suggests that 
it is linked to the inhibition of KV channels specifically in the PA. Smirnov and 
Aaronson previously reported that activation of KV channels in rat PASMCs lead 
to re-distribution of local K
+ 
concentrations (Smirnov & Aaronson, 1994). 
Recently, Firth et al. presented the evidence that KV channels are associated with 
a population of mitochondria which form submembrane compartment and 
functional coupling between KV channels and mitochondria (Firth et al., 
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2008;Firth et al., 2009a). Considering that K
+ 
ions are crucial for the regulation of 
normal homeostasis of mitochondria (Garlid & Paucek, 2003), the inhibition of 
KV channels with 4-AP would alter the balance of the local subcellular K
+ 
concentration and in that way influence mitochondrial function. This directly via 
2+
changing [Ca ]i, or indirectly via release of active substance (e.g. superoxide or 
H2O2) or via metabolic changes (e.g. changes in the ATP production) could have 
an impact on contraction. The ROS hypothesis discussed in details in Chapter 1 
(section 1.7.2.3) supports the potential ability of ROS to stimulate contraction in 
2+ 
PA. Thus, it is well established that mitochondria are responsible for Ca -
sequestration and release (Duchen, 1999;Nicholls & Budd, 2000). 
As vasoconstriction depends upon MLC20 phosphorylation which consumes up to 
50% of cytosolic ATP (Wingard et al., 1994), a difference in metabolic regulation 
of contractions in the two types of arteries may contribute to the differences in the 
4-AP-induced contraction in PA and MA. Previously, a different role of 
glycolysis and oxidative phosphorylation was demonstrated in HPV (Leach et al., 
2001). In that study, glycolysis was found to be essential for the development of 
sustained phase (phase-II) of HPV, as the inhibition of glycolysis by iodoacetate 
or 2-DOG in the absence of glucose abolished phase-II of HPV. On the other hand, 
inhibition of the mETC by inhibiting cytochrome oxidase with cyanide 
2+
potentiated the phase-II of HPV (Leach et al., 2001) as well as increased [Ca ]i 
2+ 
by stimulating Ca release from the SR and mitochondria in both pulmonary and 
systemic artery myocytes (Wang et al., 2003a). This evidence supports a potential 
ability of altered mitochondria to affect contraction in PA. It has also been 
2+
demonstrated that inhibition of cellular glycolysis with 2-DOG increases [Ca ]i 
(Bright et al., 1995) and mimics effects of hypoxia on ion channels including KV 
channels in PASMCs (Yuan et al., 1994;Yuan et al., 1995a), although similar 
effects were found in some systemic arteries (Miller et al., 1993). 
In the systemic arteries, metabolic blockade generally resulted in a decrease in 
2+
[Ca ]i and vasodilatation. Thus, metabolic blockade with 2-DOG reduced ATP 
levels in cultured A7r5 vascular smooth muscle cells (Lynch et al., 1996), and 
caused vasodilatation in rat coronary artery (Conway et al., 1994), and in guinea 
pig thoracic aorta (Gasser et al., 1993). In systemic arteries, metabolic inhibition 
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of ATP production, either by inhibiting glycolysis (2-DOG) or mitochondrial 
oxidative phosphorylation (NaCN, oligomycin), resulted in vasodilation (Gasser 
et al., 1993). Inhibition of oxidative phosphorylation with rotenone, antimycin A, 
2+
NaCN attenuated vasoconstriction of the rat tail artery without altering [Ca ]i 
(Tran et al., 1997;Swärd et al., 2002). Similar effects of metabolic inhibition 
were also observed in the heart. Thus, cyanide, 2-DOG and/or iodoacetate 
2+ 2+
decreased in inward L-type Ca current (ICa), level of [Ca ]i and the amplitude of 
contraction in rat ventricular myocytes (Eisner et al., 1989;Lancaster & Harrison, 
1998;Fukumoto et al., 2005). 
It is also possible that hypoxia may influence the cellular metabolic state in 
different manner in the systemic and pulmonary arteries. Otter and Austin (2000) 
found the differences in the effect of hypoxia and metabolic inhibition on the rat 
mesenteric arteries of different diameter. Hypoxia caused near maximal relaxation 
in both large and small mesenteric artery preconstricted with 60 mM KCl, while 
metabolic inhibition (with cyanide) resulted maximal relaxation of only small 
mesenteric arteries but in larger vessels the relaxation to cyanide was significantly 
less compared to that in hypoxic conditions (Otter & Austin, 2000). Hypoxia has 
2+
been reported not to alter basal levels of [Ca ]i in most vascular smooth muscle 
cells including coronary (Paul et al., 2009), cerebral and mesenteric (Aalkjaer & 
Lombard, 1995). In pulmonary circulation, however, hypoxia decreased basal 
2+
level of [Ca ]i in conduit pulmonary (Ureña et al., 1996) but increased in small 
pulmonary artery (Salvaterra & Goldman, 1993;Post et al., 1995;Ureña et al., 
1996). On the other hand, metabolic inhibition was found to increase in basal 
2+
levels of [Ca ]i both in systemic artery SMCs (Sward et al., 1993;Lydrup et al., 
1994) and PASMCs (Bright et al., 1995). 
The above overview of the published evidence suggests not only the existence of 
a potential crosstalk between the mechanisms contributing to the effects of 
hypoxia and those which control cellular metabolism in both systemic and 
pulmonary circulations, but also points out towards potential differences between 
the two circulations. However, characterisation of metabolic dependence of 
contraction in intact arteries and direct comparison between pulmonary and 
systemic circulations has not yet been systematically investigated. 
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In the experiments presented in this chapter I used several pharmacological tools 
including mitochondrial uncouplers, membrane permeabilisation technique and 
metabolic poisons. In this study I employed two selective mitochondrial 
uncouplers CCCP (carbonyl cyanide 3-chlorophenylhydrazone) and FCCP 
(carbonyl cyanide 4-trifluoromethoxy phenylhydrazone), which share the same 
mechanism of action and are widely used pharmacological tools to investigate the 
involvement of mitochondria in the vascular tension at the cellular level and 
whole tissue preparations. The mitochondrial uncouplers collapse mitochondrial 
membrane potential and inhibit mitochondrial function by uncoupling electron 
transport from oxidative phosphorylation. This will lead to mitochondria 
2+ 
depolarisation which could result in an accumulation of cytoplasmic Ca as a 
2+ 2+ 
result of mitochondrial Ca release and/or impaired Ca sequestration into 
mitochondria. Thus, application of FCCP, for example, caused an increase in 
2+ 
intracellular Ca in single PASMCs (Drummond & Tuft, 1999;Kang et al., 2003). 
Notably, FCCP caused membrane depolarisation mimicking the effect of 4-AP in 
single cultured PASMCs (Yuan et al., 1995a) whilst CCCP enhanced the effect of 
2+ 
hypoxia on intracellular Ca increase in rabbit PASMCs (Kang et al., 2002). Yu 
et al. (1998) used FCCP to investigate whether mitochondria contribute to 
contractions induced by sodium hydrosulfite in intact rat PAs (Yu et al., 1998b). 
Based on the previous reports, in my study I used both uncouplers to influence 
mitochondrial function in order to investigate if there is a contribution of 
mitochondria in contraction to 4-AP in intact pulmonary and mesenteric arteries. 
2+ 
If changes in cytosolic Ca are important in the initiation and maintenance of the 
4-AP-induced contraction, it will therefore be appropriate to assess this under 
2+
conditions when [Ca ]i is controlled. This can be achieved in intact arteries by 
employing membrane skinning or permeabilisation technique. I used two different 
tissue permeabilising agents, α-toxin and β-escin, to evaluate the effect of 4-AP 
2+ 
under controlled intracellular Ca environment. 
To study the metabolic dependence of contraction a range of pharmacological 
tools, previously used for this purpose, were employed. Cyanides are widely used 
to investigate the dependence of contraction on oxidative metabolism mediated by 
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mitochondria in intact arteries (Buescher et al., 1991;Tran et al., 1997;Otter & 
Austin, 2000;Leach et al., 2001;Swärd et al., 2002). To inhibit glycolysis, the 
replacement of extracellular glucose with its non-metabolised analogue, 2-DOG is 
widely used (MacLeod, 1989;Gasser et al., 1993;Conway et al., 1994;Yuan et al., 
1995a;Lynch et al., 1996;Zhao et al., 1996;Leach et al., 2001;Fukumoto et al., 
2005). Combination of cyanides with 2-DOG is thought to result in complete 
metabolic blockade of the cell, preventing majority of ATP production (Lancaster 
& Harrison, 1998). Also, the F0/F1 ATP synthetase inhibitor oligomycin is 
commonly used to selectively inhibit mitochondrial oxidative phosphorylation 
thereby preventing oxidative ATP production (Nicholls et al., 2003;Wang et al., 
2003a;Firth et al., 2009a). In this set of experiments I used sodium cyanide (1 
mM) to inhibit oxidative phosphorylation and equimolar replacement of glucose 
(5.6 mM) with 2-DOG in Krebs solution to inhibit glycolysis. In some 
experiments, oligomycin (1µM) was also used to selectively inhibit F0/F1 ATP 
synthetase. 
The above mentioned pharmacological tools were employed to test the two related 
hypotheses in this chapter: 
1.	 Whether there is a relationship between KV channels and mitochondria in 
intact PA and MA of the rat. 
2.	 Whether there is a difference in the metabolic dependence of contraction 




6.2.1 Effects of CCCP on 4-AP-induced contraction in non-
permeabilised rat PA and MA 
The effect of the mitochondrial uncoupler CCCP was investigated in the intact 
non-permeabilised preparation. Concentration-contraction responses were 
obtained in PA and MA with a series of increasing concentrations of 4-AP (0.5, 1, 
2, 5 and 10 mM) in the absence and presence of 3 µM CCCP. The representative 
traces demonstrating the effect of CCCP on 4-AP-induced contractions in PA and 
MA are depicted in Fig. 6.1. Preincubation of the arteries with CCCP potentiated 
4-AP responses in PA starting with a concentration as little as 1 mM (Fig. 6.2 A). 
The effect was significant for contractions elicited by 2, 5 and 10 mM 4-AP in the 
presence of CCCP compared to the control. On the other hand, in MA, CCCP 
evoked only a small potentiation of contraction at high concentration of 4-AP. 
This effect in MA was not however significant (Fig. 6.2 B). 
It is worth mentioning that application of 3 µM CCCP alone occasionally 
constricted both arteries with bigger amplitude in PA. Thus in PA, CCCP alone 
caused contraction of 0.76±0.40 mN or 12.4±6.5% of 80 mM KCl (n = 10) while 
in MA the contraction was comparatively smaller (0.20±0.12 mN or 2.2±1.4%, n 
= 10). However, no significant difference between the two preparations was found. 
These results clearly show that mitochondrial uncoupling with CCCP potentiated 
4-AP-induced contraction selectively in PA, thus closely resembling the effect of 
tissue pretreatment with 20 mM KCl and linopirdine described in Chapter 3. One 
possibility is that mitochondrial uncoupling with CCCP can lead to membrane 
2+
depolarisation (Yuan et al., 1995a) and [Ca ]i increase (Kang et al., 2002). 
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Figure 6.1 Effect of CCCP on 4-AP-induced concentration-responses in 
intact rat PA and MA.  
Representative traces were recorded from PA (A-B) of 455 µm i.d. and MA (C-D) 
of 244 µm i.d., showing 4-AP concentration-responses in the absence (A, C) and 
presence (B, D) of 3 µM CCCP. Concentrations of 4-AP (in mM) applied for 5 
min each are shown by arrows. Horizontal and vertical scale bars represent 5 min 




Pulmonary artery Mesenteric artery 
Figure 6.2 Summary of the effect of CCCP on 4-AP-induced contraction in 
intact rat PA and MA. 
Preincubation with 3 µM CCCP significantly potentiated 4-AP concentration 
responses in PA (A) but not in MA (B). ** p<0.01 and *** p<0.001 compare 4-
AP responses before and after CCCP treatment. Note that some of the error bars 
are smaller than symbols. Differences between control versus treatment groups 
for the same concentration of drug were tested by Bonferroni post-hoc test 










































In addition CCCP potentiated KV channels at more negative potentials (Firth et al., 
2008), the effect linked to compartmentalisation of mitochondria in the 
subplasmalemmal space (Firth et al., 2009a). Both factors will promote 
facilitation of the 4-AP-induced contraction in accordance with my observations. 
In order to address the question if 4-AP-induced contraction is linked to changes 
2+
in [Ca ]i independent on membrane depolarisation, the effect of the KV channel 
2+
inhibitor was studied in permeabilised preparations under conditions where [Ca ]i 
is tightly controlled. 
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6.2.2 4-AP-induced contraction in permeabilised rat arteries: role of 
mitochondria 
The experiments were performed in permeabilised preparations using the α-toxin 
method developed in Prof. Jeremy Ward’s laboratory. I myself carried out these 
experiments at King’s College London as a part of ongoing collaboration. In this 
set of experiments instead of CCCP, another mitochondrial uncoupler FCCP was 
used to affect mitochondrial function, because this was the drug of the choice in 
this laboratory. 
Following α-toxin permeabilisation, tissues were relaxed with G10 which contains 
‘zero’ calcium. In this state of tissue, application of 10 mM 4-AP produced no 
further tone at all (data not shown, n = 3). It is noteworthy that high concentration 
of 4-AP does not have any effect on tension on its own in permeabilised tissues. 
2+ 
However, when basal Ca levels were increased, 10 mM 4-AP elicited further 
tension both in PA and MA. 
2+ 
Basal Ca level was elevated in permeabilised tissues using solutions with 
different pCa prepared as described in Chapter 2 (Materials and Methods). 
Because PA showed a higher sensitivity to a given concentration of calcium than 
MA, PA was preconstricted with pCa 7.2, in some cases 6.8 and MA with pCa 6.4. 
The main aim of pre-constriction was to achieve a certain level of pretone before 
proceeding with a specific experimental protocol. As mentioned above, a certain 
level of pretone was necessary to observe the 4-AP effect because both PA and 
2+
MA were insensitive to 4-AP in G10 (a Ca -free solution). Results were 
normalised and expressed as percentage of contraction resulted in pCa 4.5 (10 
2+
mM Ca ) which produced a maximum response in both permeabilised tissues. 
2+ 
Elevation of basal Ca level itself produced tension both in PA (52.1±8.1%; n = 
10) and MA (20.0±7.5%, n = 9) which was further enhanced to 69.1±8.7% (n = 
10) in PA and 37.2±10.5% (n = 9) in MA upon application of 10 mM 4-AP. 
However, when arteries were pre-incubated with 3 µM FCCP the 4-AP-induced 
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tension was significantly suppressed in PA (Fig. 6.3A). Although some reduction 
in the effect of 4-AP was seen in MA this effect was not significant (Fig. 6.3 B). 
Pulmonary artery Mesenteric artery 
Figure 6.3 Effect of FCCP preincubation in α-toxin permeabilised rat PA 
and MA. 
Representative traces obtained from the same PA (A) and MA (B) showing 
differences in the response to 4-AP (10 mM) before (black trace) and after (grey 
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Pulmonary artery Mesenteric artery 
Figure 6.4 Effect of FCCP pretreatment on 4-AP contraction in rat PA and 
MA. 
FCCP, a mitochondrial uncoupler, significantly reduced 4-AP responses in 
pulmonary artery (A-B) but has no significant effect in mesenteric artery (C-D). 
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D. 
The changes in 4-AP-induced contraction in the presence and absence of FCCP in 
α-toxin permeabilised arteries are summarised in Fig. 6.4. FCCP preincubation in 
PA significantly suppressed both the absolute (from 2.45±0.51 mN to 0.55±0.04 
mN, n = 4) and normalised tension (from 21.98±4.54% to 4.91±0.25%, n = 4) 
produced by 4-AP (Fig. 6.4 A and B, respectively). On average, FCCP reduced 4-
AP response by ~78% in PA, and only by ~35% in MA. Importantly, although 
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similar trend was also in MA, the FCCP-dependent changes in 4-AP-induced 
contraction were not significant (Fig. 6.4 C-D), suggesting that FCCP has a 
selective effect on the 4-AP-induced response in PA, and not in MA. 
Similar to intact tissues, pretreatment with CPA did not alter 4-AP responses in α-
toxin permeabilised tissue (n = 3, data not shown), suggesting the intracellular 
2+ 
Ca store does not play a significant role in the 4-AP-induced contraction. 
Although the differences in the effect of FCCP on the 4-AP-induced contraction 
in α-toxin permeabilised PA and MA are consistent with the differential effects 
observed in intact preparations described in the section 6.2.1, the ability of 4-AP 
to constrict the permeabilised tissue is unexpected. Because there is no membrane 
potential preserved under this condition, this is unlikely to be due to membrane 
depolarisation. It is therefore possible that this 4-AP-induced contraction might be 
rd 
a correlate of the 3 component of contraction which was not sensitive to 
diltiazem and Y-27632 in the intact preparation. Its selective sensitivity to the 
mitochondrial uncoupler FCCP, may therefore suggest that it involves 
mitochondria. It is possible that in α-toxin permeabilised tissues some intracellular 
compartments might be intact. It has been previously shown that permeabilisation 
with α-toxin (≤1000 Da) is most gentle compared to saponin and Triton-X (Van 
Heijs et al., 2000). In order to check if this is the case, the effect of 4-AP was 
investigated in arteries permeabilised with a saponin ester β-escin to achieve a 
greater degree of permeabilisation (> 17,000 Da) (Somlyo & Somlyo, 1990). 
Representative traces comparing tissue responses to 4-AP using α-toxin and β-
escin permeabilisation are depicted in Fig. 6.5 (A-D). In α-toxin permeabilised 
tissues 10 mM 4-AP significantly increased contraction both in PA (~32%, n = 
10) and MA (~85%, n = 9) (Fig. 6.5 A and B, respectively) while in β-escin 
permeabilised arteries, the 4-AP response was rather decreased by ~10% in PA (n 
= 7), but slightly increased in MA (~5%, n = 7) (Fig. 6.5 C and D, respectively). 
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Figure 6.5 Comparison of tissue permeabilisation with α-toxin and β-escin 
on tissue response to 4-AP.  
Representative traces obtained from PA (A, C) and MA (B, D) where α-toxin 
permeabilised arteries show further contraction in response to 4-AP, whereas β-
escin permeabilised arteries show no further contraction to 4-AP. Breaks in line 
indicate time gap when tissue permeabilisation was performed between high K
+
 




Fig. 6.6 compares the effect of a different degree of permeabilisation achieved 
with α-toxin and β-escin on the 4-AP-induced contraction. It can be clearly seen 
that while 4-AP is able to produce a significant level of contraction in both PA 
and MA permeabilised with α-toxin (Fig. 6.6, A and B, respectively), this ability 
is completely lost following β-escin permeabilisation (Fig. 6.6 C-D). 
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pCa 7.2 pCa+4-AP pCa 6.4 pCa+4-AP 
0 
Figure 6.6 Comparison of tissue permeabilisation with α-toxin and β-escin 
on tissue response to 4-AP. 
Note further contraction in response to 4-AP in α-toxin permeabilised arteries 
(PA and MA), and the lack of responses in β-escin permeabilised arteries. Paired 
Student’s t-test; n numbers as shown in brackets; ns = not significant at p>0.05. 
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6.2.3 Effects of mitochondrial uncoupler CCCP on hypoxia-induced 
contraction in rat PA and MA (non-permeabilised) 
The differences in the modulation of 4-AP-induced responses by mitochondrial 
uncoupling in PA and MA may have direct functional implication in HPV as the 
mitochondrion is considered as a putative oxygen sensor in HPV (Waypa & 
Schumacker, 2002;Ward, 2003;Weissmann et al., 2006b). In Chapter 4 I found 
that the effect of hypoxia was similar in both preparations (PA and MA) 
preconstricted with low concentration of 4-AP (2 mM) in the presence of 
linopirdine. It is therefore important to assess whether mitochondrial uncoupling 
can modulate the effect of hypoxia in PA in the presence of 4-AP and linopirdine, 
differently to that described in Chapter 4. 
Figure 6.7 depicts representative traces showing the results of such experiments. 
In the absence of CCCP (which was used in this set of experiments) hypoxia 
induced a transient contraction in the presence of the two K
+ 
channel inhibitors in 
both PA (Fig. 6.7 A) and MA (Fig. 6.7 C), i.e. the effects similar to those 
described in Chapter 4. Tissue pretreatment with 3 µM CCCP revealed dramatic 
differences in response to hypoxia between the two preparations. In PA, 
contraction to linopirdine and 4-AP was firstly enhanced (which is consistent with 
the overall potentiating effect of CCCP on 4-AP-induced contraction described in 
Section 6.2.1). Importantly, the hypoxic response was also changed from being a 
transient in the control conditions to becoming a sustained response in the 
presence of CCCP (Fig. 6.7 B). On the other hand, in MA, hypoxia-induced 
transient contraction was completely eliminated (Fig. 6.7 D). Figure 6.8 
summarises and compares normalised maximal tensions obtained before and after 
preincubation with CCCP. It can be clearly seen that mitochondrial uncoupling 
significantly potentiated the hypoxic response in PA by ~2.5 times (tension 
increased from 22.2±5.7% to 79.6±17.0%, n = 3), whilst no significant change 
was observed in MA (Fig. 6.8). 
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Figure 6.7 Effect of preincubation with CCCP on hypoxia-induced 
vasoconstriction in rat PA and MA. 
Representative traces were obtained from PA (A-B) of  435 µm and MA (C-D) 
of 368 µm i.d., showing hypoxic vasoconstriction in the presence of 10 µM 
linopirdine and 2 mM 4-AP with (B and D) or without (A and C) preincubation 
for 10 min with 3 µM CCCP. Lino, linopirdine; 4-AP, 4-aminopyridine; CCCP, 
carbonyl cyanide 3-chlorophenylhydrazone (a mitochondrial uncoupler). 
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Figure 6.8 Preincubation with CCCP significantly potentiated hypoxic 
vasoconstriction in rat PA. 
Graphs summarise and statistically compare hypoxic vasoconstriction obtained in 
the presence of 10 µM linopirdine and 2 mM 4-AP (control) followed by 
incubation of the tissues with 3 µM CCCP for 10 min and repeating the control. 
Paired Student’s t-test (n = 3). 
These results clearly demonstrate the presence of the relationship between 
hypoxia, inhibition of KV channels and mitochondria function which are specific 
to the PA. It is noteworthy that in intact tissue mitochondrial uncoupling 
potentiated the response to 4-AP, whereas in α-toxin permeabilised preparations 
mitochondrial uncoupling inhibited 4-AP-induced contraction. One possible 
explanation could be the differences in the mitochondrial metabolism between 
two preparations (intact vs. permeabilised), because in the permeabilised tissue 
2+
both [Ca ]i and ATP concentration are controlled. To determine if such 
differences in metabolism exists in two preparations, the effect of agents altering 
cellular metabolism on high K
+ 




6.2.4 Metabolic dependence of high K (80 mM KCl)-induced 
contraction in rat PA and MA 
To investigate if the inhibition of cellular metabolism differentially affect 
contraction in PA and MA, the contraction of the arteries to high K
+ 
(80 mM KCl 
applied for 15 min) was studied in the absence or in the presence of 2-DOG (5.6 
mM, equimolar glucose substitution to inhibit glycolysis), NaCN (1 mM, to 
inhibit the mETC complex IV) or combination of NaCN and the inhibitor of ATP 
synthetase oligomycin (1 µM, to inhibit oxidative phosphorylation). 
Figure 6.9 A and 6.9 E show representative traces demonstrating the effect of 
prolonged (15 min) application of 80 mM KCl in control conditions on PA and 
MA, respectively. It is noteworthy that contraction to prolonged exposure to high 
K
+ 
(15 min) exhibited biphasic responses in MA under control conditions, whilst 
in PA in the presence of metabolic inhibitors (Fig. 6.9 B-D). To assess this effect 
quantitatively, the peak of contraction and contraction at 15 min were measured in 
the presence of inhibitors, normalised to the peak KCl contraction measured in 
control conditions and expressed as a percentage. Notably, a distinct difference 
was found in the kinetics of the responses between PA and MA. In PA, high K
+
-
induced contraction was suppressed by metabolic inhibition but was maintained at 
a steady level for the total 15 min period of exposure (Fig. 6.9 B-D). On the other 
hand, in MA, the initial peak contraction was suppressed much less by the 
metabolic inhibitors, but the subsequent contraction was not sustained and 
progressively declined in the presence of 80 mM KCl (Fig. 6.9 F-H). 
The metabolic inhibition of the peak and sustained contractions in PA and MA are 
statistically compared in Fig. 6.10. 2-DOG, NaCN and a combination of NaCN 
and oligomycin significantly suppressed the maximal peak contraction induced by 
high K
+ 
in both PA (Fig. 6.10 A) and MA (Fig. 6.10 C). In PA, the replacement of 
glucose with 2-DOG and the inhibition of oxidative phosphorylation with NaCN 
caused a similar decrease in high K
+
-induced contraction (41.7±7.5%, n = 5 vs. 
48.0±12.8%, n = 3). The effect of NaCN was not further enhanced by addition of 
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oligomycin (50.0±4.5%, n = 8) (Fig. 6.10 A). Qualitatively similar effects were 
observed in MA with 2-DOG (84.0±4.24%, n = 5), NaCN (77.5±8.6%, n = 3) and 
NaCN+oligomycin (83.2±3.0%, n = 8), except a greater degree of the inhibition 
observed in this tissue (Fig. 6.10 C). 
Notably, in PA the effect of all metabolic inhibitors on the sustained KCl-
contraction was quantitatively similar to that of the peak contraction (Fig. 6.10 A 
and B, respectively), whereas in MA, the inhibition of the sustained phase was 
approximately 3 times greater than that of the peak phase of contraction (Fig. 6.10 
C and D, respectively). The analysis of the inhibition of the sustained phase of 
high K
+ 
contraction clearly showed a significantly greater suppression in MA than 
in PA for all metabolic inhibitors (Fig. 6.11). 
These results clearly demonstrate that the maintenance of contraction in PA is 
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Figure 6.9 Effect of metabolic inhibitors on high K -induced contraction in 
rat PA and MA.  
Representative traces were obtained from PA of 455 µm (A, B), 398 µm (C) and 
293 µm (D) i.d.; and MA of 343 µm (E, F), 339 µm (G) and 224 µm i.d.,  
showing contractile response to 80 mM KCl in control conditions (A, E), in the 
presence of 2-DOG (B, F), 1 mM NaCN (C, G) and in 1 mM NaCN +1 µM 
oligomycin (D, H). 2-DOG, 2-deoxyglucose (equimolar replacement of 5.6 mM 
glucose in Krebs solution); NaCN, sodium cyanide; Oligo, oligomycin.  
Horizontal and vertical scale bars represent 5 min and 1 mN, respectively. 
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Pulmonary artery Mesenteric artery 
Figure 6.10 Metabolic inhibitions of the contraction induced by high K
+ 
in 
rat PA and MA. 
The graphs summarise and compare the metabolic inhibition of the sustained 
phase (A and C) and the peak phase (B and D) of 80 mM KCl-induced 
contractions in PA (A-B) and MA (C-D). 2-DOG, 2-deoxyglucose; NaCN, 
sodium cyanide; Oligo, oligomycin. Differences between control versus 
treatment groups were tested by Dunnett post-hoc test following one-way 
ANOVA, n = 3-13 (Control, n = 13; 2-DOG, n = 5; NaCN, n = 3; and 





















































































































ns (n =13) 
Figure 6.11 Comparison of the differences in the metabolic dependence of 
high K
+
-induced sustained responses between rat PA and MA. 
2-DOG, 2-deoxyglucose; NaCN, sodium cyanide; Oligo, oligomycin. Student’s 
unpaired t-test, n values are shown in brackets; ns = not significant at p>0.05. 
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6.2.5 Metabolic dependence of 4-AP-induced contraction in rat PA 
Since 4-AP-induced vasoconstriction shares common mechanisms with that 
induced by high K
+
, the effect of metabolic inhibitors on the 4-AP-induced 
contraction was therefore investigated. This set of experiments was performed 
only in PA to investigate whether metabolic inhibition has any effect on the 
rd 
residual component (3 component) of the sustained contraction which was not 
inhibited by Y-27632 and diltiazem conversely to MA. I hypothesised that this 
component may be associated with metabolic regulation in PA. 
In this set of experiments, 10 µM linopirdine was routinely used to maximise 4-
AP-induced contraction and occasionally linopirdine alone produced a measurable 
level of tone (e.g. Figs. 6.12 A and 6.14 A). Although on some occasions a small 
increase in tone upon application of 2-DOG, NaCN or 2-DOG+NaCN was 
observed, overall no significant effect of the metabolic inhibitors was noted. 4-
AP-induced contractions obtained in the presence of metabolic inhibitors 2-DOG 
(5.6 mM) or NaCN (1 mM) added alone or in combination were compared with 
the control 4-AP-induced contraction. Representative traces showing the effects of 
metabolic inhibitors on 4-AP-induced contraction are depicted in Fig. 6.12. It can 
be seen from the figure that 2-DOG and NaCN incompletely and similarly 
inhibited 4-AP-induced contraction by 58.2±9.7% (n = 10) and 55.6±8.7% (n = 8), 
respectively. Combined application of both drugs caused further suppression of 
the contraction (72.4±10.5%, n = 3), although it was not significantly different 
from the effects of metabolic inhibitors used alone (Fig. 6.13). Overall, the 
similarity between the effects caused by the inhibition of the glycolytic (2-DOG-
sensitive) and oxidative phosphorylation (NaCN-sensitive) pathways could 
suggest that they are not additive. 
It is worth mentioning that oscillations were often observed in the presence of 
NaCN (Fig. 6.12 C) but not in 2-DOG. Six out of the total eight preparations 
showed oscillations similar to those demonstrated in Fig. 6.12 C. 
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Figure 6.12 Effect of 2-deoxyglucose and sodium cyanide on 4-AP-induced 
contraction in rat PA.  
A-D, representative traces obtained form PA of 487 µm i.d. (A and B), 395 µm 
i.d. (C) and 393 µm i.d. (D) showing contractile response induced by 10 mM 4-
AP in control conditions (A), in the presence of 2-DOG (B), 1 mM NaCN (C) 
and  2-DOG+1 mM NaCN (D).  Lino, linopirdine; 4-AP, 4-aminopyridine, 
NaCN, Sodium cyanide; 2-DOG, 2-deoxyglucose (equimolar replacement of 5.6 
mM glucose in Krebs solution). Horizontal and vertical scale bars represent 5 
min and 1 mN, respectively. Note that the transient peaks in B and D upon 
































Control 2-DOG NaCN 2-DOG 
(4-AP) +NaCN 
Figure 6.13 Summary of the effects of metabolic inhibitors on 4-AP-induced 
contraction in rat PA. 
Graphs summarise and statistically compare between contraction elicited by 4-
AP (control) and that in the presence of different metabolic inhibitors. 4-AP, 4-
aminopyridine, 2-DOG, 2-deoxyglucose; NaCN, Sodium cyanide. Differences 
between control and treatment groups were tested by Dunnett post-hoc test 
following one-way ANOVA; n values are shown on the graphs. 
The above results suggest that the metabolic inhibition with either 2-DOG, NaCN 
or their combination blocked only ~50% of the 4-AP-induced contraction. The 
similarity of the effects between the inhibitors suggests that their effects are not 
additive. To assess the nature of the 4-AP-induced contraction remaining in the 
presence of the metabolic inhibitors, the effect of the Rho-kinase inhibitor Y-
27632 was investigated first. In this set of experiments, 2-DOG was chosen as a 
tool to inhibit cellular metabolism. The 4-AP responses were recorded in the 
presence of 2-DOG (5.6 mM) alone, Y-27632 (10 µM) alone or in the presence of 
the combination of these two agents. 
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The representative traces showing the inhibitory effects of 2-DOG or Y-27632 
alone or their combination on 4-AP-induced contraction are depicted in Fig. 6.14. 
Y-27632 and 2-DOG blocked the 4-AP-induced contraction to a similar degree by 
50.3±4.0%, (n = 7) and 56.8±5.9%, (n = 10), respectively. Most notably, however, 
the combination of these two agents almost completely abolished the 4-AP-
2+ 
induced contraction (97.7±4.8%, n = 6) (Fig. 6.15), suggesting that the Ca
sensitisation component and the component sensitive to cellular metabolism are 
independent. Notably, a nearly complete inhibition of the 4-AP-induced 
contraction following the pretreatment of PA with 2-DOG+Y-27632, resembles 
the complete block of the 4-AP-induced contraction as a result of the pretreatment 
with diltiazem+Y-27632 described in Chapter 5 (Figures 5.4 and 5.5). Therefore, 
it is possible that the 2-DOG-sensitive pathway could target the same pathway as 
2+ 




























Figure 6.14 Effect of 2-DOG and Rho-kinase inhibitor Y-27632 on 4-AP-
induced contraction in rat PA.  
A-D, Representative traces were obtained from PA of 373 µm (A, B), 399 µm 
(C), and 391 µm (D) i.d., showing contractile response elicited by inhibition of 
KV channels in control conditions (A), in the presence of 2-DOG (B), in the 
presence of 10 µM Y-27632 (C) and in the presence of 2-DOG+10 µM Y-27632  
(D).  Lino, 10 µM linopirdine; 4-AP, 10 mM 4-aminopyridine; Y, Y-27632; 2-



































Control Y 2-DOG Y+2-DOG 
(4-AP) 
Figure 6.15 The dependence of 4-AP-induced contraction on Rho-kinase-
2+ 
mediated Ca sensitisation and glycolytic metabolism in rat PA. 
Graphs summarise and statistically compare the effect of Rho-kinase inhibitor 
Y-27632 (10 µM), 2-DOG and combination of these two on 4-AP elicited 
contraction in PA. Y, Y-27632 (10 µM), 2-DOG, 2-deoxyglucose. Differences 
between all groups were tested by Tukey-Kramer post-hoc test following one-
way ANOVA; n values are shown on the graphs. 
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6.2.6 Effects of 2-DOG and aC on contraction evoked by U-46619 in 
rat PA 
If 2-DOG selectively inhibits L-VOCC-mediated pathway, as suggested in the 
previous section, then contraction which does not involve the activation of this 
pathway should be non-sensitive to 2-DOG pretreatment. To investigate this 
possibility in PA, the effect of 2-DOG and NaCN was studied on contraction 
produced by a stable analogue of thromboxane A2 mimetic U-46619 in the 
2+ 
presence of 10 µM diltiazem (added 5 min prior to U-46619) to block the Ca -
2+ 
entry via L-type Ca channels. The effect of 2-DOG was also compared with that 
caused by the inhibitor of oxidative phosphorylation NaCN. 
The representative traces and summary graphs of this set of experiments are 
shown in Fig. 6.16. The results shown in Fig. 6.16 B clearly shows that 
contraction recorded under such conditions was completely insensitive to 2-DOG, 
thus supporting the proposed hypothesis. On the other hand, U-46619 contraction 
was virtually completely abolished by NaCN (Fig. 6.16 C). The summary of the 
results is shown in Fig. 6.16 D. Note that the low n number (due to time 
constraints) does not allow to perform statistical analysis of this set of data. 
Nevertheless, these results clearly suggest the existence of at least two 
independent pathways (i.e., glycolytic and oxidative phosphorylation) which 

















































Figure 6.16 Metabolic inhibition of contraction to U-46619 in rat PA.  
A-C, Representative traces were obtained from PA of 420 µm i.d., showing 
contractile response induced by 1 µM U-46619 in the presence of 10 µM 
diltiazem in control conditions (A), in the presence of 2-DOG (B), and in the 
presence of 1 mM NaCN (C). D, Compares the results obtained from two to four 
different rings of PA. Dil, 10 µM diltiazem; U, 1 µM U-46619; 2-DOG, 2-
deoxyglucose; NaCN, 1 mM sodium cyanide. Horizontal and vertical scale bars 






The main findings of this chapter can be summarised as following: 
1) In intact arteries, mitochondrial uncoupling significantly potentiated 4-
AP-induced contraction only in PA, and not in MA, indicating the presence of 
specific interactions between mitochondria and inhibition of KV channels in PA. 
2) 4-AP-induced contraction was dependent on the degree of tissue 
permeabilisation, being significant in α-toxin permeabilised arteries of both types 
and absent in β-escin permeabilised preparations which may indicate the presence 
of intact cellular compartments in α-toxin permeabilised preparations, which has 
much less disruption of the cell membrane compared to other skinning agents. 
3) Mitochondrial uncoupling significantly potentiated and altered hypoxia-
induced contraction in the presence of linopirdine and 4-AP significantly in PA, 
but not in MA, suggesting that the interaction between the putative oxygen sensor 
mitochondria and the inhibition of K
+ 
channels could be important in HPV. 
4) The investigation of the effects of metabolic inhibition showed that 
sustained, but not the peak, contraction caused by high K
+ 
was significantly more 
metabolic dependent in MA than that in PA. In the PA, contraction to both high 
K
+ 
and 4-AP were similarly suppressed by the inhibition of glycolysis (2-DOG) 
and mitochondrial oxidative phosphorylation (NaCN) alone or in combination, 
suggesting that the two metabolic pathways are reciprocal. 
5) In the PA, the component of the 4-AP-induced contraction, which was 
insensitive to the metabolic inhibitors, ablated by further addition of the Rho-
2+ 
kinase inhibitor Y-27632, suggesting that Ca sensitisation is relatively 
independent of the cellular metabolism. 
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It is well documented that 4-AP acts via blocking KV channels and that KV 
channels expressed in inner mitochondrial membranes play an important role in 
cellular function (Szabo et al., 2005). The results of this chapter demonstrate that 
the contraction occurring as a result of the blockade of KV channels with 4-AP 
could be linked to mitochondrial function. To the best of my knowledge, this is 
the first demonstration of the existence of such interactions between the KV 
channels and mitochondria at the level of a whole multicellular preparation. The 
ability of CCCP to enhance the 4-AP-induced contraction in PA in a similar 
manner as 20 mM KCl and 10 µM linopirdine can have several possible 
explanations. Firstly, as it was demonstrated in the previous chapters in intact 
arteries, and in this chapter in α-toxin-permeabilised arteries, that the 4-AP-
induced contraction depends on the level of membrane depolarisation (which 
increases the number of opened KV channels) hence a greater 4-AP-induced effect 
2+
which in turn is associated with increased [Ca ]i. The maintenance of the 
2+
contraction to 4-AP will require both factors as 4-AP is not effective in Ca -free 
2+ 
Krebs in intact preparations, and in zero Ca G10 solution in α-toxin-
permeabilised arteries. Mitochondrial uncouplers can cause both an increase in 
2+ 
intracellular Ca (Hughes & Schachter, 1994;Yuan et al., 1996;Drummond & 
Tuft, 1999;Kamishima et al., 2000;Kamishima & Quayle, 2002;Kang et al., 2003) 
and membrane depolarisation (Yuan et al., 1995a) in pulmonary and systemic 
2+
arterial SMCs. The latter could be indirectly due to activation of Ca -dependent 
2+
NSCCs or ClCa by elevated [Ca ]i (Klöckner & Isenberg, 1991;Greenwood et al., 
1997;Bae et al., 1999) leading to membrane depolarisation and activation of KV 
channels, hence a greater effect of 4-AP. These effects however would be 
expected to be similar in PA and MA, which was not the case in my experiments, 
thus indicating the presence of the mechanism which is specific for PA. Secondly, 
an alternative explanation could be the dependence of the activity of KV channels 
on mitochondrial function specifically in PA. This possibility was demonstrated 
by Firth et al. (2008) in single PASMCs, where it was shown that inhibition of 
mitochondrial function has a dual effect on the KV current, potentiating at 
negative potentials and inhibiting at positive voltages. This effect was not 
observed in MASMCs (Firth et al., 2008). A greater KV current at rest in PA can 
explain a greater potency of 4-AP selectively in PA. In intact tissue, however, it is 
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likely that both mechanisms may contribute to increased 4-AP-induced 
contraction in the presence of CCCP in PA. 
The significance of the mitochondrial involvement in 4-AP-induced contraction in 
PA was further demonstrated in permeabilised arteries. Tissue permeabilisation is 
a widely used experimental tool to investigate the role of signalling pathways 
under controlled intracellular conditions (Kitazawa et al., 1989;Kobayashi et al., 
1989;Fu et al., 1998;Evans et al., 1999;Thomas et al., 2005;Snetkov et al., 
2006;Knock et al., 2008;Knock et al., 2009). The use of α-toxin and the saponin 
ester β-escin allows a different degree of tissue permeabilisation while leaving 
receptor mediated signalling intact [reviewed in (Somlyo & Somlyo, 1990)]. The 
α-toxin creates holes in the cell membrane allowing molecules of <1000 Da to 
enter and leave cells while β-escin makes bigger pores allowing molecules of 
≥17,000 Da to permeate cells (Kobayashi et al., 1989). 
In both type of permeabilisation, the voltage-dependent mechanism of contraction 
via membrane depolarisation is suppressed as there should be no ion flux across 
the cell membrane provided that the cell membrane is equally permeabilised 
across cells. Under such conditions, the ability of 4-AP alone to contract arteries 
may indicate a non-specific effect of the drug. Indeed, being a weak base, large 
concentrations of 4-AP (5-10 mM) are able to produce alkalisation of intracellular 
2+ 
pH and increase intracellular Ca (Guse et al., 1994;Gobet et al., 1995). This 
process however requires an intact cell membrane and is unlikely to occur in 
permeabilised preparations as intracellular pH is well controlled. The most strong 
evidence against the non-specific action of 4-AP under such experimental 
conditions comes from the ability of FCCP to significantly reduce 4-AP-induced 
contraction in PA but not in MA, suggesting that mitochondria could be, at least 
in part, responsible for 4-AP-induced contraction in PA. Although the non-
specific action of 4-AP (which may be responsible for the FCCP-insensitive 
component) cannot be entirely ruled out, such a possibility is unlikely as greater 




Although it is difficult to explain fully the mechanism underlying the effects of 4-
AP and FCCP in permeabilised tissues, the presented evidence do not contradict 
the hypothesis that the strong functional relationship between mitochondria and 
KV channels exists due to the presence of a population of subplasmalemmal 
mitochondria specifically in PA, and not in MA (Firth et al., 2008;Firth et al., 
2009a). Gentle tissue permeabilisation with α-toxin may leave such compartments 
relatively intact providing the basis for the action of 4-AP in this condition. In β-
escin permeabilised tissue this compartmentalisation could be disrupted more 
substantially thus removing the structural basis for 4-AP action. The ability of 4-
AP to produce contraction in MA, which was relatively insensitive to 
mitochondrial uncoupling, may suggest a different relationship in this type of 
artery. Because MA was not a primarily focus of this study, its mechanism has not 
been specifically investigated in this work. One possible explanation could be a 
close association between mitochondria and SR in systemic arteries that has been 
documented previously (Kamishima et al., 2000;Gordienko et al., 2001). Further 
experimentation is required to completely understand both mechanisms. In any 
case, the experimental approach adopted in my study using different degrees of 
tissue permeabilisation represent a very useful technique to address certain 
questions raised for example in the single cell studies at the level of intact 
preparations. 
The interactions between the KV channel inhibition and mitochondrial uncoupling 
specifically in PA can have important functional implications in HPV, an 
adaptation mechanism which is unique to the pulmonary circulation but the 
mechanisms remain controversial and highly disputable (Robertson et al., 
2000b;Moudgil et al., 2005;Waypa & Schumacker, 2005;Aaronson et al., 
2006;Sommer et al., 2008;Ward & McMurtry, 2009). The ability of hypoxia to 
transiently contract both PA and MA has been demonstrated previously (Leach et 
al., 1994;Robertson et al., 2003) and confirmed in this study (Chapter 4; and Fig. 
6.7 A and C). It does not however represent an ability which is unique to PA. The 
difference in hypoxic responses observed in the presence of CCCP clearly suggest 
the presence of a specific and synergistic effect between mitochondria function 
and KV channel inhibition in PA under hypoxic conditions. As mitochondria, one 
of the important oxygen sensors in PA (Rounds & McMurtry, 1981;Waypa et al., 
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2001;Waypa & Schumacker, 2002;Weissmann et al., 2003;Michelakis et al., 
2004;Waypa & Schumacker, 2005), are depolarised by hypoxia (Duchen & 
Biscoe, 1992;Di Lisa et al., 1995) and the KV channels are known to be blocked 
by hypoxia (Post et al., 1992;Archer et al., 1993;Weir & Archer, 
1995;Olschewski et al., 2002;Archer & Michelakis, 2002;Platoshyn et al., 2006), 
this synergistic action could be one of the contributing mechanisms to the 
complex HPV response. In MA, the pretreatment with CCCP under identical 
condition completely inhibited the transient hypoxic contraction, an observation 
which supports the well-known relaxatory action of hypoxia in the systemic 
arteries (Ishida & Honda, 1992;Aalkjaer & Lombard, 1995;Shimizu et al., 2000). 
Another important consequence of the action of mitochondrial uncouplers could 
be uncoupling of electron transport mechanism and oxidative phosphorylation, 
which could influence metabolism and thus contractility. This possibility is 
directly supported by the following findings described in this chapter. In PA, the 
contraction initiated by high K
+ 
is suppressed and maintained, whereas in MA, the 
contraction becomes transient with a little effect on the initial peak component. 
This could indicate stronger metabolic requirements for the maintenance of 
contraction in MA than in PA. One of the reasons for the difference in the 
metabolic dependence of contraction in the two tissue types could be the 
difference in ATP consumption, which could be greater in MA compared to PA. 
This can be speculated from the observation that the dependence of oxidative 
energy production for endothelium-dependent relaxation to acetylcholine and 
adenosine differs between the rat PA and aorta, being greater in the latter 
(Rodman et al., 1991). The authors suggested that this could be an adaptive 
mechanism as the maintenance of low pulmonary tone is likely to be less 
metabolic dependent. Although my experiments do not provide a direct answer to 
the exact molecular mechanisms responsible for such differences, dissimilar rates 
of phosphorylation and/or dephosphorylation could be a contributing mechanism. 
There is very little further published evidence which address this interesting and I 
believe an important question. 
The differences between PA and MA described in this chapter suggest that the 
rate of consumption of ATP during contraction may be enhanced in MA, and if 
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less supply of ATP is provided in the presence of metabolic inhibitors the 
contraction is failed to maintain (Fig. 6.9 E-H). It has previously been suggested 
that, unlike the systemic artery, PA possesses an additional mechanism which 
allows an enhanced glycolytic ATP production and glucose uptake (Leach et al., 
2002). There is convincing evidence that cellular energy production and 
utilisation is compartmentalised in smooth muscle cells (Paul, 1983). In PA, ATP 
production resides largely within mitochondria (Leach et al., 2002). A recent 
study revealed that PASMCs have a greater number of mitochondria which are 
compartmentalised closer to the cell membrane compared to mitochondria in 
MASMCs which are more centrally distributed (Firth et al., 2009a). The role of 
this subplasmalemmal population of mitochondria in ATP production is not clear. 
In systemic vasodilation, the total concentration of ATP has been shown to be 
unchanged during hypoxia (Leach et al., 1998;Shimizu et al., 2000), although the 
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method used (e.g. P NMR) is not capable to detect localised changes of ATP 
within the cell. As metabolic inhibition mimics the effects of hypoxia (Miller et 
al., 1993), hypoxia per se could be considered as an equivalent to a metabolic 
inhibitor, at least in the pulmonary circulation. It has been reported that hypoxia 
causes less deterioration in energy state in the pulmonary than in systemic artery 
(Leach et al., 1998). Several other metabolic markers such as intracellular pH and 
phosphocreatine are also better conserved or unchanged during hypoxia and HPV 
in pulmonary arteries (Leach et al., 2000). Furthermore, it has been reported that 
hypoxia increased glucose uptake into PASMCs during HPV by ~250% whilst 
glucose uptake into MASMCs remained less than 50% of that in PASMCs 
whether in normoxia or hypoxia (Leach et al., 2001), possibly reflecting the 
capacity of pulmonary artery to maintain sustained contraction during metabolic 
inhibition. These unique properties of PASMCs could indicate the presence of 
specific mechanisms that allow improved maintenance of cellular energy state, 
such as enhanced glucose uptake and glycolytic ATP production specifically in 
PA. This notion is supported by the evidence presented in this chapter. 
An interesting additional observation was the presence of oscillations in PA in the 
response to 4-AP in the presence of cyanide. The exact mechanism however is not 
clear. Interestingly, CN causes transitions in mitochondrial energetics due to 
block of ATP production by inhibiting complex IV of the mETC (Aon et al., 
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2003). However, it is not clear if this process contributed to tension oscillations 
observed in this study. 
The contractile response elicited by K
+ 
channel inhibition clearly showed 
involvement of two reciprocal metabolic pathways: glycolysis and mitochondrial 
oxidative phosphorylation. There is a possible link between these two pathways 
since glycolysis not only produce ATP but also provides pyruvate for the 
mitochondrial oxidative phosphorylation which further produces ATP. Such 
potential interaction between these two pathways could explain a reciprocal action 
of 2-DOG and cyanide on high K
+
- and 4-AP-induced contractions. Glycolytic 
pathway itself provides relatively little energy (only 2 ATP per each molecule of 
glucose is derived) compared to subsequent oxidative phosphorylation pathway 
(upto 38 ATP molecules net) (Leach et al., 2002). However, vascular smooth 
muscles are exceptional in that they exhibit high levels of glycolysis, which is 
associated with a large lactate production derived almost entirely from this source. 
In VSMCs glycolysis generates ~30% of total ATP production during normoxia, 
and accounts for ~90% of the glucose utilised by the cell (Paul, 1989). 
An important observation in this chapter is that inhibition of 4-AP-induced 
contractions by 2-DOG and Y-27632 are additive in pulmonary artery mirroring 
the findings that diltiazem and Y-27632 are additive in contraction produced by 
high K
+ 
and 4-AP (described in Chapter 5). It is therefore possible that the 
inhibition of 4-AP-induced contraction by 2-DOG may be due to selective 
suppression of or interference with the function of L-VOCCs. This hypothesis is 
supported by the observation that 2-DOG did not have an effect on contraction 
caused by U-46619 under conditions when L-VOCCS were inhibited by diltiazem. 
In addition, in ventricular cardiac myocytes, ICa was found to be regulated by 
intracellular ATP derived from glycolysis (Losito et al., 1998). This study 
revealed that a complete metabolic inhibition with 2-DOG and cyanide resulted in 
a 40% decrease in peak ICa (Losito et al., 1998). Another notable finding of this 
chapter is the total blockade of the 4-AP-induced contraction with Y-27632 in the 
2+
presence of 2-DOG, suggesting that the Ca -sensitisation component (Y-27632-
sensitive) of contraction is relatively independent of the cellular metabolism 
because these are completely additive effects. If the Y-27632-sensitive component 
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was dependent on glycolytic metabolic pathway then Y-27632 and 2-DOG would 
have a little further change in the 4-AP-induced contraction. It is noteworthy that 
complete block of 4-AP response also supports the specificity of 4-AP and is 
consistent with previous evidence supporting this notion. 
Interestingly, the voltage-independent component of the U-46619-induced 
contraction showed different sensitivity to the inhibition of glycolysis (with 2-
DOG) and mitochondrial oxidative phosphorylation (with NaCN). Greater 
dependence of NaCN suggests perhaps different compartmentalisation of energy 
2+ 
sources, for example Ca re-uptake into the SR using SERCA which utilises ATP 
for its activity. A high demand of ATP for SERCA activity can be provided via 
oxidative phosphorylation pathway, hence its higher sensitivity to cyanides. I 
would like to mention here that due to time constrain these are rather preliminary 





IVESTIGATIO ITO THE ROLE OF KV 
CHAELS I THE REGULATIO OF 
COTRACTILITY I MOUSE PULMOARY AD 
SYSTEMIC MESETERIC ARTERIES 
7.1 Introduction 
Mouse is a widely used experimental animal model and, genetically, is closely 
related to humans. In addition to the wild type, transgenic or knock out (KO) mice 
are increasingly being used to investigate disease mechanisms and in drug 
discovery. KO mouse models are also increasingly being used to investigate and 
unveil the mechanisms of HPV and pulmonary hypertension (MacLean et al., 
2004;Millen et al., 2006;Morecroft et al., 2009;Morrell et al., 2009;Kelland et al., 
2010;MacLean & Dempsie, 2010;Morecroft et al., 2010). Many KO mouse 
models have already been used to evaluate mechanisms of the modulation of 
pulmonary vasoconstriction and remodelling in connection to i) altered function 
of ion channels and transporters (Rios et al., 2005;Dietrich et al., 2005), ii) altered 
superoxide production (Liu & Folz, 2004;Liu et al., 2006), iii) endothelial nitric 
oxide synthase disruption (Fagan et al., 1999;Ozaki et al., 2001), and iv) 
vasoactive and mitogenic agonists such as hypoxia inducible factor 1α and 2α (Yu 
et al., 1999;Brusselmans et al., 2003). However, to explore the basic 
physiological phenomenon the wild type mouse model still plays significant role. 
Recently, several studies have carried out functional characterisation of agonist-
induced pulmonary vasoconstriction (Xu et al., 2008), and also characterisation of 
KV channels in mouse PASMCs (Ko et al., 2007) using wild type mouse model, 
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but neither of these studies compared the findings with systemic arteries. Recent 
evidence revealed that KV channels in mouse PASMCs possess different 
pharmacological characteristics, being sensitive to both TEA and to 4-AP (Ko et 
al., 2007) which is different to the rat model. This pharmacological profile may 
suggest abundant expression of KV2 α-subunits in mouse tissue, in comparison to 
rat PASMCs (Smirnov et al., 2002). Notably, expression of KV1 and KV2.1 α-
subunits was demonstrated in mouse MASMCs (Fountain et al., 2004). Using 
KV1.5 KO mice Archer et al. (2001) found that a K
+ 
channel containing KV1.5α-
subunits is an important effector of HPV in mice. In addition to the abundant 
expression of 4-AP sensitive KV1.5, mouse PASMCs also express KV1.2 which is 
sensitive to TEA (Grissmer et al., 1994;Archer et al., 2001). Also, in contrast to 
rat PASMCs, a greater proportion of BKCa current is present in mouse vascular 
tissues (Fountain et al., 2004;Ko et al., 2007). It has been previously 
demonstrated that BKCa channels play an important role in the regulation of 
cerebral vascular tone in mice (Plüger et al., 2000). Notably, KCNQ channels are 
also expressed in murine vasculature including portal vein (Ohya et al., 
2003;Yeung et al., 2008), aorta, carotid, femoral and mesenteric arteries (Yeung 
et al., 2007). Functional role of KCNQ channels have also been reported in 
murine non-vascular smooth muscles including myometrium (McCallum et al., 
2010) and gastrointestinal tract (Jepps et al., 2009). The ability of specific KCNQ 
channel inhibitors to constrict mouse PA (mPA) was greater than mouse MA 
(mMA) (Joshi et al., 2006). Also, KCNQ channel openers were able to cause 
greater relaxation effects on mPA than on mMA (Morecroft et al., 2009). These 
reports indirectly suggest that the interaction between the two channel types may 
be also important in the mouse, i.e. similar to the phenomenon I described in the 
rat model in this thesis. However, the basic characterisation of the pulmonary 
vascular reactivity in the mouse model is still lacking. Furthermore, no direct 
comparison of the involvement of KV channels in the regulation of excitability 
and contractility of the murine pulmonary and systemic arteries has been yet 
undertaken. 
To address the question what is the role of KV channels in intact mPA and mMA, 
the effects of pharmacological inhibitors of KV channels 4-AP and TEA (which 
will inhibit TEA-sensitive KV channels like KV2.1) were compared between these 
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two tissue types. In this study, male CD mice (10-12 weeks old) weighing 35-40 g 
nd rd 
were used. First order intrapulmonary (i. d. 313±26 µm, n =7) and 2 to 3 order 
mesenteric arterial rings (i. d. 167±17 µm, n = 7) were used for tension 
measurement. Arterial rings were mounted in the small vessel dual wire myograph 
(as described in Chapter 2) and set up at tensions equivalent to their mean in vivo 
resting tension; i.e. ~15 mmHg for mPA (Kelland et al., 2010) and ~100 mmHg 
for mMA (Madhani et al., 2003). It is notable that due to lack of time the data 
presented in this chapter are rather preliminary and further studies will be 




7.2.1 Effect of 4-AP on basal tone in mPA and mMA 
Arterial rings were preconstricted with 80 mM KCl 3-4 times before the 
beginning of the experiment. Concentration-response curves were constructed in 
mPA and mMA with KV blocker 4-AP adding cumulatively at 0.5, 1, 2, 5 and 10 
mM, each concentration applied for 5 min (Fig. 7.1 A). Similar to the rat PA, in 
mPA as well, only small contraction of 0.56±0.26 mN (n = 8) and 1.07±0.23 mN 
(n = 8) was observed at 5 and 10 mM 4-AP, respectively. Membrane 
depolarisation by pretreatment of the tissue with 20 mM KCl enhanced 4-AP-
induced contraction (0.87±0.16 and 1.64±0.16 mN at 5 and 10 mM 4-AP, 
respectively) (Fig. 7.1 B). The difference was, however, statistically significant 
only at 10 mM 4-AP (Fig. 7.2 A). Similar trend was observed in mMA treated 
with increasing concentration of 4-AP in the absence (Fig. 7.1. C) and presence of 
20 mM KCl (Fig. 7.1 D). However, in contrast to mPA, no significant difference 
was observed in mMA even at high concentration of 4-AP when the responses 
were compared between control and depolarised conditions (Fig. 7.2 B). It is 
notable that 20 mM KCl per se posed only a little contraction with 0.12±0.05 mN 
(n = 6) or ~ 5% of 80 mM KCl contraction in mPA and 0.65±0.16 mN (n = 6) or 
~19% of 80 mM KCl contraction in mMA. 
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Figure 7.1 Potentiation of 4-AP concentration-contraction responses by low 
concentration of KCl in mPA and mMA. 
Representative traces were obtained from mPA (A-B) and mMA (C-D) in the 
absence (A, C) and presence (B, D) of 20 mM KCl. Concentrations of 4-AP in 
mM and time of their application are indicated by arrows. Internal diameters of 
mPA were 381 µm (A) and 259 µm (B); and of mMA were 207 µm (C) and 115 
µm (D). Horizontal and vertical scale bars represent 5 min and 1 mN, 
respectively.    
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Pulmonary artery Mesenteric artery 
Figure 7.2 Tissue specific differences in potentiation of 4-AP-induced 
responses by 20 mM KCl. 
Concentration-response curves obtained from mPA (A) and mMA rings (B) in the 
absence and presence of 20 mM KCl. ** (P < 0.01) denotes significant 
potentiation of 4-AP response at 10 mM concentration following treatment with 
20 mM KCl in mPA. Differences between control versus treatment groups for the 
same concentration of drug were tested by Bonferroni post-hoc test following 
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B. 
Notably, some oscillations were observed in the presence of 10 mM 4-AP in 6 out 
of 8 mPA in the presence of 20 mM KCl, and 3 out of 8 mPA in the absence of 20 
mM KCl. In mMA, however, no oscillations were observed in either condition. 
The 4-AP-induced oscillatory contractions were blocked by diltiazem suggesting 
the involvement of L-VOCCs in this process. Interestingly, similar type of 
oscillations have also occasionally been observed in rat PA but not as common as 
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Figure 7.3 Inhibition of KV
 
channels with 10 mM 4-AP elicits spontaneous 
oscillations in mPA in the absence (A) and presence (B) of 20 mM KCl. 
Representative traces obtained from mPA (black traces) and mMA (grey traces). 
Internal diameters of mPA were 382 and 320 µm (A and B, respectively) and of 
mMA were 186 and 140 µm (A and B, respectively). Inserts (i) and (ii) show 
oscillations at an expanded time scale for A and B, respectively.  
 
 
Figure 7.3 summarises the characteristics of 4-AP-induced spontaneous 
oscillations observed in mPA in the absence (Fig. 7.3 A) and presence of 20 mM 
KCl (Fig. 7.3 B). The amplitude and frequency of oscillations recorded in the 
absence of 20 mM KCl was 0.55±0.11 mN (n = 3) and 0.50±0.09 Hz (n = 3), 
respectively. No difference was observed in the amplitude (0.45±0.07 mN, n = 6) 




































7.2.2 Effect of TEA on contractility of mPA and mMA 
TEA sensitive KV channels include KV1.1, KV1.2 KV1.3, KV1.6, KV2.1, KV2.2, 
KV3.1 and KV3.2 (Gutman et al., 2005). Among these KV subtypes, the KV1.2 and 
KV2.1 isoforms are known to be sensitive to TEA (Kd = 560 nM for KV1.2 and Kd 
=1-3 mM for KV2.1) and are expressed in murine VSMCs (Grissmer et al., 
1994;Archer et al., 2001;Ko et al., 2007). To investigate if these isoforms 
contribute to the regulation of contractility in intact murine vasculature 
concentration-contraction responses to TEA (1-20 mM) were constructed in mPA 
and mMA in the absence (Fig. 7.4 A and C) and presence (Fig. 7.4 B and D) of 20 
mM KCl. In the absence of 20 mM KCl both mPA and mMA revealed only small 
contraction to high concentration of TEA. However, in the presence of 20 mM 
KCl both murine tissues demonstrated increased contractility to TEA although 
this potentiation did not reach significance at the number of performed 
experiments (Fig. 7.5). 
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Figure 7.4 Effect of TEA on contractility of mPA and mMA in the absence (A 
& C) and presence (B & D) of 20 mM KCl.  
Representative traces of tension recordings were obtained from mPA (A-B) and 
mMA (C-D) showing concentration-dependent contraction to TEA. Internal 
diameters of mPAs were 203 and 259 µm (A and B, respectively) and of mMA 
were 104 and 115 µm (C and D, respectively). Concentrations of TEA in mM and 
time of their application are indicated by arrows. 20 K
+
, 20 mM KCl; 80 K
+
, 80 
mM KCl; TEA, tetraethylammonium. Horizontal and vertical scale bars represent 
5 min and 1 mN, respectively. 
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Pulmonary artery Mesenteric artery 
Figure 7.5 Summary of the concentration-contraction responses to TEA in 
mPA and mMA. 
Concentration-contraction responses were obtained from 5 mPA (A) and 5 mMA 
(B) in the absence and presence of 20 mM KCl showing trend of potentiation of 
TEA responses in both mPA and mMA in the presence of elevated K
+
. 20K, 20 
mM KCl; TEA, tetraethylammonium. Differences were not significant with 
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7.2.3 Comparison of the responses to 4-AP and TEA between PA and 
MA of mouse and rat 
A comparison of the responses to 10 mM 4-AP and 20 mM TEA, expressed as a 
percentage of contraction elicited by 80 mM KCl, between the two species, rat 
and mouse, and the two types of tissues, pulmonary and systemic, are tabulated 
below. In comparison to the rat, mouse vasculature (both PA and MA) was 
apparently more sensitive to 4-AP and TEA in both stimulated and non-stimulated 
tissues causing greater contraction in relation of 80 mM KCl responses (Table 
7.1). 
Table 7.1 Comparison between 4-AP and TEA-induced responses between 
pulmonary and mesenteric arteries of mouse and rat 
Mouse tissues 
(% contraction of 80 mM KCl) 
Rat tissues 







(n = 8) 
118±22 
(n = 8) 
5±3 
(n = 5) 
14±5 
(n = 5) 
mMA 
37±10 
(n = 8) 
37±10 
(n = 8) 
7±3 
(n = 5) 
14±5 
(n = 5) 
rPA 
22±7 
(n = 8) 
74±9 
(n = 8) 
5.8, 0.7 
(n = 2) 
10.8, 1.2 
(n = 2) 
rMA 
4±3 
(n = 8) 
38±12 
(n = 8) 
1.2, 1.0 
(n = 2) 
1.1, 1.3 
(n = 2) 




7.2.4 Comparison of the effect of diltiazem on 4-AP-induced 
contraction in mPA and mMA 
I have previously found (Chapter 3) that in the rat the L-VOCC blockers were 
inhibiting 4-AP-induced contractions incompletely in the PA, in contrast to the 
MA. To determine if similar type of action of L-VOCC blockers exists in mouse 
2+ 
arteries, the effect of a selective Ca channel blocker diltiazem on contraction 
induced by 4-AP was investigated. Contraction was induced by increasing 
concentrations of 4-AP in the presence of 20 mM KCl in mPA and mMA as 
described above. When contraction reached a steady state level in the presence of 
10 mM 4-AP, 10 µM diltiazem was applied. Fig. 7.6 A shows that the tension was 
declined only partly in mPA, but it was declined rapidly and almost completely in 
mMA (Fig. 7.6 B). Thus, similarly to the rat PA, the 4-AP-induced contraction is 
only partly voltage-dependent in mPA but almost entirely voltage-dependent in 
mMA. Application of 10 µM diltiazem decreased the 4-AP-induced contraction 
only by 35% in mPA (Fig. 7.6 A) whereas the contraction in mMA was reduced 
by 93% (Fig 7.6 B). These effects on both absolute (Fig. 7.7 A) and normalised 
(Fig. 7.7 B) tension are summarised in Figure 7.7. Thus, these results suggest 
similarity between rat and mouse models in relation to 4-AP responses, i.e. a 
tissue specific and species independent phenomenon. 
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Figure 7.6 Effect of diltiazem on tension induced by 4-AP in mPA and mMA.  
Representative traces were obtained from mPA (A) of 259 µm i.d. and mMA (B) 
of 115 µm i.d., showing the effect of increasing concentrations of 4-AP in the 
presence of 20 mM KCl followed by addition of 10 µM diltiazem. These traces 
are taken from the same tissues as shown in figure 7.1 (B and D). Concentrations 
of 4-AP in mM and time of their application are indicated by arrows. Horizontal 
and vertical scale bars represent 5 min and 1 mN, respectively. 
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Figure 7.7 Comparison of the diltiazem-insensitive component of 4-AP-
induced contraction in mPA and mMA. 
A and B show absolute tension and contraction normalised to the peak 4-AP-
induced force, respectively. Significance was evaluated with paired Student’s t-




The main observations described in this chapter can be summarised as follows: i) 
contraction to 4-AP was significantly potentiated by 20 mM KCl in mPA; ii) TEA 
was able to potentiate contraction in the presence of 20 mM KCl; iii) application 
of 4-AP-induced oscillatory activity which were more frequently observed in 
mPAs compared to mMAs; and iv) contraction to 4-AP in mPA had a significant 
diltiazem-insensitive component, which was practically absent in mMAs. 
The contractile response to KV channel blocker (10 mM 4-AP) was increased by 
~100% of it’s normalised tension and more than 50% of it’s absolute tension 
(mN) in the presence of 20 mM KCl, which itself did not significantly affect the 
basal tone of mPA. This depolarisation-induced potentiation of 4-AP-induced 
contraction in the mouse PA was quantitatively similar to that observed in the rat 
PA in the presence of 20 mM KCl and in the KCNQ channel inhibitor linopirdine 
(as described in Chapter 3). It is notable that the presence of KCNQ channels was 
functionally characterised in mouse PAs (Joshi et al., 2006), mouse portal vein 
smooth muscle cells (Yeung & Greenwood, 2005) and other systemic vasculature 
of mouse including aorta, carotid artery, femoral artery and mesenteric artery 
(Yeung et al., 2007). In rat PA and MA, I also observed potentiation of 4-AP 
responses in the presence of a specific KCNQ channel blocker (10 µM 
linopirdine) (Chapter 3). Although the effect of linopirdine (or any other KCNQ 
channel blocker) was not studied in the mouse arteries due to time constrain these 
preliminary findings from mouse arteries suggest that a similar interaction 
between the two channel types, KV and KCNQ, might exist in the pulmonary 
arteries of both rat and mouse. Overall, however, the similarity of the results 
obtained in the rat and mouse arteries presented in this study and previously 
published evidence do not contradict the notion that the mechanism of the 
regulation of membrane potential by two channel types (KV and KCNQ) in 




Sensitivity of mPA to TEA is likely to indicate the presence of TEA-sensitive 
conductances. Low concentrations of TEA (around 1-2 mM) are known to block 
BKCa channels (Blatz & Magleby, 1984;Robertson et al., 1993;Nelson & Quayle, 
1995). Some voltage-dependent KV channels such as KV3.1b which are expressed 
in PA (Platoshyn et al., 2004) are highly sensitive to TEA. On the other hand, 
high concentrations of TEA (above 5-10 mM) can block delayed rectifier channels 
encoded by the members of KV2 channel subfamily, another type of KV channels 
present in PA (Patel et al., 1997;Archer et al., 1998;Smirnov et al., 2002;Hogg et 
al., 2002). Since TEA constricted mPA only at high concentrations, it is therefore 
likely that KV2.1 channels are responsible for this effect. On the other hand, a 
small effect at low concentrations of TEA was observed in mMA. This may 
suggest the presence of either BKCa or KV channels with high TEA-sensitivity in 
this artery. In any case, these data are consistent with findings published by others 
where the functional expression of both 4-AP and TEA sensitive channels (KV2 
type) in both mPA and mMA was documented (Fountain et al., 2004;Ko et al., 
2007). For the further continuation and advancement in the line of this work here I 
propose to investigate the possible interplay between the different KV channels by 
i) combination of linopirdine with 4-AP and TEA; and ii) utilising KCNQ channel 
activators (e.g. retigabine, flupirtine) on channel- and receptor-mediated PA 
contractions. It would also be appropriate to use other more potent and more 
specific KCNQ channel inhibitors (e.g. XE991) as well as alternative KCNQ 
openers (e.g. acrylamide S-1) to advance further the knowledge of the functional 
role of KCNQ channels and their interaction with KV channels in murine PA, and 
to compare that with systemic arteries. 
One of the most interesting observations in this chapter is the inability of the L-
VOCC blocker diltiazem to completely relax 4-AP-induced contraction 
specifically in mPAs, but not in mMAs. Nearly two third of the 4-AP-induced 
contraction in mPA was insensitive to diltiazem, while in mMA, 4-AP-induced 
contraction was nearly entirely abolished with diltiazem. These effects are closely 
mirroring those in the rat arteries, which are described and characterised in 
Chapter 3. Such similarities strongly indicate that the principal cellular 
mechanism responsible for 4-AP-induced contraction is tissue-specific and not 
species dependent. Because the mouse with a wide availability of genetically 
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modified types represents an ideal experimental model, it could help in pursuing 
this issue at the molecular level. Further work is essential to explore these 
mechanisms in full details. 
Tension oscillations in response to 4-AP in mPA is another interesting finding. 
The oscillatory behaviour of contraction elicited by 4-AP has also been 
demonstrated previously in normal mPA (Xu et al., 2008). In rat PA oscillations 
have only been reported in certain conditions such as chronic hypoxia (Bonnet et 
al., 2001), pulmonary hypertension (Kiyoshi et al., 2003) or endothelin-1-induced 
vasoconstriction (Hyvelin et al., 1998). I have also occasionally observed 
oscillations in response to 4-AP in the rat PA (Fig. 6.12 C) but not as often as 
observed in mouse PA. Interestingly, in the rat MA, oscillations were observed 
more frequently compared to rat PA (Figs. 3.7 C, 3.15 C and 4.1 B), whereas 
reversed relation was found in the mouse arteries. Although the mechanism of 
oscillations has not been specifically addressed in this study, several explanations 
could be brought forward. Oscillations might occur to maintain a balance between 
2+ 2+ 
Ca influx and extrusion and/or Ca release and sequestration (Xu et al., 2008). 
Cell membrane depolarisation as a result of inhibition of KV channels with 4-AP 
may trigger voltage-dependent oscillatory process (Tammaro et al., 2004). Thus, 
the 4-AP-induced oscillatory contraction suggests that inhibition of voltage-gated 
K
+ 
channels and membrane depolarisation may indirectly activate mechanisms or 
2+ 
pathways for Ca extrusion and sequestration in mPA. Another possibility could 
be the activation of KCNQ channels in the presence of 4-AP. This could lead to 
membrane hyperpolarisation, however since the KV channels are still inhibited, 
the cell membrane will be destabilised and small depolarisation can occur 
triggering L-VOCC and thus contraction. Then the process can repeat itself 
causing oscillatory behaviour. This type of spontaneous contractions has been 
reported previously by Yeung and Greenwood (2005) in mouse portal vein, where 
XE991 (10 µM) and linopirdine (50 µM) increased the frequency of contractions 
and also in some tissues large increase in frequency resulted in a tonic contraction 
(Yeung & Greenwood, 2005). It would be interesting therefore to investigate the 
effect of KCNQ channel blockers in the mouse arteries, to assess the role of the 




COCLUSIO AD FUTURE DIRECTIOS 
8.1 Summary 
This study was focussed on the investigation and the understanding of the role of 
KV channels in intact pulmonary arteries. KV channels are ubiquitous and are 
expressed in all known vascular smooth muscles. The main strength of this study 
which distinguishes it from the previously published works in the pulmonary field 
is the parallel comparison of the pulmonary and systemic mesenteric arteries 
recorded under the same experimental conditions. This approach allowed the 
identification of the mechanisms which are specific to the pulmonary artery and 
thus provides new insights into the role of the KV channels in the pulmonary 
circulation and their contribution to the HPV response. 
Figure 8.1 summarises the major mechanistic pathways determined in this study 
and they can be involved in the normal pulmonary function and in the HPV 
response. 
The role of both KV and KCNQ channels in the pulmonary function has been 
proposed, but up-to date the functional significance of each channel type was 
investigated separately. This is the first study focussed on the interaction between 
the two channel types and the relative role each channel plays in the control of 
tissue excitability. The importance of both channel types in the basal tone has 
been demonstrated specifically in the pulmonary artery. The involvement of both 
K
+ 
channels has an important functional implication in the maintenance of the low 
resistance and low pressure in the pulmonary circulation. This observation may 
also enhance a future therapeutic use of KCNQ channel activators (e.g. retigabine 
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and flupirtine which are currently used experimentally) to reduce pulmonary 
blood pressure in PAH (Joshi et al., 2009;Gurney et al., 2010). In addition, the 
understanding of this interaction between the two channel types, allowed me to 
address the important question whether KCNQ channels are affected by hypoxia. 
The findings are consistent with the notion that the KV channels are inhibited by 
hypoxia, whereas the KCNQ channels in the pulmonary artery are likely to be not 
affected by acute hypoxia. This observation is one of the novel findings of this 
work. 
Another novel finding was the demonstration that the mechanism of contraction 
resulted from the inhibition of KV channels by 4-AP is complex and involves both 
the voltage-dependent (via L-VOCCs) and voltage-independent (Rho-kinase 
dependent) components in the pulmonary artery. Also another important 
observation was the presence of the third component of contraction that was not 
sensitive to L-VOCC blocker and Rho-kinase inhibitor in the pulmonary but not 
in the mesenteric artery. Furthermore, parallel comparison of the effects of various 
agents which stimulates and inhibits contraction via the voltage-dependent and 
voltage-independent manner allowed the proposal for a new hypothesis that 
describes the principal differences between the maintenance of contraction in 
these two artery types. In the pulmonary artery, the voltage-dependent and 
2+ 
voltage-independent (Ca sensitisation) pathways resulting in contraction operate 
in a parallel manner, whereas, in the mesenteric artery, they occur sequentially. 
The investigation of the nature of the third component of the 4-AP-induced 
contraction in the pulmonary artery, allowed me to hypothesise that it may 
involve specific interactions between the KV channels and mitochondria. Such 
interactions have been recently demonstrated in single PASMCs and not in 
MASMCs (Firth et al., 2008;Firth et al., 2009a). The evidence presented in this 
thesis suggests for the first time that such interaction could exist in intact 
pulmonary arteries and that they may be involved in acute HPV response. 
In addition, the results obtained in this work demonstrate the importance of the 
glycolytic pathway in the regulation of pulmonary contractility initiated by the 
2+ 
activation of the voltage-dependent Ca entry pathway. 
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Finally, my preliminary data suggests that the mechanisms described in the rat 
(including the involvement of the two types of K
+ 
channels in the regulation of 
pulmonary vascular tone, and the presence of voltage-dependent and voltage-
independent components of contraction) also exist in the mouse pulmonary artery, 
suggesting that they are not species dependent, and might be the common 
mechanism intrinsic to the pulmonary circulation. 
In conclusion, the findings in this work such as mutually important role of KV and 
KCNQ channels in the regulation of pulmonary vascular tone, the existence of 
specific cellular mechanisms controlling pulmonary contractility and the specific 
relationship between the KV channels and mitochondria, which are important in 
the regulation of normal pulmonary function and in HPV, provide a significant 
advance in our understanding of the basic mechanisms governing pulmonary 
excitability and contractility. These can potentially lead to the development of 
new therapeutic strategies to the treatment of pulmonary related diseases. 
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Figure 8.1 Schematic diagram summarising proposed interactions between 
different intracellular pathways targeted in this study. 
2-DOG, 2-deoxyglucose; KV, voltage-gated K
+ 
channels; KCNQ, KV7.1-7.5 
channels; VOCC, voltage-operated calcium channel; Mito, mitochondria; Ox-
Phos, oxidative phosphorylation; [ATP], net intracellular ATP; [Ca
2+
], net 
intracellular calcium; CaM, Calmodulin; MLCK, myosin light chain kinase; 
MLCP, myosin light chain phosphatase; MLC20, 20 kDa myosin light chain; 
pMLC20, phosphorylated 20 kDa myosin light chain; (-), inhibition or negative 






































8.2 Future directions 
The results of this study not only provide novel and important insights into the 
function of both the pulmonary and the mesenteric artery, but also set up new 
intriguing questions which I was not able to address in full in this thesis due to 
time constrain and limited resources. 
The relationship between the KV channels and mitochondria in the pulmonary 
artery deserves further investigation. One of the potential approaches could be the 
investigation of 4-AP responses in tissues where mitochondrial function is 
impaired (e.g. the use of tissue culture and low concentrations of mitochondrial 
inhibitors/uncouplers). The role of the glycolytic pathway could be further studied 
in a similar way. 
Mitochondrial function in the pulmonary circulation is frequently linked to ROS. 
Whether ROS are involved in the above mechanisms has not been addressed in 
this study and is an important question. The use of novel technologies to quantify 
ROS, like the recently developed redox-sensitive, ratiometric fluorescent protein 
sensor (RoGFP) (Waypa et al., 2010), or the use of mitochondria-targeted 
antioxidant like SkQ1 (Shipounova et al., 2010) will provide new opportunities to 
investigate this and related questions. The novel mitochondria-targeted 
antioxidant SkQ1 [10-(60-plastoquinonyl) decyltriphenylphosphonium] 
selectively accumulates in mitochondria because these organelles form the only 
negatively charged compartment in the cell. Selective accumulation of SkQ1 in 
the mitochondria is favoured by high membrane potential of the inner 
mitochondrial membrane (about 180 mV) together with membrane potential 
(inside negative) of the plasma membrane and the strong hydrophobicity of 
SkQ1(Shipounova et al., 2010). 
To overcome the limitations and disadvantages of investigations on the isolated 
cells due to artificial environment and the loss of native cell-cell interactions, the 
application of new technologies for targeted ROS measurement on the level of the 
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intact tissue or organ or even whole animals can be helpful. This can be achieved 
in sophisticated mouse models, where an inducible or conditional knock out or 
targeted gene deletion can be utilised (Said et al., 2007;Starr et al., 2008;Gayen et 
al., 2010). Indeed, a strain of mice with mitochondrial dysfunction has been 
developed (Inoue et al., 2000). Because the mechanisms controlling pulmonary 
contractility and excitability are likely to be similar between the rodent and 
murine species (as my results suggest), the use of this and other genetically 
modified mice could help to answer a number of intriguing questions about exact 
mechanisms for the interactions between the KV channels and mitochondria. 
Although being a challenging task due to small artery sizes, the setting up the 
mouse model is probably most important to further advance my findings because 
of the availability of a variety of knock out mice. 
The identification of the exact signalling pathways involved in the pulmonary and 
mesenteric arterial contractions is another very important question in my opinion. 
However, the complexity and cross interactions between the potential mechanisms 
involved demand a separate focussed study that combines functional, biochemical 
and molecular biological techniques. In this type of study, in addition to the 
standard biochemical and molecular biological techniques (Western blot, RT-
PCR), a novel, specific and versatile molecular biological technique called the 
proximity ligation assay (Soderberg et al., 2006;Soderberg et al., 2007), can be 
useful in addressing the questions about the molecular composition of the KV and 
KCNQ channels that can be heteromultimeric (Zhong et al., 2010a). This 
approach will be also beneficial for the understanding of the mechanisms 
responsible for the differences in the maintenance of contraction in the pulmonary 
and systemic arteries (to investigate the proposed parallel and sequential 
hypotheses). 
2+ 
The use of the combined measurement of contraction, intracellular Ca and/or pH, 
as well as Po2 levels will also be important for further understanding of the 
mechanisms described in this thesis. Such combined approach is widely used to 
study vascular function (Waypa et al., 2002;Evans et al., 2005;Quayle et al., 
2006;Kajimoto et al., 2007). Unfortunately, the required equipments were not 
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